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Résumé en français 
Dans cette thèse, nous décrivons les résultats d’un projet de recherche visant à mesurer et 
évaluer la qualité des soins obstétricaux des hôpitaux de référence au Mali et au Sénégal. 
Dans ces pays, la mortalité maternelle hospitalière est élevée et est liée en partie à la 
pratique médicale inadéquate. Cette recherche a été réalisée dans le cadre de l’étude 
QUARITE, un essai randomisé en grappe évaluant l’efficacité du programme GESTA 
International visant à réduire la mortalité maternelle hospitalière. GESTA a été mis en 
œuvre entre 2008 et 2010 et consistait en la formation des professionnels de santé et en la 
revue des cas de décès maternels. En parallèle de QUARITE, les programmes de 
prévention de la transmission du VIH de la mère à l’enfant (PTME) ont été mis à l’échelle 
à travers les pays. Ces derniers ayant également la capacité d’augmenter la qualité des 
soins obstétricaux, nous avons donc évalué les effets des deux programmes (GESTA et 
PTME) sur la qualité des soins. 
Dans un premier temps, à l’aide d’une recension des écrits nous avons évalué la capacité 
d’un audit clinique basé sur des critères à mesurer la qualité des soins obstétricaux. Cet 
audit vérifiait si l’offre des soins avait respecté les critères cliniques définissant la 
meilleure prise en charge selon l’évidence scientifique et l’avis des experts. Nous avons 
démontré que cet outil est largement utilisé dans les pays à faibles et moyens revenus, 
malgré le peu d’évidence sur sa validité (article 1).  
Dans un deuxième temps, nous avons développé un audit clinique basé sur des critères qui 
s’applique au contexte ouest-africain et qui a été approuvé par des experts-obstétriciens 
nationaux et internationaux. À partir des dossiers obstétricaux, les actes médicaux posés 
pendant le travail et l’accouchement ont été évalués à l‘aide de cet instrument. La qualité 
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des soins a été estimée sous forme de pourcentage de critères atteints. Appliqué dans 
différents contextes et par différents auditeurs, nous avons démontré que notre instrument 
est fiable et valide (article 3). Néanmoins, l’expérience de l’audit nous a amenés à nous 
questionner sur le mauvais remplissage des dossiers médicaux et ses conséquences sur la 
qualité des soins (article 2).  
Dans un troisième temps, l’outil a été appliqué à large échelle pour évaluer les effets de 
l’intervention GESTA (article 4). Nous avons mené une révision de plus de 800 dossiers 
obstétricaux dans 32 hôpitaux de référence (16 bénéficiaires de l’intervention et 16 non-
bénéficiaires). Grâce à cet audit clinique, nous avons démontré que le programme GESTA 
contribue à l’amélioration de la qualité des soins, spécifiquement l’examen clinique lors 
de l’admission et le suivi après l’accouchement. 
Dernièrement, nous avons utilisé cet instrument afin d’évaluer les effets des programmes 
de PTME sur la qualité des soins obstétricaux (article 5). Notre travail a documenté que 
seulement certaines composantes du programme de PTME améliorent la qualité des soins 
telles que la formation des professionnels et les services complémentaires en nutrition. En 
conclusion, cette recherche a identifié plusieurs pistes d’intervention pour améliorer la 
qualité des soins obstétricaux en Afrique de l’Ouest. 
Mots clés : Services de santé, Santé maternelle et infantile, Qualité des soins, Prévention 
de la transmission du VIH de la mère à l’enfant, Développement d’un instrument de 
mesure, l’Afrique de l’ouest, épidémiologie 
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English Summary: 
In this thesis, we describe the results of a research project that aimed to measure and 
evaluate quality of care in referral hospitals in Mali and Senegal. In these countries, 
hospital maternal mortality is high and linked, in part, to inadequate medical practice. This 
research was conducted as part of the QUARITE cluster randomized trial that assessed 
whether the program, ALARM International, could reduce facility maternal mortality. 
ALARM was implemented from 2008 to 2010 and consisted of the training of local health 
professionals and the use of maternal death reviews. At the same time as QUARITE was 
ongoing, programs for the prevention of maternal to child transmission of HIV (PMTCT) 
were scaled- up; these can also improve obstetrical quality of care. Thus, we evaluated the 
effects of both programs (ALARM and PMTCT) on quality of care.  
We began with a systematic review of the literature to evaluate the capacity of a criterion-
based clinical audit to measure the quality of obstetrical care (article 1). This type of audit 
verifies if the care provided meets criteria indicative of best clinical practices, according to 
the literature and expert opinion. Our review demonstrates that this tool has been used in a 
variety of low- and middle-income settings, but the way it has previously been employed 
leaves doubts as to its validity (article 1).  
We thus developed a criterion based clinical audit specific to the West African context and 
approved by national and international expert obstetricians. Using patient medical records, 
with this instrument we evaluated obstetrical care provided during labour and delivery. 
Quality of care was calculated based on the percentage of care criteria met. Applied to 
different sites and by different auditors, our instrument demonstrated concordant results 
and provided a valid image of the quality of obstetrical care provided at hospitals in the 
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region (article 3). Nonetheless, the audit experience raised concerns about the implications 
of poor medical recordkeeping and archiving on quality of care (article 2). 
We used the criterion-based clinical audit to review over 800 medical records at 32 
QUARITE hospitals (16 intervention and 16 control hospitals) in order to evaluate the 
effects of the ALARM intervention. We demonstrated that the ALARM program 
contributes to better obstetrical quality of care, especially during the first clinical 
examination and postpartum monitoring of women treated at intervention hospitals  
(article 4).  
Finally, we used this instrument to evaluate the effects of PMTCT programs on obstetrical 
quality of care (article 5). Our work demonstrated that certain components of a PMTCT 
program, specifically training of healthcare professionals and supplementary nutritional 
services, are associated with better obstetrical care. In all, this research identified several 
mechanisms that can be targeted by quality improvement interventions in West Africa.  
Key Words: Health services, Maternal and child health, Quality of care, Prevention of 
mother to child transmission of HIV, Scale development, West Africa, Epidemiology 
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Prologue 
 
Imagine that today, two Boeing 747s crashed and that they were filled entirely with 
pregnant women. The public outcry would be deafening. While not by means of a downed 
airplane, this is, in reality, what happens every day. However, there is no public uproar. 
 
Today, over 800 women will die during childbirth and of childbirth related causes. These 
deaths will not, in their vast majority, occur in Canada, the United States or in Europe; but 
rather, they will occur in poorest regions of the world, especially in sub-Saharan Africa. 
Of today’s estimated 800 maternal deaths, 1 to 10 will occur in all industrialized countries 
combined. Even within the poorest communities, where nearly all maternal deaths occur, 
those most at risk of a maternal mortality are the poorest, most remote, and least educated 
women. In other words, vulnerability and maternal mortality go hand in hand. 
 
Maternal mortality is entirely preventable. We know what is needed to dramatically 
reduce it, but there are no magic bullets. Long-term, women’s status in societies around 
the world must be improved. There is an inverse relationship between gender 
empowerment and maternal mortality. More immediately, we need to improve health 
systems in low- and middle-income countries. Not every woman needs to give birth in a 
hospital, but she must have access to medical care should a life-threatening complication 
arise. This includes removing financial barriers, such as user-fees, to care. Not only must 
she have access to care, but that care must be high-quality. Obstetrical complications are 
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often, as their name implies, complicated and cannot be managed appropriately with 
poorly trained, poorly equipped, or poorly motivated staff. And therein resides the 
problem, health systems in low- and middle-income countries, particularly those in sub-
Saharan Africa, have been neglected, and by some accounts, actively dismantled for 
decades. They have been the victims of structural adjustment programs, poor governance 
and corruption, and ill-conceived income generating schemes (the Bamako Initiative). 
Health workers are frequently paid too little, overworked, poorly trained, and in some 
settings, disproportionate victims of the HIV/AIDS epidemic. 
 
Meaningful and sustainable reductions in maternal mortality will not occur in the absence 
of health systems transformations. Nor, in the long run, will lasting improvements happen 
without changes in how women are viewed and treated. At times the picture appears 
bleak, and in some cases it truly is (in Afghanistan, a combination of failing State 
infrastructure, gender discrimination, and war has made the country the most dangerous 
place to give birth in the world). Health system’s reform does not happen overnight and in 
addition to requiring a substantial influx of resources (from development dollars, taxation 
schemes, income generating activities, etc.); it also entails changes in value systems, 
particularly regarding women’s health. And yet, despite the challenges, there is promise 
on the horizon. 
 
Since 1990, global maternal mortality rates are believed to have declined by nearly half. 
Some of the most successful interventions work from within existing systems, to 
transform them from the inside out. Inspired by a regular practice in the United Kingdom, 
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maternal death enquiries and other forms of audit, draw maternity staff attention to the 
divergent causes behind maternal mortality and seek ways to improve care from within 
health facilities. Audits increase staff accountability and encourage creative solutions to 
the health system dysfunctions that contribute to maternal mortality.  
 
Health system transformation is not only occurring from the inside out. Since the 
launching the Millennium Development Goals, the international community has 
contributed an unprecedented amount to global health initiatives. Without question, 
HIV/AIDS has been the recipient of a lion’s share of this aid. However, as a result of 
significant criticism of the President’s Emergency Plan for AIDS Relief, which in its first 
phase provided 15 billion United States dollars to HIV/AIDS prevention and treatment, 
many donors are now focusing on the strengthening of health systems. Programs are 
attempting to link HIV/AIDS funding with other priorities, such as maternal and child 
health. It is widely believed that if HIV/AIDS funding can be used to successfully 
strengthen health systems, maternal mortality rates will decline. 
 
In this thesis, we explore how inside-out (audits) and outside-in (HIV-funding) programs 
affect maternal mortality at hospitals in two of the poorest countries of the world- Mali 
and Senegal. In this work, we are interested in the mechanisms, particularly around quality 
of care, by which health systems drive maternal mortality. By identifying these 
mechanisms, we hope to make programmatic recommendations that can lead to evidence-
based decisions on how to improve maternity care.
 
 
Chapter 1- Introduction 
 
1.1 Maternal Mortality in sub-Saharan Africa 
Each year, an estimated 8 million women worldwide suffer complications related to 
pregnancy and birth (1). Of these, 300 000 die (2). For every woman who dies, another 30 
endure chronic stigmatizing morbidities, such as obstetric fistula, which can entail 
incontinence, nerve damage, infection, and kidney failure (1, 3). In many countries, 
maternal mortality is the leading cause of death for women of reproductive age (4) and is 
“almost inevitably, a double tragedy,” as it is also an important cause of infant mortality (5 
p642, 6).  
 
The highest levels of maternal mortality in the world are in sub-Saharan Africa and some 
of the highest of these can be found in West Africa (7). For example, a Malian woman has 
a one in 28 chance of succumbing to a maternal death; a Senegalese woman has one in 54 
chance of maternal death. In comparison, the average lifetime chance in a high-income 
country, such as Canada, is one in 5200 (see table 1 for comparative indicators of maternal 
and perinatal mortality) (2). Of all the human development indicators frequently used, 
maternal mortality exhibits the widest gap between high- and low-income countries; the 
rate of maternal mortality in low-income countries is 100 times higher than in high-
income countries (8, 9). However, maternal mortality is largely avoidable (10) and the fact 
that countries, such as Canada, can achieve such low levels of maternal mortality is 
indicative that these levels are possible elsewhere. 
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Five direct obstetrical complications- haemorrhage, obstructed labour, eclampsia, sepsis, 
and complications from unsafe abortion- are responsible for the majority of global 
maternal deaths. An estimated 15 percent of pregnancies will result in obstetrical 
complications. Consequently, all pregnancies must be considered at risk (1). All of these 
complications can be treated by a skilled health worker (i.e. a medically qualified provider 
with midwifery skills) working in an environment capable of providing care for normal 
deliveries and complications (1). Indirect complications, especially HIV/AIDS and 
malaria, are increasingly contributing to maternal mortality in sub-Saharan Africa (1), but 
recent, dramatic increases in access to antiretroviral treatment for HIV/AIDS has 
substantially reduced the impact of the virus on maternal mortality (2).  
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Table 1: Select maternal and perinatal indicators (and corresponding definitions) for 
Senegal, Mali, and Canada  
Country  Fertility 
rate (11-
13) 
Maternal 
mortality 
ratio (2) 
(per 100 000) 
Lifetime 
risk of 
maternal 
death (2) 
Neonatal 
mortality 
ratio (14) 
(per 1000) 
Perinatal 
mortality 
ratio (14) 
(per 1000) 
Mali 7 540 1 / 28 54 50 
Senegal  5 370 1 / 54 35 59 
Canada 2 12 1 / 5200 3 6 
 
Definitions  
1) Fertility rate- The number of children that would be born to a woman if she were to 
live to the end of her childbearing years and bear children in accordance with current 
age-specific fertility rates (13) 
2) Maternal mortality- The death of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the duration and site of the pregnancy, from 
any cause related to or aggravated by the pregnancy or its management, but not from 
accidental or incidental causes (7).  
3) Neonatal mortality- The cumulative mortality rate of live-born infants within 28 
days of life (15).  
4) Perinatal mortality- Total number of late foetal deaths (28 or more weeks of 
gestation) plus postnatal deaths (first week of life) over the total number of live births 
per year (15).  
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1.2 Early Childhood Mortality in sub-Saharan Africa 
In 2010, eight million children under the age of five were estimated to have died (16). 
Almost all of these deaths occurred in low-income countries or in the poor communities of 
middle-income countries. As of 2000, rates of child survival in sub-Saharan Africa had not 
yet reached those of the USA in 1950 (17). Most children die of treatable childhood 
diseases, preventable health problems during the neonatal period, or because of inadequate 
care of mothers during pregnancy and childbirth (18). Estimates for Western and Central 
Africa calculate under-five mortality at 143 per 1000 live births and neonatal mortality at 
39 per 1000 live births. In other words, neonatal morality accounts for more than a quarter 
of childhood deaths in the region (16). Over half of neonatal deaths are due to birth 
asphyxia and neonatal sepsis (19); both are avoidable complications with quality 
obstetrical care during labour, delivery, and the immediate postpartum period. 
 
Stillbirths, which are not included in estimates of neonatal mortality, are also unduly 
elevated in low-income settings. The WHO defines stillbirth as a late fetal loss beyond 28 
weeks, or if gestational age is unknown, loss of a fetus greater than 1000 grams (20). In 
2009, there were an estimated 2.6 million stillbirth around the globe (range 2.1 to 3.8 
million) (21). Data on stillbirth are highly unreliable and some believe that reported rates 
may underestimate the global number by half (22). 
 
Population-based studies have shown that stillbirths account for greater than 60 percent of 
all perinatal deaths in West Africa (23). The types of stillbirth that occur in low-income 
settings differ from those that occur in high-income settings. In places like Canada, 
stillbirths that occur shortly before birth (intrapartum stillbirths) comprise less than ten 
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percent of all stillbirths. In low-income countries, such as Mali and Senegal, intrapartum 
deaths comprise up to 50 percent or more of stillbirths (22). Intrapartum stillbirth is an 
especially sensitive indicator of quality of care (24) and elevated levels are particularly 
suggestive of poor access to and quality of care. 
 
Most cases of stillbirth and early neonatal mortality can be avoided with better 
management of the mother during labour and delivery (14). Stillbirth and maternal 
mortality are strongly correlated; both decline with improved access to caesarean section 
and skilled attendance
1
 at birth (25). For both stillbirth and maternal mortality, the 
immediate cause of death is often the same: complications during childbirth (22). Thus, it 
can be expected that reductions in maternal mortality will also lead to reduction in under-
five mortality due to fewer stillbirths and early neonatal deaths. 
 
1.3 Millennium Development Goals  
Maternal mortality has moved to the international spotlight through its inclusion in the 
United Nation’s Millennium Development Goals. By 2015, the international community 
aims to reduce by three quarters the maternal mortality ratio. Child mortality is also 
included among these goals; by the same date, the aim is to reduce under-five mortality by 
two-thirds (26). The latest estimates show that substantial progress has been made in 
reducing child mortality with 106 countries showing accelerated declines in child 
mortality between 2000 and 2010 compared to 1990-2000. Thirty-one countries are on 
                                                          
1
 Skilled attendance refers to a medically qualified provider working in an enabling environment or health 
system that can provide care for normal and complicated deliveries. WHO defines a skilled attendant as “an 
accredited health professional – such as a midwife, doctor or nurse – who has been educated and trained to 
proficiency in the skills needed to manage normal (uncomplicated) pregnancies, childbirth and the 
immediate postnatal period, and in the identification, management and referral of complications in women 
and newborns” (31).   
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track to achieve a two-thirds reduction in child mortality (27). A similar accelerating trend 
has not been shown for maternal mortality with only 13 countries on track to achieve the 
Millennium Development Goal (27). Achieving the health outcomes targeted by the 
Millennium Development Goals will not be possible without major improvements to 
health systems (28).  
 
 
Chapter 2- Review of the Literature 
 
2.1 Determinants of Maternal Mortality 
The major determinants of maternal mortality have been well-described starting with 
McCarthy and Maine’s (1992) A framework for analyzing the determinants of maternal 
mortality (4). In their framework, distal determinants such as socioeconomic and cultural 
factors influence intermediate determinants such as health and reproductive status, access 
to health services, and healthcare utilization. These, in turn, influence whether a woman 
will become pregnant, the likelihood of an obstetrical complication during pregnancy, and 
finally of death or disability due to pregnancy and/or birth (4). 
 
Distal determinants: Socioeconomic and gender inequities  
Maternal mortality is a sensitive indicator of inequality and social development (29). In 
societies where the status of women is low, women start having children too soon, have 
too many children, end childbearing too late and give birth at intervals too close together 
(30). The poorer the socioeconomic conditions within which women live, and the more 
gender-related inequalities they experience, the more vulnerable they are to the risks of 
childbirth. For example, anemia is an important indirect cause of maternal mortality and 
frequently a result of malnutrition. Where women are viewed as inferior to men, they may 
consume smaller amounts of food, as well as less protein and iron-rich foods than men 
(29). 
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At the country level, there is a strong correlation between Human Development and 
Gender-Related Development Indices (HDI and GDI, respectively)
2
 and maternal 
mortality. In analyses of 148 countries, HDI and GDI were negatively correlated with 
maternal mortality and could explain 83 and 81 percent of the variance in national 
maternal mortality estimates (31). Measures of female education were moderately 
correlated with national maternal mortality rates and could explain 50 percent of the 
variance in these rates (31). The lower a country ranked in terms of HDI, GDI, and female 
education, the higher the expected rate of maternal mortality. Other cross-national 
analyses have shown that women’s level of education relative to men, the presence of 
attendants at birth, contraceptive prevalence, age of first marriage, and total fertility are all 
important predictors of maternal mortality at the national level (29).  
 
At the individual level of analysis, the relationship between socioeconomic status and 
maternal mortality has been more difficult to detect. In general, it is assumed that maternal 
mortality is most elevated among the poorest, especially in view of the high cost of 
treatment for obstetrical complications (32). However, there are historical contradictions 
to this relationship. In the early 1900s in the United Kingdom, maternal mortality was 
highest among the richest classes. However, this is believed to have been due to the 
greater use of unhygienic obstetrical interventions by the more wealthy, who could afford 
to give birth with a doctor, when compared to low-income classes who relied mostly on 
midwives and less technology (33). More recent evidence supports the assumption that 
poverty is associated with maternal mortality. Using data from Indonesia, Graham and 
colleagues (2004) showed that maternal mortality is substantially more elevated in the 
                                                          
2
 These are composite indices developed by the United Nations Development Programme. 
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poorest quintile of the population compared to the richest quintile; in fact, the relative risk 
of maternal death in women from the poorest quintile was three- to four-fold higher than 
the risk in women from the richest quintile. In addition, using data from 11 low-income 
countries, they also showed that women who died of maternal causes were more likely to 
have had no education and poorer living conditions than women who were still alive (32). 
 
It is likely that countries with poor HDI and GDI rankings will have less healthy 
populations who are in turn, at greater risk of developing obstetrical complications. HDI 
and GDI capture collective attributes of an entire society that can be interpreted as social 
determinants of maternal mortality. Because they are collective attributes, they vary little 
within a given society. Consequently, poor index rankings would be associated with 
higher absolute numbers of women succumbing to complications, but would not affect the 
relative risk of complication for individuals. Gender inequities, should also be considered 
as social determinants of maternal mortality (34) and like HDI and GDI, would affect the 
absolute numbers of maternal deaths but not individual risk. Interventions seeking to 
modify these determinants of maternal mortality would have to alter societal norms; such 
interventions frequently require changes in national policy (35, 36). While the effect of 
poverty on the individual risk of maternal mortality is more easily detectible within a 
given society, interventions combating poverty in low-income setting also frequently 
require policy changes
3
. 
 
                                                          
3
 Both Mali and Senegal have recognised the role of poverty on maternal mortality. In the chapter four, we 
discuss national policies in both countries which attempt to remove financial barriers to delivery care. In 
Senegal, the national policy particularly targets the poorest regions of the country. Both of these policies aim 
to reduce maternal mortality. 
10 
 
Intermediate determinants: Reproductive status and access to health services 
In following with McCarthy and Maine’s framework, distal determinants such as 
socioeconomic status, influence reproductive health and access to health services. For 
example, with greater access to education, employment, and contraception, women tend to 
have fewer children. Further, in societies where women have greater social status, they 
start childbearing at a later age than in societies where the status of women is low. 
Teenage marriage, where frequent, is an indicator of the low status of women in society 
(29). Consequently, public health interventions can target up to three reproductive health 
outcomes:  
1. Pregnancy 
2. Development of obstetrical complications 
3. Death due to complication  
 
Interventions aimed at the first target endeavour to reduce the number of pregnancies 
through the widespread uptake of family planning practices (4). However, family planning 
does not affect a woman’s risk of dying once she becomes pregnant (37). Thus, while the 
prevention of unwanted pregnancies will reduce the absolute number of maternal deaths, it 
does not affect the relative risk in those who do become pregnant. Further, the uptake of 
family planning methods is strongly dependent on the availability and acceptability of 
such methods. In many patriarchal societies, men do not allow women to practice family 
planning (29). Thus, a woman’s status in society will influence her ability to avoid 
unwanted pregnancies. 
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In continuing with the framework, the next target is a reduction in the number of 
complications due to pregnancy. Unfortunately, most obstetrical complications cannot be 
predicted during antenatal care (38-40) and most maternal deaths occur in women at low 
risk of complication
4
 (4, 41). While few obstetrical complications can be predicted or 
prevented, the majority can be treated by sufficiently trained personnel employing a few 
well-known technologies that make up a package known as Emergency Obstetrical Care 
(EmOC) (42, 43).  
 
Internationally, there is a strong inverse association between the utilisation of delivery 
care services and maternal mortality. The WHO estimates that over 90 percent of maternal 
deaths could be avoided if women had access to adequate reproductive health services 
(44). Timing is key, nearly all maternal deaths can be averted with rapid treatment of 
obstetrical complications (41). In the case of a complication such as post-partum 
haemorrhage, in the absence of EmOC, the estimated modal time to death is two hours 
(45). Clearly, when women deliver at functional health facilities, there are fewer 
opportunities for life-threatening delays.  
 
Proximal determinants: Three delays model 
In their seminal article, Thaddeus and Maine (1994) described three delays that contribute 
to maternal mortality: Delays in seeking emergency care, transportation delays, and delays 
                                                          
4
 These studies look at individual predictors of complication such as age and previous caesarean section. A 
distinction should be made between individual and societal predictors. For example, in a society where a 
large proportion of the female population is malnourished, one would expect that absolute levels of 
complications would be greater. That is, the risk distribution for complications would shift (more of the 
population is at risk) while the individual risk factors remain the same. In other words, it is possible that an 
entire population of women can be at greater risk of complication and maternal mortality.  
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in receiving EmOC from health professionals (41). Access to healthcare is thus a driving 
force in maternal mortality. That is, delays can occur because women must wait for their 
husbands or mothers-in-law to give them permission to seek care (46, 47); physical 
barriers such as poor roads or heavy rains may impede transport (48, 49); transportation 
may not be available or health centres too far away (46, 48, 50); a woman and her family 
may have insufficient resources to pay for transportation and/or care for the complication 
(46); and sufficiently trained healthcare providers may not be available nearby (41, 50).  
 
Access, however, is but one component of health service utilisation. Health services may 
be sufficiently accessible, but women and/or their families may choose not to use them. 
To some extent, cultural preferences may impede health service utilisation; however, this 
is not an insurmountable barrier as services can be adapted to be more culturally 
appropriate (51). Education also influences health service utilisation. Low-educated 
women consistently under-utilise maternal health services which may reflect access issues 
(autonomy and decision-making power) as well as attitudes towards health or even 
Western medicine (44). Additionally, women and their families may avoid health facilities 
because they do not trust the healthcare system (52). That is, they perceive the system to 
be so poor or dangerous that they feel safer giving birth at home. There is some evidence 
that quality of care is considered before the cost of services suggesting the perceived 
quality may be instrumental in driving utilisation patterns (41).  
 
Once a woman becomes pregnant, she can avoid maternal death due to obstetrical 
complication through adequate and timely medical care. This means encouraging health 
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service utilisation during pregnancy and birth in order to reduce delays associated with 
recognizing and receiving care for obstetrical complications (41, 53). As a result, the 
United Nations has set a benchmark of 90 percent for the proportion of women giving 
birth with a skilled birth attendant by 2015 (54). With a quarter to a half of women giving 
birth with a skilled attendant (12, 55), both Mali and Senegal are far from achieving this 
benchmark. Even if these benchmarks are achieved, the coverage rate for skilled 
attendance at birth does not provide any information about what activities were carried out 
between the mother and the provider, nor if the care provided by the attendant was 
acceptable and adequate (56). 
 
2.2 Importance of Good Quality Obstetrical of Care 
Maternal mortality is highly sensitive to standards of obstetric care. Historically, hospital 
births were associated with horrific levels of maternal mortality because of poor 
obstetrical practice; women, no matter what their social class, were much safer giving 
birth at home (33). Presently, the majority of evidenced-based strategies advocate that 
women routinely deliver in health facilities under the watchful supervision of a skilled 
attendant (57). As a result, international efforts have focused primarily on augmenting the 
quantity of services offered, and less on the quality of these services (58). Yet, ensuring 
high quality of care is essential to reducing maternal mortality and to re-enforcing 
women’s confidence in the health system (59). Maternal mortality cannot be drastically 
reduced without efforts to improve service delivery, including medical practices (60).  
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Giving birth has been described as war by certain anthropologists working in the West 
African milieu (61). Numerous researchers from Lasdel, an influential social studies 
research institution in West Africa, have documented gross deficiencies in the quality of 
care provided to women during childbirth (61-64). The obstetrical literature has also 
described insufficiencies in health personnel training (61), poor infection control and 
irrational medication use (56), life-threatening delays in providing emergency surgery 
(65), shortages of basic obstetrical equipment (61), and dramatic, even violent interactions 
between care givers and parturients (66, 67).  
 
There is limited quantitative work describing the role of quality of care on maternal 
mortality
5
. Many agree that quality is a concern and are descriptive of the problem (56, 
68-70), but few have quantified its contribution to the problem. However, one study of 
multiple sites in West Africa demonstrated that up to 70 percent of facility-based maternal 
deaths could have been avoided with improved quality of care (71) while another in 
Kayes, Mali, concluded that half of recorded maternal deaths were due in part, or entirely 
to, poor quality care (72). Thus, while quantitative evidence on the subject is scarce, what 
does exist strongly suggests that a focus on improving the quality of obstetrical care 
should be a priority for reducing maternal mortality.  
 
Given that obstetrical care is often shockingly sub-standard, it is no wonder that only 
about half or fewer of women in Mali and Senegal give birth within a health facility. The 
perception by women and their families that quality of care is poor influences decision-
                                                          
5
 To a lesser extent, the same is true for related indicators such as maternal morbidity, perinatal and neonatal 
mortality, and process-indicators such as skilled attendance rates. 
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making and may mitigate against the seeking of timely care (73, 74) Yet, this does not 
mean that these women have never been in contact with the health system; 70 (Mali) to 90 
percent (Senegal) of women have at least one prenatal exam (11, 12). Why these women 
do not return to the health facility to give birth is unknown and suggestive of flaws in the 
manner in which maternal health care is provided in West Africa.  
 
In summary, there is a growing body of evidence to suggest that poor quality of care 
contributes to maternal mortality in West Africa. However, to date, we have little 
indication of the amplitude of the quality problem or which aspects of care to target. One 
of the reasons for this knowledge gap is the difficulty inherent to measuring the quality of 
obstetrical practice (described in the paragraphs to follow). 
 
2.3 Quality of Care- A difficult concept to measure 
According to Donabedian (1966), quality of care can be conceptualized and measured on 
three levels: structure, process, and outcome. Structure is concerned with the adequacy of 
facilities and equipment, the qualifications of medical staff, the administrative structure 
and operation of programs, fiscal organisation, etc. The assumption is that given an 
adequate setting and equipment, quality medical care will follow. Process considers the 
appropriateness and completeness of information obtained through clinical history, 
physical examination and diagnostic tests; the evidence of preventive management; 
coordination of the continuity of care; the acceptability of care to the recipient; etc. The 
assumption is that without proper medical procedures, good health outcomes will not be 
achievable. Finally, patient outcomes can be used globally to indicate good and bad 
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quality of care and can be used to assess changes in the quality of care (75). Of the three, 
process is the most difficult to measure and there are significant gaps in the literature on 
how to define, assess, and improve the quality of obstetric care at the point of service 
delivery, particularly in developing countries (76). However, it may be the best indicator 
for determining whether medicine is being practiced properly (75). 
 
There are several methods for measuring medical practice: standardized patients, direct 
observation, vignettes, and chart abstraction. Standardized patients require a trained actor 
to engage medical professionals in a clinical examination related to a topic of research 
interest. For obvious reasons, it is impossible for an actor to convincingly recreate the 
birth process. It is also possible to measure quality of care through direct observation, but 
this method is subjective and risks the Hawthorne effect. Finally, there are vignettes and 
chart abstraction. Vignettes are written scenarios involving a fictitious patient (77). Work 
in high-income countries show that vignettes have promising measurement properties 
(78), but there are limitations: they measure individual provider knowledge versus team 
practice, no validation studies have been conducted in low-income countries, and current 
tools target physicians versus midwives or other lower-cadre staff. 
 
Chart abstraction is a general term for when researchers retrieve predefined information 
from patient medical records and compare that information against agreed-upon standards 
of care. A criterion-based clinical audit (CBCA) is a specific type of chart abstraction that 
can be effectuated by non-medically qualified audit assistants. Assistants screen the 
medical records of patients and extract relevant data. Standardized criteria for evaluating 
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good quality care are predetermined and then compared against extracted data to evaluate 
whether or not a minimal standard of care has been met [5, 14]. CBCA are gaining 
traction in the domain of obstetrical care in resource-limited settings, as they can dually 
serve to measure and improve care [5, 14-22]. For epidemiologists, CBCA are particularly 
interesting because they can provide a quantitative measure of quality of care which, 
hence far, is largely lacking from the literature. However, as will be expanded upon later, 
despite the promise of CBCA, very little work has attempted to evaluate whether this is a 
valid tool to measure obstetrical quality of care. Thus, research on maternal mortality has 
reached a significant obstacle. We suspect strongly that poor quality of care is contributing 
to high rates of maternal mortality in low-income setting such as Mali and Senegal, but we 
are unable to successfully measure care in order to ascertain where the gaps are. 
 
2.4 Maternal death reviews- promising method to improve quality of care 
Despite concerns about measurement, there are promising interventions for improving 
quality of care. One of these interventions consists of a form of clinical audit known as a 
maternal death review (MDR) (79). Defined as, “a qualitative, in-depth investigation of the 
causes and circumstances surrounding maternal deaths occurring at health facilities,” (79 
p4) MDR target the process component of quality of care. They help professionals to 
identify avoidable factors associated with deaths occurring in their facilities, develop 
mechanisms for improvements in care, promote teamwork, and increase the skills, 
motivation and accountability of health workers (79). To date, evidence from a pilot study 
in Senegal suggests that MDR can reduce in-hospital maternal mortality by as much as 50 
percent (80).  
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MDR can be seen as a qualitative instrument for quality improvement. They are highly 
context specific and focus on singular events (e.g., maternal deaths). As such, they can 
provide clues about deficiencies in the care process, but because they are not standardized, 
nor quantitative, results from MDR cannot be compared across sites and the amplitude of 
quality of problem is unknowable. Further, they measure the circumstances around 
maternal deaths and therefore may provide a biased picture of general maternity care. 
Finally, the mechanism between MDR and lower hospital maternal mortality rates, while 
most likely due to quality of care improvements, may be due to other factors such as 
improved provider satisfaction or better teamwork. Without a precise measure of quality 
of care, it is difficult to understand how MDRs work and their contributions to quality 
improvement, if any. 
 
2.5 Health systems contribute to poor quality care 
In sub-Saharan Africa, a substantial reduction in maternal mortality cannot occur in the 
absence of improvements to health systems (81-83). All success stories in maternal 
mortality have occurred in the presence of health systems’ strengthening (84). The sad 
truth is that those countries with high-mortality rates are, without exception, those 
countries with, “failing, grossly deficient, often inequitable healthcare systems that have 
been unable to provide the interventions necessary to save women’s lives” (81 p100). In 
these settings, health structures are incapable of handling even basic obstetrical 
complications, quality of care is often doubtful and transportation, treatment, and services 
are unaffordable. 
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The scientific consensus is that to reduce maternal mortality, emergency obstetrical care 
and assisted delivery are necessary (10, 42, 57, 85). Both require functional health systems 
that are capable of providing: referrals to higher-up facilities when emergencies ensue; 
basic materials and equipment including forceps, vacuums, oxytocin, anticonvulsants, and 
antibiotics among others; and functioning surgical theatres with a safe supply of blood for 
transfusions (42, 86, 87). These basic services and materials enable and support quality 
obstetrical care, but are frequently lacking from health facilities in sub-Saharan Africa 
(88). 
 
While there is consensus about the strategies necessary to reduce maternal mortality, there 
has been a general neglect of the human resources needed to implement these services 
(88). There is a positive correlation between the availability of skilled health professionals 
and maternal and neonatal health outcomes. Most sub-Saharan African countries face 
critical shortages of doctors, nurses, and midwives. These shortages are further 
exasperated by a misdistribution of human resources favouring urban, especially capital 
settings (89). Augmenting the supply of healthcare professionals, however, is not 
sufficient; these professionals must be adequately trained and then apply that training 
appropriately. The scale-up of healthcare professionals for maternal and child health has 
frequently occurred in the absence of attention to these professionals’ skills. For example, 
there has been insufficient investment in midwifery training, deployment and supervision, 
as well as inadequate regulations and policies to support and protect midwives in their 
practice (88).  
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The case of midwifery training and skills deserves special attention, as midwives are the 
primary providers of maternity care in West African hospitals (90). Investing in a 
specialist cadre of midwives has been shown to make a difference in reducing maternal 
mortality in many countries (88). However, too little attention has been paid to the 
proficiency of midwives in basic emergency obstetrical and neonatal care. This is partially 
due to a lack of understanding and/or appreciation of what a professional midwife can 
offer, historical prioritization of physician skills, and misguided beliefs on the part of 
international donors that midwifery care could be provided by volunteers with limited 
training (e.g., traditional birth attendants) (88). In many low-income settings, investing in 
midwives has been challenging because it is primarily a female profession and midwives 
are regarded as doing “women’s work.” Midwives suffer the same gender-related 
inequalities of other women and the result has been gross underinvestment in the building 
and maintaining of a professional cadre of midwives in many low-income settings (88).  
 
Deficient health systems do not simply affect the quantity of services and human resources 
that are available, but also organisation and motivation of healthcare professions. Many 
hospitals throughout sub-Saharan Africa adhere to an out-dated hierarchical model 
wherein midwives and other mid-level workers are seen as subservient to physician (88). 
Obstetrical complications require a team of medical staff and the current organisational 
model found throughout most of the continent undermines collaboration and teamwork, 
resulting in dysfunctional health services. Health services may also be undermined by the 
content and allocation of continuing education programs. Opportunities for continuing 
education frequently align with priority programmes, which are dictated by international 
donors, and may or may not represent the actual training needs of an individual or hospital 
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(91). Training opportunities tend to be motivating for health staff, but some have 
questioned whether the motivating factor is per diems or the opportunity to build 
professional skills (91, 92). Irrespective, the training programs offered by multiple priority 
programs lead to frequent staff absences at places where human resources are already in 
short supply (93). 
 
Poor working conditions and overwhelming workloads have resulted in a high level of 
occupational burn-out among maternity staff, particularly of midwives (88, 90). In 
Senegal, it is estimated that over half of midwives working in the public sector have 
burnout, with 80 percent combating emotional exhaustion and 60 percent experiencing 
depersonalization (90). Concerns about burnout in sub-Saharan Africa have been 
exasperated by the HIV/AIDS epidemic. Up until the advent of antiretroviral treatment for 
HIV/AIDS, half of all hospital beds in sub-Saharan Africa were occupied by people with 
AIDS. The presence of such a large number of patients with poor outlooks, insufficient 
staff to treat these patients, and a lack of basic materials to protect medical staff from 
infection, has caused high levels of work-related stress, elevated rates of depression, post-
traumatic stress, and burnout, as well as emigration to better resourced settings (94, 95). 
All of these factors - deficient infrastructure, human resource shortages, outdated 
hierarchies, and poorly motivated staff - contribute to weak health systems and poor 
quality of care. 
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2.6 HIV/AIDS funding may strengthen health systems 
Recent years have seen unprecedented inputs into global health, largely because of 
initiatives such as the President Bush’s emergency plan for AIDS relief (PEPFAR), the 
Global Fund, and the Bill and Melinda Gates Foundation; most of this support is for 
HIV/AIDS. There has been a dramatic increase in HIV/AIDS funding in the past 15 years 
from US$250 million in 1996 to US$14 billion in 2008. Moreover, mobilisation for 
HIV/AIDS has increased available resources for other important international health 
priorities, specifically malaria and tuberculosis. This is largely because of fundraising 
from the Global Fund (96).  
 
Funding for maternal, newborn, and child health programs has been highly variable in the 
past decade. When this research project was conceived, funding for these programs 
represented only a tiny proportion of the international aid budget, about two percent of 
gross aid disbursements to developing countries (6, 97). In an analysis of donor trends 
conducted by Countdown to 2015, of the approximately US$1.9 billion for all maternal, 
neonatal, and child health services in 2003 and 2004, the proportion allocated for maternal 
health fell from about a third to one quarter (98). The most recent analysis from 
Countdown to 2015 indicates substantial improvements by the international community in 
regards to maternal, neonatal, and child health funding. Official development aid estimates 
for 2007 calculate that 31 percent of assistance for health went to this sector. It was not 
specified how much went to maternal health (99). 
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At the 2006 International AIDS Conference, former US president Bill Clinton suggested 
that well-financed and staffed HIV/AIDS programs could be used as a platform for 
improving other health initiatives including maternal and child health (100). The premise 
behind this statement is that the substantial funds behind HIV/AIDS contribute to the 
strengthening of health systems. In fact, the Global Fund and PEPFAR have each 
contributed US$4 billion to health systems including support for human resources, 
infrastructure and equipment, and monitoring and evaluation (96). More specifically, 
HIV/AIDS programs may improve health systems by constructing health facilities and/or 
renovating existing ones; reinvigorating primary health care; improving the reliability of 
supply chains (e.g., essential drugs, laboratory reagents, etc.); increasing the availability of 
well-trained health professionals; strengthening links and referrals between HIV/AIDS 
programs and other health services; and augmenting demand for care (94, 96, 101, 102).  
 
These beneficial changes to health service provision have been linked to improvements in 
maternal and child health. For example, AIDS treatment programs in Uganda have been 
associated with declines in infant mortality in HIV-negative children (103). In Rwanda, 
massive scale-up of HIV/AIDS programs has been associated with increased utilisation of 
reproductive health services (101). While some evidence suggests that HIV/AIDS 
programs may improve health services for mothers (104), little research has quantitatively 
explored the mechanisms underpinning these improvements. We do not know what 
specific components of HIV/AIDS programs may have been associated with spillover, or 
how. 
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2.7 Prevention of Mother to Child Transmission of HIV and quality of care 
Of the many HIV/AIDS programs presently being scaled-up in sub-Saharan Africa, 
prevention of mother to child transmission of HIV (PMTCT) programs are most likely to 
directly influence obstetrical quality of care. PMTCT programs are difficult to 
characterize because they differ dramatically from one context to the next (see appendix 1 
for a list of possible PMTCT components and activities). The most basic programs 
provide a single-dose of the antiretroviral nevirapine to HIV-positive women and their 
newborns. These programs can reduce HIV transmission by as much as 50 percent (105). 
Other programs, such as many financed by the Global Fund, are more comprehensive. At 
the beginning of this research project, the Global Fund PMTCT program in Mali provided 
antiretroviral drugs according to national guidelines; trained health personnel with a 
minimum two-week specialised PMTCT course; equipped hospitals with rapid testing 
reagents and supplementary supplies for HIV testing (e.g., syringes); allocated adequate 
staff and supervision to the program; and put aside time for counselling and support of 
women and their families (106)
6
. Other programs, known as PMTCT Plus are even more 
expansive. In addition to antiretroviral therapy to pregnant mothers, PMTCT Plus 
programs provide HIV-related primary health care services including: opportunistic 
infection prophylaxis, screening and treatment of other diseases such as tuberculosis, 
nutritional and psychological support, adherence counselling, and clinical and laboratory 
monitoring. For HIV-exposed infants, PMTCT programs also include clinical and 
virological monitoring and assessments of growth and developmental status (107). 
PMTCT programs, specifically those with combination therapy, counselling on infant 
feeding strategies, and laboratory monitoring can bring mother to child transmission of 
                                                          
6
 It should be noted that official documents state that the Global Fund PMTCT programs contained each of 
these components, but frequently, the full program was not implemented. For example, based on our 
interviews of staff, few attended a full two-week training course.  
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HIV to below five percent in resource-limited settings, compared to 25 to 48 percent 
without treatment (105, 108). 
 
PMTCT is one of the few consistently successful HIV prevention programs and is thus 
prioritized in the arsenal to combat global HIV/AIDS (109). The United States alone 
provides approximately 300 million $US annually to PMTCT (110). Scale-up of PTMCT 
programs has been extraordinarily rapid with coverage of the program more than doubling 
in three years, from 14 in 2005 to 33 percent in 2007 (96). To successfully scale-up 
PMTCT, international donors typically support capacity-building activities that require 
significant resource inputs. For example, many PMTCT programs provide continuing 
education programs to maternity staff, bring with them resources such as medications, 
gloves, and needles, as well as renovate maternity, laboratory and pharmaceutical 
infrastructures. These inputs may lead to overall health facility improvements. For 
example, Delvaux
 
et al. (2008) provided evidence from Côte d’Ivoire suggesting that 
PMTCT programs improve the quality of antenatal and delivery services used by both 
HIV-positive and negative women (104). On the other hand, PMTCT programs may have 
a negative impact of maternal health care, by through increased workload, burnout, and 
reduced availability of other services (111, 112). Empirical evidence of the effect of 
PMTCT programmes on maternal health is scarce and more research is badly needed 
(113). For example, given the wide variety of PMTCT programs found in resource-limited 
settings, it is likely that the potential benefits of the program depend on the components and 
level of implementation of the program and not merely on its presence or absence. 
 
26 
 
2.8 Dissociating the effects of different initiatives on quality of care 
At the same time that massive HIV/AIDS scale-up was occurring (2006 to present), 
several important initiatives directly targeting maternity care were also launched. Some of 
these initiatives include: the QUARITE trial in Mali and Senegal which assessed whether 
MDRs and training in evidence-based practices could improve obstetrical quality of care 
and reduce maternal mortality (114); the Audobem trial in Niger, Burkina Faso and Benin 
which assessed if two types of facility-based audit (CBCA and MDR) could improve 
obstetrical quality of care, reduce delays in accessing emergency obstetrical care, and 
lower perinatal mortality (trial registration number: ISRCTN67206260); and the 
MaiMwana Project in rural Malawi which tested two community-based interventions 
aimed at improving health care and reducing maternal and infant mortality (115). 
Evidence demonstrating a link between HIV/AIDS programs and other health outcomes 
has insufficiently attempted to dissociate the effects of concomitant programs. Thus, it is 
possible that previously observed associations between HIV/AIDS programs and maternal 
and child health are partially or entirely due to the effects of other initiatives. Or, it is 
possible that there could be interaction between programs, leading to greater 
improvements in quality of care than would be expected of either program alone.  
 
The possibility of interaction between maternal mortality reduction and HIV prevention 
programs has led to a recent wave of literature arguing for joint interventions targeting 
both problems (109, 116-122), particularly as such joint interventions could reduce the 
duplication of efforts and competition for scarce resources (116, 122, 123). Nevertheless, 
the feasibility and impact of integrating services has not yet been rigorously evaluated 
(124). The decision of when and which services to integrate, and to whom, must be based 
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on epidemiological data on the effects of joint programs, identified need for prevention 
and treatment services, and on resource availability (119). 
 
2.9 Summary of literature review 
We can reduce maternal mortality by assuring that women give birth with a qualified 
attendant, within a functioning health facility providing quality care (43, 57). The 
literature demonstrates that neither can be assured in the West Africa context and this 
translates into poor quality of care and poor maternal health outcomes. One promising 
intervention, MDR, may reduce in-hospital maternal mortality by as much as 50 percent, 
but because of gaps in our knowledge of how to measure obstetrical quality of care, the 
hypothesized mechanism driving MDR- improved quality of care- has yet to be 
demonstrated. Nonetheless, two large-scale trials
7
 in sub-Saharan Africa have included 
MDR in their interventions to reduce maternal mortality. In parallel, while these trials 
were ongoing, there was substantial concurrent mobilization of funding and scale-up of 
programmes in the fight against HIV/AIDS. This has translated into enormous 
investments into African health systems, which in turn, may benefit maternal and child 
health. Specifically, PMTCT programs may independently improve obstetrical quality of 
care or even interact with maternal and child health initiatives to greater effect than if 
either program was implemented alone.  
                                                          
7
 These are the QUARITE and Audobem cluster randomized trials in West Africa.  
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2.10 Key points from the literature review 
1) Maternal mortality is preventable. 
2) Improving the socioeconomic circumstances within which women live, as well as 
their status in society, will lead to reductions in the absolute numbers of maternal 
deaths. 
3) Even with such improvements, a proportion of women will still develop obstetrical 
complications. They will need treatment within a functioning and accessible health 
system. 
4) Quality obstetrical care is a key element of such a health system and essential to 
reducing maternal mortality. Indirectly, good quality care gives women confidence 
to use life-saving health services. Directly, adequate and appropriate care for 
complications saves lives. 
5) Poor quality of care is a result of multiple health service dysfunctions from 
insufficient infrastructure, equipment, and medicines, to poorly trained, 
dissatisfied, and/or overworked health professionals.  
6) Interventions to improve quality of care can originate from within individual health 
structures, such as through the use of MDR. Or, interventions to improve care can 
come from external sources, such as donor funding for HIV/AIDS that also aims to 
improve health centre infrastructure and resource availability.  
7) Many prioritize the linking of maternal and HIV/AIDS programs in order to 
capitalize on the strengths of each and reduce duplication.  
8) To successfully link up programs, evidence is needed regarding to the mechanisms 
of action, in other words, evidence on why programs work. 
9) Before programs are linked, evidence is needed to show that these programs are in 
fact, improving the quality of care provided.
 
 
Chapter 3: West African Context 
 
Mali and Senegal are two of the poorest countries in the world. Mali has a Human 
Development Index of 175 out of 187. Senegal has an index of 155 (125). Mali’s 
population is amongst the poorest in the world with 51.4 percent of the population living 
on less than a dollar and a quarter per day. In Senegal, the equivalent statistic is 33.5 
percent (125). In both countries, public expenditures on health are abysmally low; 2.9 and 
3.2 percent of gross domestic product is spent of health in Mali and Senegal, respectively 
(125).   
 
3.1 Organisation of health system 
The health systems in both countries are organised according to a pyramid formation with 
three levels of public healthcare structure: district, regional, and central. The district level 
is comprised of health posts and a district health centre. In general, district level health 
centres are located in rural regions and cover 100-150 000 inhabitants (126). The second 
level of the health system consists of regional hospitals which typically correspond to the 
administrative districting of the country and are referral sites for district healthcare 
centres. Finally, the central level consists of national hospitals including university 
hospital structures, national laboratories, and administrative structures.  
 
3.2 Fees for maternal health services 
In order to reach 2015 benchmarks for the proportion of births assisted by a skilled 
attendant, barriers in accessing delivery care will have to be reduced. One of the most 
important of these barriers has been financial access (127). Both Mali and Senegal have 
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experimented with policies to reduce or eliminate user fees for maternal health services in 
the public sector. There has been a particular focus on caesarean section. National 
estimates of caesarean sections in both countries are well below the minimum 
recommended proportion of 5 percent. In Mali, 1.7 percent of women give birth by 
caesarean section and in Senegal, this statistic is 3.5 percent (12, 55).   
  
In Mali, it was announced in 2005 that caesarean sections would be provided free of 
charge (128). Previous to that date, the direct cost of a caesarean section was around 60 
000 CFA (approximately 135 Canadian dollars)
8
, an exorbitantly high price in a country 
where over 50 percent of the population lives on less than a $1.25 a day (128, 129).  Under 
this policy, women in need of an emergency caesarean section are supposed to receive 
pre- and post-operative examinations, caesarean section and materials for the surgery, 
laboratory tests, and hospitalization for no charge. Indirect costs of the policy, such as 
transportation for emergency referrals, are not included (130). However, implementation 
of the policy has been heterogeneous. Certain administrative regions, such as Kayes, 
decided that all EmOC would be covered under the policy (personal communication with 
Caroline Tourigny).  Further, many hospitals still charge for laboratory examinations and 
materials necessary for the caesarean section, such as gloves
9
. In Mali, user-fees are still 
charged for normal deliveries (130). 
 
                                                          
8
 This cost represents the procedure itself and does not include costs associated with transportation, lodging, 
food, or even the procurement of supplies such antibiotics, dressings, and blood for the procedure. 
9
 During a feasibility study conducted by the candidate in 2008, she requested information about the cost of 
services and materials related to childbirth at 10 hospitals in Mali and Senegal.  
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Senegal relies heavily on private contributions to healthcare with only 40 percent of total 
costs coming from public sources (127). In 2005, Senegal exempted users from paying 
delivery and caesarean section fees at hospitals in the five poorest regions of the country. 
The goal of this policy was to reduce financial barriers to delivery care and to increase 
facility-based deliveries (127). In 2006, Senegal extended this policy to the rest of the 
country, except the capital of Dakar (126). Under the revised policy, normal deliveries at 
lower level health centres (health posts and certain district hospitals) were covered in the 
five poorest regions of the country and all caesarean sections were covered at the regional 
hospital level (126). As in Mali, the implementation of this policy has been variable. 
Misinterpretations of the policy have been common (126). As a result, especially for 
delivery care, women often pay for materials and services which in theory, should be 
covered under the policy (127). Nonetheless, the policy appears to have increased the 
utilisation of health services without necessarily harming quality of care
10
 (127). 
 
3.3 Availability of human resources for health 
The strategies necessary for reducing maternal mortality require contact with the health 
system. In Mali and Senegal, both the availability and utilisation of maternal health 
services are remarkably low. National densities of doctors, nurses and midwives in Mali 
and Senegal, are 3/10 000 and 5/10 000, respectively.  These ratios are well-below the 
critical threshold of     23/10 000, established by the WHO (89). The availability of health 
                                                          
10
 One concern about user-fee removal has been that health services would be further overloaded and quality 
would suffer. In Senegal, quality of care after the implementation of the free delivery and caesarean section 
policy was evaluated based on the numbers of fresh stillbirths. The authors claimed that stillbirth rates did 
not change and thus quality of care of was unchanged by the policy. (Witter S, Armar-Klemesu M, Dieng T 
(2008) National fee exemptions schemes for deliveries:Comparing the recent experiences of Ghana and 
Senegal. Studies in Health Services Organisation & Policy 24: 167-98). Fresh stillbirths are believed to 
proxy care during the intrapartum period, but the authors did not provide a reference for how they obtained 
the stillbirth estimates. Stillbirths are notoriously hard to measure and thus, inferences about quality of care 
based in this metric should be cautiously interpreted.  
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personnel is inversely associated with numbers of births assisted by a skilled health 
professional (89), which in both countries, requires giving birth in a health facility, such as 
a hospital or clinic. In Mali, only 45 percent of women give birth in a health facility, with 
rural regions documenting levels of utilisation well below 30 percent (11). In Senegal, a 
slightly higher proportion of women give birth in a health facility (62%); however, like 
Mali, utilisation in rural regions is much lower (45%) (12).  
 
In both countries, midwives are a key component to reducing maternal mortality as they 
attend more births than any other healthcare provider in both rural and urban settings 
(131). In order to achieve coverage targets for 2015, in which 90 percent of all births are 
assisted by a skilled professional (54), both Mali and Senegal will have substantially 
increase their maternal health workforces. In Senegal, an estimated additional 450 workers 
are needed to reach the skilled provider benchmark. In Mali, 1280 additional workers are 
needed (131). Table 2 presents key human resource indicators for both countries.  
Table 2: Human resource indicators for Mali and Senegal (131)  
Indicator Mali Senegal 
Total population (% urban) 13, 323, 000 (36%) 12,861,000 (42%) 
% women of reproductive age 24 25 
Number of midwives 1579 990 
Number of obstetricians 84 126 
Midwives per 1000 live births 3 2 
Physicians who attend births 
     Urban 
     Rural 
 
≈ 5%  
≈1% 
 
≈ 10%  
≈2% 
Midwives who attend births 
     Urban 
     Rural 
 
≈65%  
≈15% 
 
≈80%  
≈30% 
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A particularity of the Senegalese context has been the blossoming of private midwifery 
schools. In Senegal, there are 136 midwifery educational institutions. Of these, only ten 
are public (131).While these schools are helping to meet workforce shortages, the quality 
of education provided in these schools has been of concern; graduates from private 
institutions have significantly lower passage rates of the national exam than publically-
educated graduates (132). While the absolute number of private midwifery schools in Mali 
is much less than in Senegal (45 schools), the proportion of private to public institution in 
also very high, as there are only three public midwifery institutions in the county (131). 
The quality of training at these private schools has been largely uninvestigated.  
 
In summary, Mali and Senegal represent two of the world’s poorest countries and have 
highly fragile health systems with gross insufficiencies of healthcare professionals. Both 
Mali and Senegal are far from achieving international benchmarks for births with a skilled 
attendant and births by caesarean section. To remedy this, both countries have made 
attempts to remove financial barriers to care, though the quality implications of these 
efforts have not been sufficiently evaluated. There is little doubt that reductions in 
maternal mortality will not be possible without reinforcement of the health system. 
 
 
Chapter 4: Description of the QUARITE Cluster Randomized Trial and 
General Study Methods 
 
In light of mounting evidence highlighting poor quality obstetrical care in sub-Saharan Africa 
(59-61, 66, 133, 134, 135), the cluster randomized control (CRT) trial Qualité des soins, 
gestion du risque et technologie obstétricale dans les pays en développement, or QUARITE, 
was conceived. The QUARITE study took place in 46 of the largest hospitals in Mali and 
Senegal, spanned 4 years (2007-2011), and evaluated whether the program, Advances in 
Labour and Risk Management (ALARM), could significantly reduce maternal mortality by 
improving the quality of obstetrical care provided at maternities in the region. The trial has 
been described in detail elsewhere (114).  
 
This PhD thesis was a sub-study within the QUARITE trial. In the beginning sections of this 
chapter, we provide an overview of the methodological elements of the trial that most apply to 
this thesis. In the sections that complete this chapter, we summarize methods specific to the 
doctoral research. As subsequent chapters, which consist of peer-reviewed articles, describe 
the methods used to respond to our research objectives at great length, we only briefly 
describe them here. 
 
4.1 Trial setting and eligibility criteria 
The QUARITE trial took place at referrals hospitals in Mali in Senegal. Referral hospitals 
are sinks for complicated deliveries and in theory, should have sufficient infrastructure to 
provide comprehensive EmOC including caesarean section and blood transfusion (87). In 
both countries, there are a sufficient number of comprehensive EmOC facilities for the 
population, although these hospitals are not well-distributed and rural areas are 
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underserved (86).To be eligible for the QUARITE trial, the referral hospital needed to 
have comprehensive EmOC capacity and at least 800 births per year. The trial included 46 
of the 49 eligible hospitals in the region (23 in Mali and 26 in Senegal). 
 
4.2 Intervention 
The QUARITE trial contained a one-year pre-intervention period, a two-year intervention 
period, and a final year post-intervention period. The intervention, known as the ALARM 
International Program, was developed by the Society of Obstetricians and Gynecologists 
of Canada. It combines clinically-oriented and evidence-based outreach visits with 
facility-based maternal death reviews (MDR). Specifically, the intervention included the 
following activities: 1) A six-day workshop to train and certify opinion leaders (one 
physician and one midwife from each intervention site) in EmOC best practices, audit 
techniques, and sexual and reproductive rights; 2) the creation of a multidisciplinary audit 
committee (physicians, midwives, nurses, and administrators) at each site; 3) 
commencement of a once-monthly audit cycle according to WHO guidelines; 4) the 
training of qualified staff in obstetrical best practices with 4-8 training sessions during the 
intervention period organized by local opinion leaders and external facilitators; 5) 
Educational outreach every three months by external facilitators including a national 
opinion leader and a AIP international coordinator to support local opinion leaders in their 
activities and; 6) Recertification of local opinion leaders a year after initial certification 
with an accelerated training workshop. The ALARM International Program targets health 
professionals in maternity units and is believed to reduce maternal mortality by improving 
obstetrical quality of care (114).   
 
36 
 
4.3 Randomization 
The ALARM International Program was randomly allocated to referral hospitals in both 
countries. To avoid contamination between health professionals, and because the 
intervention targets teams of professionals, a cluster design was deemed more appropriate 
than a traditional randomized control trial. Hospitals were included based on formal, 
informed consent by the hospital director and the person in charge of maternity services. 
In August 2008, after a one-year pre-intervention data collection phase, each hospital was 
randomly assigned to either an intervention group, in which the ALARM International 
Program was implemented, or a control group with no intervention (114). 
 
The participating hospitals were stratified into six strata. These strata corresponded to the 
two countries (Mali and Senegal) and three hospital types (hospitals in the capital, 
regional hospitals, and district hospitals outside of the capital) eligible for the study. We 
attempted to ensure optimal balance between the hospitals assigned to each study group 
based on the number of hospital deliveries per year. Within each stratum, we first ranked 
the hospitals with respect to deliveries and then used blocked randomization, with each 
block containing two hospitals with adjacent ranks, i.e., similar number of deliveries per 
year. All participating hospitals were randomized simultaneously to eliminate any risk of 
allocation bias (114). 
 
4.4 Blinding 
Patients attending the study facilities were unaware of group assignment. For obvious 
reasons, those health professionals implementing the intervention were not blinded (114). 
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4.5 Trial Objectives 
The primary objective of the trial was to reduce the overall maternal mortality rate. 
Secondary objectives of the trial included: 1) reducing the number of cases of stillbirth 
and neonatal mortality; 2) reducing severe maternal morbidity; 3) improving quality of 
care and 4) increasing health professional job satisfaction (114). For this research project, 
we address the secondary objective of improving quality of care. Specifically, we are 
interested in obstetrical quality of care during labour, delivery and the immediate post-
partum period. It is during this period that most maternal deaths occur (57).   
 
4.6 Measures  
The QUARITE trial collected data on a large number of measures to respond to the 
aforementioned objectives. For the purposes of brevity, we will only describe those 
measures of interest to this thesis.   
 
Indicator of facility resource availability  
The trial annually collected data on hospital material and human resources using a 
Complexity Index derived from the WHO Global Survey on Maternal and Perinatal 
Health (136). A copy of the form used to collect data for this index is provided in 
appendix 2. The Complexity Index is comprised of eight categories describing: 1) basic 
services, 2) screening tests, 3) basic emergency obstetrical resources, 4) intrapartum care, 
5) general medical services, 6) anaesthesiology resources, 7) human resources and, 8) 
academic resources and clinical protocols. We applied an Africa-specific grading scheme 
to the Index (137). A list of services under each of the categories described above was 
classified as essential, comprehensive, or advanced. Each service classified as essential 
received one point, each comprehensive service received two points, and each advanced 
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service received 3 points. Points for the Complexity Index were summed up for each 
hospital in trial and scores could vary from 0 to 100.  
 
Patient demographic and obstetrical variables  
A data sheet was completed for every woman who gave birth in participating hospitals 
(appendix 3). Among other variables, it included the mother’s survival outcome, age, 
parity, number of prenatal visits, and previously diagnosed maternal conditions.  It also 
included the vital status of the infant at birth and at discharge. 
 
4.7 Ethics 
The QUARITE trial received ethics committee approval from Sainte Justine Hospital in 
Montreal (ref. 2425), the Ministry of Health and Preventive Medicine in Senegal (ref. 
0869), and the National Ethics Committee for Health and Life Sciences in Mali (ref. 
034/MS-SG-CNESS). Copies of the ethics certificates can be found in appendix 4.  
 
4.8 Important Methodological Elements of Thesis 
There were two phases to this study. In the first phase, we developed and validated a 
measurement instrument to evaluate quality of care in terms of the medical procedures and 
practices applied to women during labour, delivery and childbirth. This instrument is 
known as a CBCA (see Quality of care- A difficult concept to measure on page 15). As 
will be shown in subsequent chapters, it was necessary to develop and validate such a tool, 
because existing instruments had not been sufficiently assessed in low-income settings.  
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In the second phase of the study, we used the validated CBCA tool to evaluate two 
programs believed to improve obstetrical quality of care. These programs were the 
ALARM International Program of the QUARITE trial and PMTCT. Both programs are 
defined in the table of variables provided below. We evaluated the associations between 
both programs and quality of care, as measured with the CBCA instrument, during the 
final year of the trial, when the effects of the ALARM program were expected to be most 
pronounced. We were particularly interested in assessing the joint and independent effects 
of both programs.  
 
4.9 Population and Sample for this Thesis 
The same hospital eligibility criteria for the QUARITE trial applied to the research in this 
thesis. However, because of financial and logistic constraints, only 32 of the 46 
QUARITE sites were sampled in this study. The subsample included 16 ALARM and 16 
control sites. It was also equally balanced by location: 11 hospitals were located in the 
capitals (Bamako or Dakar), 11 were regional and 10 were district. 
 
At the hospitals included in this study, we undertook two phases of data collection. The 
first phase occurred at 4 hospitals in Bamako, Mali and 4 hospitals in Dakar, Senegal. 
During this phase, we used a development sample of patient medical records (N=185) to 
assess certain measurement properties of the CBCA instrument. In the second phase of 
data collection, we used a finalized version of the CBCA questionnaire to test the 
associations between ALARM and PMTCT and the quality of patient obstetrical care. 
This phase of data collection took place at 32 hospitals in Mali and Senegal (13 in Mali 
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and 19 in Senegal). The candidate used the CBCA instrument to audit the medical records 
of over 800 obstetrical admissions. For both phases of the study, women who were 
admitted for elective caesarean section were excluded. We did this because we were 
evaluating the quality of care during labour, delivery, and childbirth (when the risk of 
maternal mortality is greatest) and these women are admitted prior to labour.  
 
On the next page, we provide a table with the main variables included in this study and a 
definition for each. This study contained variables occurring at both the hospital (also 
known as cluster) and patient levels. As mentioned earlier, in this chapter we have only 
briefly summarized the methods used in this thesis. We have done so to provide a 
preliminary guide to the reader as to the main steps taken to conduct this research while at 
the same time, aiming to limit redundancy.  
41 
 
 
Table 3: List of variables and corresponding definitions 
TERM DEFINITION 
HOSPITAL-LEVEL VARIABLES 
ALARM  Program to improve obstetrical quality of care, developed by the Society of 
Obstetricians and Gynecologists of Canada. It combines clinically-oriented 
and evidence-based outreach visits with facility-based maternal death review. 
Specifically, the intervention included the following activities: 1) A six-day 
workshop to train and certify opinion leaders (one physician and midwife 
from each intervention site) in EmOC best practices, audit techniques, and 
sexual and reproductive rights; 2) the creation of a multidisciplinary audit 
committee (physicians, midwives, nurses, and administrators) at each site; 3) 
commencement of a once-monthly audit cycle according to WHO guidelines; 
4) the training of qualified staff in obstetrical best practices with 4-8 training 
sessions during the intervention period organized by local opinion leaders and 
external facilitators; 5) Educational outreach every three months by external 
facilitators including a national opinion leader and an AIP international 
coordinator to support local opinion leaders in their activities and; 6) 
Recertification of local opinion leaders a year after initial certification with an 
accelerated training workshop. 
PMTCT A program to prevent the vertical transmission of HIV from mother to child. 
In this thesis, PTMCT was measured on a continuum using with a modified 
version of Columbia University’s International Centre for AIDS Care and 
Treatment Programs’ (ICAP) PMTCT/VCT site assessment tool. The 
questionnaire described 10 dimensions of a PMTCT program: training in 
PMTCT, counseling, testing for the virus, general physical evaluation, 
laboratory clinical evaluation, knowledge of prophylaxis for the mother, 
laboratory surveillance of the mother, knowledge of prophylaxis for the 
newborn, follow-up of the newborn’s health, and nutritional services. 
Complexity 
Score 
The material and human resources available at each hospital. Score derived 
from an instrument used in the WHO Global Survey on Maternal and 
Perinatal Health. It is comprised of eight categories describing: 1) basic 
services, 2) screening tests, 3) basic emergency obstetrical resources, 4) 
intrapartum care, 5) general medical services, 6) anaesthesiology resources, 
7) human resources and, 8) academic resources and clinical protocols. We 
used an Africa-specific grading scheme for the Index proposed by Shah. A 
list of services under each of the categories described above is classified as 
essential, comprehensive, or advanced. Each service classified as essential 
receives one point, each comprehensive service receives two points, and each 
advanced service gets 3 points. Points for the Complexity Index were 
summed up for each hospital. Scores can vary from 0 to 100. 
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Facility 
maternal and 
perinatal 
mortality 
rates 
Facility perinatal mortality is defined as the number of newborn deaths 
(including stillbirths) occurring prior to the woman’s discharge divided by the 
number of livebirths occurring at the hospital during the eligible three-month 
study window. Facility maternal mortality is defined as the number of 
maternal deaths occurring at a given hospital during the study period divided 
by the total number of livebirths during that same period. Both rates are given 
per 1000 livebirths. 
PATIENT-LEVEL VARIABLES 
Criterion 
based 
clinical audit 
(CBCA) 
score 
Measure of process-level quality of care (e.g. medical procedures and 
practices). CBCA is a form of chart abstraction that uses standardized criteria 
for evaluating care. Criteria are predetermined, usually with medical literature 
and expert opinion, and then compared against data extracted from medical 
records to evaluate whether or not a minimal standard of care has been met. 
We used a CBCA containing 26 unweighted criteria that measured five 
dimensions of care: patient history, clinical examination, laboratory 
examinations, labour management (partograph), delivery care and postpartum 
monitoring. A CBCA score was applied to each woman’s medical record 
audited during the trial. 
Age Number of years of life since birth. 
Parity The number of full-term children previously borne by a woman. This 
excludes miscarriages and abortions in early pregnancies but does include 
stillbirths. 
Number 
prenatal 
visits 
The number of visits by a woman to prenatal care services prior to the onset 
of labour. The WHO recommends a minimum of four visits. 
Previously 
diagnosed 
maternal 
condition 
These include a variety of pathologies diagnosed during prenatal care that 
could put a woman at risk of obstetrical complication and death. The most 
common of these pathologies include: anemia, HIV/AIDS, vaginal bleeding, 
hypertension, pre-eclampsia, risk of premature birth, and premature rupture 
of the membranes.  
 
  
 
 
Chapter 5: Study Objectives  
 
Improvements in obstetrical quality of care are believed to reduce facility maternal 
mortality in Mali and Senegal. This is the premise behind the QUARITE study. The 
ALARM International Program is believed to improve the care of pregnant women during 
labour, delivery, and the immediate postpartum period. In order to demonstrate that 
ALARM influences obstetrical quality of care, care must be measured first.  
The first objective of this study was:  
 To develop a measurement tool to assess  obstetrical quality of care in maternity 
hospitals in Senegal and Mali  
 
Once quality of care has been measured, then it is possible to determine whether the 
ALARM International program is associated with improvements in obstetrical quality of 
care. It is hypothesized that quality of care scores, specifically those measuring medical 
procedures and practices, will be significantly greater at ALARM sites.  
Our second study objective was thus: 
 To assess whether the ALARM international program is associated with 
obstetrical quality of care 
 
PMTCT programs may also improve the quality of care provided by hospitals serving 
both HIV+ and HIV- women, since these programs provide needed financial, 
infrastructural, and technical support. PMTCT programs were scaled-up in Mali and 
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Senegal while the QUARITE trial was ongoing. Evaluating the relationship between both 
programs on obstetrical quality of care is necessary to rule out the possibility of 
uncontrolled confounding and to identify strategic linkages between the two programs. 
The third objective of this study was:  
 To assess whether PMTCT is associated with good obstetrical quality of care 
and which components of PMTCT independently contribute to quality of care  
 
Finally, it is also possible that PMTCT and ALARM programs act synergistically. The 
presence of both programs may improve quality of care over and above either program 
alone.  
Thus, our final objective was  
 To evaluate whether there is effect interaction between PMTCT and ALARM 
programs. That is, is the combined effect of the two programs greater than (or 
less than) would be expected based on the contribution of each program alone? 
 
 
 
 
 
 
Methods to measure obstetrical quality of care 
 
Strategies for reducing maternal mortality are known (57) but require the utilisation of 
health services that may be of dubious quality in many low-income settings (57, 61, 64, 
71). Before quality can be improved, it must first be measured. As previously mentioned, 
quality of care can be conceptualized and measured on three levels: structure, process, and 
outcome. Structure measures of care evaluate whether there is an adequate setting and 
equipment to provide quality medical care (75). In the QUARITE trial, the structural 
attributes of quality were measured at each hospital through a Complexity Index 
(described in chapter 5). However, the relationship between structure and process 
components of quality may not be strictly linear. Insufficient training of health 
professionals, absenteeism, lack of provider motivation, and poorly organised staff 
functions can all undermine care, no matter how well-equipped the hospital. In addition to 
structure measures of care, the QUARITE trial also recorded maternal and perinatal 
mortality outcomes with the patient data sheets (described previously). These measures 
provide clues as to the overall quality of care in a given setting and across time (75). That 
is, if mortality is high at a particular hospital, it may reflect poor care. However, it may 
also reflect sicker patients.  
 
Process measures of quality consider the appropriateness and completeness of information 
obtained through clinical history, physical examination and diagnostic tests; the evidence 
of preventive management; coordination of the continuity of care; etc. (75). Process may 
be the best indicator for determining whether medicine is being practiced properly (75) 
and unlike quality of care at a structural level, where hospitals are reliant on State 
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allocations of resources, process level quality of care is amenable to change at an 
individual level. In other words, it can be modified with improvements in health 
professionals’ knowledge and behaviours (138). In the original protocol of the QUARITE 
trial, process measures of quality were to be assessed through clinical audits of patient 
medical records (114). Given that the mechanism by which the ALARM International 
Program is believed to reduce maternal mortality is through improvements in quality of 
care, it was important to have a valid measure of quality at the process level. At the 
commencement of this thesis, the specific form these audits would take had not yet been 
determined.  
 
Clinical audits are standardized methods for evaluating whether medicine is being 
properly practiced (process-level quality of care) (75, 79). They can provide important 
insights into the causes of substandard care and are routinely used as part of quality 
assurance efforts in industrialized countries, but underemployed in resource-limited 
settings (79). In general, clinical audits involve structured peer review, whereby clinicians 
examine their practice against agreed upon standards of good quality care (79). A CBCA is 
a specific form of audit that compares clinical practice against normative standards of 
good care (75, 79). These standards are normative in that they are derived from the 
sources that set the standards of knowledge and practice in dominant medical care 
including standard textbooks, peer-reviewed publications, and expert opinion (75). In a 
CBCA, the standards, or criteria, are pre-established based on the subject of the audit and 
then standardized (79). Because criteria are standardized, non-medically qualified audit 
assistants can be trained to screen the medical records of patients and extract relevant data 
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(79). Extracted data are then reviewed to determine the proportion of criteria that have 
been met and whether this proportion meets an established standard of care [5, 14].  
 
As mentioned in the literature review, a CBCA is likely the best way to measure quality of 
care across a variety of settings, when a quantitative measure is required. We thus 
conducted a systematic review of the literature to survey the use of this measurement tool in 
low and middle-income settings. Initially, the goal of this review was to find the best-adapted 
tool available and apply that tool to the QUARITE study. As the review demonstrates, the 
CBCAs available from other studies have not been validated and after the review, it was 
apparent that we would need to develop our own CBCA instrument. Our review of CBCA has 
been published in the International Journal for Quality in Health Care (139).  
 
 
Chapter 6: Criterion-based clinical audit to assess quality of obstetrical 
care in low- and middle-income countries: a systematic review (article 1) 
 
AUTHORS: Catherine M Pirkle, Alexandre Dumont, and Maria-Victoria 
Zunzunegui 
 
Abstract  
Purpose: Low quality obstetric care in low- and middle-income countries contributes to 
high in-hospital maternal mortality. Criterion-based clinical audits are increasingly used to 
measure and improve obstetric care in these settings. This article systematically reviews 
peer-reviewed literature to determine if these audits are feasible, valid, and reliable 
measurement tools for assessing the quality of obstetric care. 
Data Sources: PUBMED, Google Scholar, and Web of Science databases were searched 
for peer-reviewed articles published between 1995 and 2009 and which used criterion-
based clinical audits to measure the quality of obstetric care in low- and middle-income 
countries.  
Study selection: Sixty-nine studies were identified by key terms and subsequently 
reviewed. Ten were retained based on inclusion/exclusion criteria. 
Data extraction: 1) general characteristics of the study; 2) compliance with expected 
standards of care and on maternal/child health outcomes; 3) selection of the study 
population and sampling methods; and 4) quality control and reliability. 
Results of Data Synthesis: Criterion-based clinical audit is increasingly used in low- and 
middle-income countries. Most audits were conducted in sub-Saharan Africa. Studies had 
cross-sectional or before-and-after designs. Sampling methods were poorly reported and 
selection bias was a concern. No studies compared audit against other measures of quality 
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of care or against patient outcomes. Methods for quality control and assurance were 
generally not documented and reliability was mostly unaddressed. 
Conclusions: Criterion-based clinical audit appears feasible. No studies have rigorously 
evaluated its measurement properties in low- and middle-income countries. Without such 
evaluation, measurement properties of the audit remain under question. 
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Purpose 
Maternal mortality rates in low- and middle-income countries are around 50 times higher 
than those of better-resourced countries [1]. The strategies necessary for reducing maternal 
and perinatal mortality are known and include: antenatal care, assisted delivery, and 
emergency obstetrical care [2, 3]. All strategies require contact with health systems often 
characterized by low levels of service utilisation and poor quality of care [4]. 
 
Evidence suggests that an important contributor to maternal mortality in low- and middle-
income countries is sub-optimal quality of obstetrical care [3-8]. Numerous authors have 
demonstrated gaps in the provision of obstetric care to women treated at hospital [1, 9, 
10]. Poor quality of care can contribute to maternal mortality both directly (inappropriate 
medical practice) and indirectly (deterred/delayed health service utilisation). 
Improvements in quality of care have been shown to reduce in-hospital maternal mortality 
by as much as 50% [9].  
 
In order to assess improvements in quality of care, it must be measured. Quality of care is 
a problematic concept to measure, as it is a multifaceted construct. A common 
conceptualization of quality of care is to divide it into three components: structure, 
process, and outcome [11, 12]. Structure is concerned with the adequacy of facilities and 
equipment, the qualifications of staff, and the operation of programs. Process considers the 
appropriateness of patient management and care. Patient outcomes can indicate good and 
bad quality of care in aggregate [12]. Of these three components, process is the most 
difficult to measure [11] but may be the best indicator of whether medicine is properly 
practised [12]. 
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Clinical audits are useful methods for evaluating the process component of quality of care 
and can provide important insights into deficiencies in clinical practice. Clinical audits are 
routinely used as part of quality assurance efforts in industrialized countries, but 
underutilized in low- and middle-income countries [13]. In general, clinical audits involve 
structured peer review, whereby clinicians examine their practice against agreed standards 
of good quality care [13]. 
 
A criterion-based clinical audit is a specific form of clinical audit that can be effectuated 
by non-medically qualified audit assistants who screen the medical records of patients and 
extract relevant data. Standardized criteria for evaluating good quality of care are 
previously determined and then compared against patients’ medical records to evaluate 
whether or not a minimal standard of care has been met [5, 14]. Patient data is aggregated, 
thereby preserving anonymity but also allowing for a global picture of whether a health 
structure is meeting an agreed-upon standard of care [13].  There are five steps to a 
criterion-based clinical audit: 1) establish criteria, 2) measure practice, 3) feedback 
findings and set standards, 4) implement change, 5) re-evaluate practice and feedback 
findings (79). Recently, such audits have been given attention in the domain of obstetric 
care in low- and middle-income countries [5, 14-22]. In addition to quality assurance, the 
first two steps of the audit cycle may also be useful to researchers, as they allow for a 
standardized measure of the process component of quality of care. 
 
This paper is a systematic review of studies using criterion-based clinical audit to measure 
the quality of obstetric care in low- and middle-income countries. Our objective was to 
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review available evidence to determine if criterion-based clinical audit is a feasible, valid, 
and reliable measurement tool for assessing quality of obstetric care in these settings. By 
feasible, we refer to whether the audit can be implemented across a variety of settings. By 
valid, we are broadly referring to both the epidemiological concept of internal validity 
(e.g. efforts to minimize bias) as well as validity in the sense of measurement, specifically, 
construct validity (e.g. does the audit measures what it is purported to measure) and 
criterion validity (does operationalization of the audit perform as expected based on 
theory). For reliability, we are interested the reproducibility of results. We hypothesize that 
criterion-based clinical audit is feasible in most low- and middle-income settings, but that 
validity and reliability are heterogeneous and could influence the effectiveness of the 
audits. 
 
Data sources:  
PUBMED, Google Scholar, and Web of Science databases were searched for potential 
articles. The key terms “criteria-based,” “criterion-based,” and “evidence-based” were 
paired using the AND Boolean operator with “case review,” “quality assessment,” and 
“audit.” A total of nine search terms were employed. We used the MeSH term “Delivery, 
obstetric” to limit search results to those articles discussing in-hospital obstetric care. We 
also hand-searched the reference sections of relevant articles including general articles 
discussing the quality of obstetric care in low- and middle-income countries and articles 
discussing the use of audits in these same settings. Finally, we searched the table of 
contents of quality of care journals. 
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Study selection:  
An MPH researcher (CP), a gynaecologist (AD) and an epidemiologist (MVZ) reviewed 
English and French language articles using criterion-based clinical audit to measure the 
quality of obstetric care in low- and middle-income countries. Articles were retained based 
on the following inclusion and exclusion criteria. Inclusion criteria included: Original 
research article published between January 1995 and July 2009; study conducted in low- 
and middle-income country; and quality of intrapartum care measured by a pre-determined 
criteria list. We excluded studies which did not provide a quantitative measurement of 
standard attainment or for which we could not calculate this measure based on data 
reported in the article (before exclusion, we contacted the authors for unpublished data).   
 
Data extraction: 
From the retained articles, we extracted the following information: 1) settings (year, 
country, type of facility); 2) general characteristics of the study (study design, number of 
cases audited, evidence to develop criteria, and number of criteria); 3) compliance with 
expected patient management (according to pre-defined criteria) and maternal/child health 
outcomes; 4) sampling and quality control methods: selection of the study population, 
quality control, and reliability. A simple checklist was created using basic epidemiological 
principles to assess sampling and data collection methods. The quality attributes of the list 
refer to the following concepts: Representativeness and appropriateness of the sample, 
assessed by the description of the study population, sampling methods, and consideration 
of missing data; quality of data collection, assessed by pre-/ pilot testing, data collector 
profile and training, validity checks of data and data entry; and reliability assessed by 
standardized data entry forms and consideration of inter-observer or inter-site variability. 
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Results of data synthesis: 
Sixty-nine articles were reviewed and of these, ten met the inclusion and exclusion criteria 
described above. Articles not retained were mostly descriptive of the audit process. One 
article did not provide a quantitative measure of standard attainment and we attempted to 
contact the authors for this information. We received no response. 
 
Table 4 presents the general characteristics of the retained studies. Criterion-based clinical 
audit has been used to assess the quality of obstetric care in cross-sectional [9, 15, 16, 19-
21] and before-and-after study designs [5, 14, 17, 18, 22]. To our knowledge, in low- and 
middle-income settings, this form of audit has never been used in other forms of 
observational studies or in randomized control trials to assess the aetiology of maternal 
mortality as it relates to quality of care. Most criteria for audit have been developed based 
on WHO publications and the Cochrane Library [5, 9, 14-17, 20, 21]. Expert opinion and 
consensus were used to refine criteria lists and to arrive at final criteria [9, 14-18, 22]. The 
numbers of criteria included varied from 6 to 43 (median= 13). More restricted criteria 
lists were employed in studies focusing on specific complications (e.g. haemorrhage), 
whereas studies evaluating normal delivery care, or several complications, used longer 
criteria lists. Sample sizes varied greatly between studies (n = 43 to 9550). Smaller sample 
sizes tended to be characteristic of before-and-after study designs [17, 18, 22]. Small 
sample sizes prevented the percentage of standard attainment from being related directly 
to mortality indicators [17, 22]. 
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Table 4: General characteristics of the studies meeting inclusion and exclusion criteria 
Author, Date Study setting and dates Cases Audited Study Design Evidence used to develop criteria No of 
Criteria 
1) Graham et al. 2000; 
Wagaarachchi 200111 
Jamaica & Ghana. 
Audit 1: Jun. 1997-Dec. 1998. 
Audit 2: May 1999- May 2000. 
Audit 1: 551 
Audit 2: 338 
Before and after 
design 
Standard obstetric texts; Cochrane Library; 
WHO publications, peer-reviewed literature, 
expert opinion 
31 
2) Qian et al. 2001 Shanghai and Sihong, China 
Apr. to May 1999 
599 Cross-sectional WHO reproductive library 8 
3) Hussein et al. 2004 Ghana. 
Jun.-Aug. 2001. 
416 Cross-sectional Standard obstetric texts; Cochrane Library; 
WHO publications; expert opinion. 
≤43 
4) Weeks et al. 2005 Uganda. 
Audit 1: Jul. –Oct. 2001 
Audit 2: Jan. –Mar. 2002. 
43 both audits Before and after 
design 
Standard obstetric texts; Cochrane Library; 
WHO publications; national guidelines, 
expert opinion. 
9 
5) Dumont et al. 2005 Senegal 
Mar. 2001-Feb. 2002 
712 Cross-sectional 12 WHO reproductive library; national 
guidelines; peer-reviewed literature; expert 
opinion 
≤12 
6) Okong et al. 2006 Uganda 
Jan. 1999- Sep. 2000 
229 Cross-sectional Unknown 16 
 
7) Kongnyey, Mlava, van den 
Broek. 2008 (PPH) 
Malawi 
Audit 1: May –Jun. 2007 
Audit 2: Oct. –Nov. 2007 
Audit 1: 
40 
Audit 2: 
45 
Before and after 
design 
Standard obstetric texts; Cochrane Library; 
WHO publications; national guidelines, peer-
reviewed literature, expert opinion. 
6 
                                                          
11
 Both articles refer to a single study and will thus be cited together. Briefly, the article by Graham et al. (2000) describes the audit process and how criteria were 
established for the study, while the article by Wagaarachchi et al. (2001) describes the results of the audit. 
12
 This study used a before and after design with two baseline periods and one post-intervention period to evaluate changes in maternal outcomes. Criterion-based 
clinical audit was only used at one time point, and changes in quality of care were not evaluated. Thus, this study is listed as transversal in regards to the objectives of 
this literature review. 
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8) Kongnyey, Mlava, van den 
Broek. 2008 (referral) 
Malawi 
Audit 1: Apr -May 2007 
Audit 2: Aug.- Sep 2007 
Audit 1: 
60 
Audit 2: 
62 
Before and after 
design 
Expert opinion 7 
9) SEA-ORCHID, 2008 South East Asia 
Jan.-Dec. 2005 
9550 Cross-sectional Cochrane Library; WHO reproductive library 14 
10) Kidanto et al. 2009 Tanzania 
Apr.-Dec. 2006 
389 Cross-sectional Standard obstetric texts; Cochrane Library; 
WHO publications; national guidelines, peer-
reviewed literature, expert opinion. 
18 
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Table 5 shows that criterion-based clinical audit has been used in a variety of hospital 
settings from first level and district health centres [5, 14, 17, 18] to tertiary hospitals [9, 
15-17, 19-22], in both rural [19, 20] and urban settings [9, 16, 19, 20, 22]. Quality of 
obstetric care was mostly reported in terms of the number of criteria met [5, 14-22] though 
one study reported the percentage of substandard care [9]. Outcome indicators such as 
maternal and perinatal mortality were inconsistently reported [15]. For maternal mortality, 
some studies reported case-fatality rates [5, 14, 17, 18], others provided the number of 
maternal deaths [19, 21, 22], and two provided both [9, 16]. A few studies reported 
perinatal mortality [16-18, 21], despite it being a more frequent outcome than maternal 
mortality. 
 
 
Table 6 provides a checklist of quality assurance attributes to be considered when 
conducting a criterion-based clinical audit. The table shows the number of articles 
mentioning each attribute. Relatively more attention was paid to the study population and 
sampling than to data quality control and reliability. Sampling methods to identify cases 
were variable and included: all women meeting the case definition [9, 16, 18], sampling in 
sequential order until a specified sample size was met [15, 21, 22], and convenience 
sampling [20]. In three of the studies, sampling methods were not clearly specified [5, 14, 
17, 19]. Of the studies that did not include all women meeting the case definition, only a 
few discussed whether the study sample was random [5, 14, 15]. None of these studies 
attempted to compare characteristics of patients included and not included in the sample. 
The possibility of missing data was mentioned in a few studies [5, 14, 15]. Only a single 
study attempted to determine if retrievable case files were a random subset of all admitted 
deliveries [5, 14]. 
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Table 5: Hospital characteristics, percent of criteria met, and patient outcomes 
Author/ Date No. Hospitals, Type % Compliance with Criteria Maternal Mortality Perinatal Mortality 
1) Graham et al. 2000; 
Wagaarachchi 2001 
4 first level referral facilities 1st Audit:13 
General: 69.5% 
Hem: 56.6% 
Eclampsia: 53.2% 
Sepsis: 68.6% 
2nd Audit: General: 
84.7% 
Hem: 64.7% 
Eclampsia: 69.5% 
Sepsis: 75.5% 
Case fatality rate: 
Audit 1: (18/551); 3.3% 
Audit 2: (17/338); 5.0% 
No test of significance 
Not mentioned 
2) Qian et al. 2001 4 hospitals: Specialist, City MCH, 
District MCH, Rural 
32.3% Not mentioned Not mentioned 
3) Hussein et al. 2004 6 centres including: government 
hospital, mission hospital, government 
health centre, & private maternity home 
On average: 65.5% (CI: 64-67%) 
Range: 32.6-93.0% 
Not mentioned Not mentioned 
4) Weeks et al. 2005 High-risk labour ward of Mulago 
Hospital 
1st Audit: (57/232), 
24.6% 
2nd Audit: (134/264), 
50.8% 
Audit 1: 4 deaths 
Audit 2: 0 deaths 
No significant difference 
Not mentioned 
5) Dumont et al. 2005 District hospital in Dakar, Senegal Proportions of substandard care: 
Post-partum haemorrhage: 63% 
Pre-eclampsia: 52% 
Eclampsia: 46% 
Placental abruption: 42% 
Placenta previa: 33% 
29 maternal deaths (20 due 
to haemorrhage or 
hypertension) 
CFR both complications: 
5% 
 
Not mentioned 
6) Okong et al. 2006 4 referral hospitals, 3 districts (799/16), 50.0% 269 maternal deaths over 
study period 
MMR: 482/ 100 000 
Not mentioned 
 
 
                                                          
13
 Uterine rupture and dystocia were not included in these calculations because data for these two complications were not available for all the hospitals included in the 
study. 
59 
 
7) Kongnyey, Mlava, 
van den Broek. 2008 
(PPH) 
8 hospitals in 3 districts: 4 mission 
hospitals, 1 government community 
hospital, 1 tertiary referral hospital 
1st Audit: (146/240), 
60.8% 
2nd Audit: (203/270), 
75.2% 
Case fatality rate: 
Audit 1: 10% 
Audit 2:  6.7%. 
No significant difference 
 
 
 
 
Audit 1: 50/1000 
Audit 2: 44/1000 
No significant 
difference 
 
8) Kongnyey, Mlava, 
van den Broek. 2008 
(referral) 
9 referral health centres 1st Audit: 
(238/407), 
58.5% 
2nd Audit: 
(401/424) 
94.6% 
Case fatality rate: 
Audit 1: 5.0% 
Audit 2:  3.2% 
No significant difference 
 
Audit 1: 8.3% 
Audit 2: 4.8% 
No significant 
difference 
9) SEA-ORCHID, 2008 9 hospitals: tertiary, referral, and district 
hospitals. 
Beneficial Care: 
Indonesia: 47% 
Malaysia: 51% 
Philippines: 43% 
Thailand: 63% 
Harmful Care: 
Indonesia: 33% 
Malaysia: 34% 
Philippines: 30% 
Thailand: 65% 
0 maternal deaths Indonesia: 35/1000 
Malaysia: 12/1000 
Philippines: 4/1000 
Thailand: 16/1000 
10) Kidanto et al. 2009 1 tertiary level hospital in Dar es 
Salaam. 
Antepartum: (1915/3055), 62.68% 
Intrapartum: (1581/2611), 60.55% 
Postpartum: (368/644), 57.14 
30 maternal deaths 
Case-fatality rate: 7.7% 
 
161 perinatal deaths; 
214 per 1000 
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Table 6: Checklist of quality criteria and the number of articles that considered each attribute 
Criterion-based Clinical Audit 
Quality Criteria 
YES NO 
Selection of Cases 
Description of study population 
with clear case definition
14
 
7 
(Refs: 5, 14-17, 19, 21, 22) 
3 
(Refs: 20, 9, 18) 
Description of sampling strategy 8 
(Refs:  9, 15, 16, 18-22) 
2 
(Refs: 5, 14, 17) 
Consideration of missing cases 2 
(Refs: 5, 14, 15) 
8 
(Refs: 9, 16-22) 
Data Quality Control 
Criterion-based clinical audit pilot 
or pre-tested 
5 
(Refs: 15, 22, 19, 18, 16) 
5 
(Refs: 5, 14, 20, 9, 17, 21) 
Description of staff profile 6 
(Refs: 5, 9, 14-16, 19, 20) 
4 
(Refs: 22, 17, 18, 21) 
Training of staff 4 
(Refs: 16, 18, 20, 21) 
6 
(Refs: 5, 9, 14, 15, 17, 19, 22) 
Data entry validity checks 3 
(Refs: 19, 20, 21) 
8 
(Refs: 5, 9, 14-18, 22) 
Reliability 
Standardized data collection form 4 
(Refs: 17-19, 21) 
6 
(Refs: 5, 9, 14-16, 20, 22) 
Inter-observer/ Inter-site 
variability assessed 
2 
(Refs: 5, 14, 19) 
8 
(9, 15-18, 20-22) 
 
 
                                                          
14
Articles 5 and 14 refer to a single study and are thus cited together. 
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Quality control and reliability were not well documented. Five studies included a pilot 
phase [15, 17, 18, 22] or pre-tested questionnaire [19]. In three, piloting was conducted to 
estimate sample size [17, 18, 22]; in another, it was used to determine if delivery records 
were traceable [15]. Most studies described the profile of data-collectors [5, 9, 14-16, 19, 
20]. Two studies touched on the contents of auditor training [18, 21] and two studies 
attempted to verify the quality of data collected by audit [19, 20]. One study performed an 
external validity check, by comparing data obtained through exit interviews with that of 
hospital case notes [20]. Another study supplemented gaps in medical dossiers with 
personal interviews [19]. In none of the studies were results from criterion-based clinical 
audit compared against another instrument. 
 
Data entry and management were poorly reported. It can be inferred that most studies used 
a standardized data-extraction form; however, this was not always explicitly stated [21]. In 
one study, an online form used built-in validation checks to reduce data-entry error and a 
random sample of 5-10% of extraction forms to independently re-check data [13]. No 
other studies reported methods used to minimize data entry error. 
 
None of the studies quantitatively attempted to calculate a reliability coefficient for 
criterion-based clinical audit. Most studies involved several health centres and several data 
collectors, or multiple time points; yet, only two studies looked into whether there was 
concordance between evaluators [23, 24]. In both cases, the authors stated that there was 
little discordance, but this information is qualitative. None of the before-and-after studies 
looked into test-retest reliability. 
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Conclusions: 
Efforts to reduce maternal mortality have focused on augmenting the quantity of services 
offered in low and middle-income countries, but less on the quality of these services [13]. 
Increasingly, there is recognition that maternal mortality cannot be reduced without 
improvements in service delivery, including medical practice [15]. To assess 
improvements in quality of care, it must first be measured. The standardized nature of 
criterion-based clinical audit makes it a potentially powerful measurement tool. We have 
provided a textbox at the end of this article with useful references and recommendations to 
help assure the quality of criterion-based clinical audit in low and middle-income 
countries as well as to encourage its use in these settings. The conclusions below formed 
the basis of the textbox recommendations.  
 
Our review demonstrates that the available peer-reviewed evidence does not allow us to 
conclude if criterion-based clinical audit is a valid and reliable measurement tool. Given 
the extent to which this audit has been applied across various settings and obstetrical 
conditions it does, however, suggest that it is feasible in low- and middle-income countries 
[25, 26]. Further, the review shows that the use of criterion-based clinical audit in these 
settings is increasing (4 of 10 studies were published in the past 2 years) and one reason 
may be that criterion-based clinical audit can be conducted by non-medically qualified 
audit assistants. It is also considered less expensive than other forms of audit [13]. 
 
This review demonstrated several gaps in the assessment of internal validity. While issues 
related to bias, particularly the appropriateness of case selection, were more frequently 
dealt with than issues related to quality control and reliability, sampling strategies were 
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nevertheless poorly described, with little discussion of sample representativeness. Most 
notably, missing data were mostly unaddressed. Only two studies mentioned a possibility 
for missing data in regards to retrievable case files [5, 14, 15].  
 
Criterion-based clinical audit assumes that what is recorded was actually performed and 
what was not recorded, was not performed. Incomplete ascertainment of case files can 
lead to systematic bias, such as when files of maternal deaths are archived separately from 
general case files [13]. Missing and poorly completed case files are potentially a larger 
problem for studies using criterion-based clinical audit in the audit cycle, because audit 
has been shown to improve data recording. To improve confidence in audit results, 
systematic recording of missing data is needed. One way to do this is to compare the 
contents of the birth registry with retrievable case files. For example, the auditor could 
randomly sample 30-50 cases from the birth registry and record the number retrievable 
files. In many birth registries, there is information on maternal complications, as well as 
age, gravidity, and parity. By comparing the characteristics of retrievable patient files with 
non-retrievable files (based on information in the birth registry), researchers can assess 
both the extent to which patient records are missing and if records are missing at random.  
 
Criterion-based clinical audit has been used across multiple settings, by multiple 
reviewers, and at different time points; yet, no study assessed test-retest reliability and 
only two mentioned inter-observer variability. This is of concern because evidence from 
better-resourced contexts suggests moderate agreement between observers [27]. Better 
descriptions of staff profiles, training, and data collection methods and tools are needed. 
Future research should calculate reliability coefficients for criterion-based clinical audit.  
 64 
 
 
Despite the intended role of criterion-based clinical audit in the audit cycle, most papers 
employed cross-sectional study designs. These were descriptive studies. They measured 
the frequency of standard attainment but did not relate this measure to patient outcomes 
[13]. Four other studies employed criterion-based clinical audit in the audit cycle, using a 
before-and-after design [28]. Use of such a study design assumes that the tool is 
measuring the same underlying construct (e.g. quality of care) across time points, which 
has yet to be demonstrated. Two of these studies linked criterion-based clinical audit with 
maternal or perinatal outcomes [29] by comparing outcomes at initial and re-audit. 
However, for both of these studies sample sizes were very small. 
 
Overall, the studies did not evaluate the statistical link between quality of care (as 
measured by criterion-based clinical audit) and patient outcomes. Results showing that 
patient outcomes, such as maternal deaths, decrease with increased standard attainment 
would provide evidence that criterion-based clinical audit is measuring the underlying 
construct of quality of care. Given that maternal mortality is rare event and that sufficient 
power is difficult to obtain for such comparisons, future research could also compare 
standard attainment with process indicators such as the percentage of assisted deliveries or 
caesarean sections. Other outcome indicators could include stillbirths and near-miss 
events. Similarly, criterion-based clinical audit could be validated against another 
measurement tool, such as vignettes. Vignettes are written simulations of patient visits and 
can be given to medical professionals to measure their ability to evaluate, diagnose, and 
treat specific conditions. They have been shown to provide consistently better 
measurements of quality of clinical care than medical record abstraction when compared 
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to a gold standard and have been shown to be robust in multiple situations [29]. Such 
comparisons would provide useful information on criterion validity. 
 
Our review is limited by what has been published. Some omissions noted by this review 
may have been addressed but not reported, because there was more interest in applying 
criterion-based clinical audit than assessing it. Because criterion-based clinical audit is 
gaining popularity [13], there is a need to formally assess its measurement properties and 
to assure that selection bias pertaining to retrievable patient records in minimized. Given 
that criterion-based clinical audit is typically used in the audit cycle, further research is 
needed to evaluate whether the process of data collection influences other steps in the 
audit cycle, as well as audit effectiveness in improving maternal and perinatal outcomes. 
 
Finally, we would like to highlight that this article reviewed criterion-based clinical audit 
in the context of published research. We recognise that the funding and human resource 
capacity that generated such research is often vastly superior to that of the average 
hospital or clinician hoping to employ criterion-based clinical audit to improve obstetrical 
quality of care. Outside of the research setting, it is unrealistic to ask for comparison of 
audit results with vignettes or for the calculation of the inter-rater reliability coefficient. It 
is precisely for this reason the additional research is needed to fill these knowledge gaps. 
Data on the measurement properties of criterion-based clinical audit will give non-
researchers greater confidence in using the tool, help in the interpretation of audit results, 
and most importantly, assure that criterion-based clinical audit is truly measuring 
obstetrical quality of care.  
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Textbox: Recommendations to improve audit implementation and useful 
references for developing and employing criterion-based clinical audit  
RECOMMENDATIONS 
Audit piloting:  improves the pertinence of criteria selection (e.g. criteria actually apply to a given context) and reduces 
unnecessary variability (e.g. unclearly-worded criteria, differences between sites). 
 Perform a pilot test with ideally a minimum of 30 case files. Evaluate if all criteria are pertinent (should some be 
removed due to unusually high or low criterion-attainment) and clear (are auditors confident when selecting if a 
criterion has been met or not?) 
Sufficient auditor training: while non-medically trained auditors can be used for criterion-based clinical audits, 
sufficient training is still needed to assure that audits are both valid and reliable. 
 Train auditors in classroom and/or onsite. Provide a procedures manual. 
Assess missing data: compare data in the birth registry with retrievable case files to determine the number of missing 
files and if files are missing at random. 
 If there are too many missing records, medical record archiving needs improvement. 
 If data recording within the files is incomplete, medical staff need additional training on filling-out case files. 
Evaluate data recording over time: higher score attainment after initial audit may be attributable to better record 
keeping.  
 Evaluate the completeness of case files over time. Improvements in record keeping is a good thing, but if this 
occurs after the first audit, interpretations regarding improved obstetrical care need to be nuanced against more 
complete case file recording. 
Report process and outcome indicators: when using criterion-based audit in the audit cycle, report both process (% 
assisted deliveries, % caesarean sections, etc.) and outcome indicators (case-fatality rates, maternal and perinatal 
mortality ratios, etc.). 
 Quality improvements can lead to reductions in mortality levels and to improvements in service utilization. By 
reporting both forms of indicators, those employing audit can have a more complete picture of how audit is 
affecting their facility. 
SUGGESTED ARTICLES: 
1) Fortney JA, Leong M. Saving mother's lives: programs that work. Clin Obstet Gynecol 2009,52:224-236. 
2) Campbell OM, Graham WJ. Strategies for reducing maternal mortality: getting on with what works. Lancet. 2006 
Oct 7;368:1284-99. 
Both articles provide a concise review of interventions proven to reduce maternal mortality. These articles along with 
the Cochrane Library, the WHO reproductive health library and standard textbooks can help in development of a 
criterion-based clinical audit. 
SUGGESTED WEBSITES: 
1) Beyond the numbers: reviewing maternal deaths and complications to make pregnancy safer (2004), published 
by the World Health Organization, is available both online and as a book. This document details multiple forms of 
audit, in addition to the criterion-based clinical audit, that can be used to improve obstetrical quality of care. 
http://www.who.int/reproductivehealth/publications/monitoring/9241591838/en/index.html (last accessed 
March 19, 2011).  
2) Averting Maternal Death and Disability (AMDD): http://www.amddprogram.org/d/ (last accessed March 19, 
2011). This website contains a resource page with links on clinical training and quality improvement. One link 
specifically addresses how to improve emergency obstetrical care through criterion-based audits: 
http://www.amddprogram.org/v1/resources/CriterionBased%20AuditEN.pdf (last accessed March 19, 2011). 
3) The global research initiative for maternal mortality programme assessment or Immpact http://www.immpact-
international.org/index.php?id=1 (last accessed March 19, 2011). This website contains a module in their 
resource centre describing the steps in conducting a criterion-based clinical audit.
 
 
Development and Validation of CBCA Instrument 
 
Given the standardized and quantitative nature of CBCA, it could prove useful as an 
epidemiological tool for measuring obstetrical quality of care during the intrapartum 
period. Our review of the literature on the use of CBCA in resource-limited settings 
documented that an increasing number of researchers, particularly in sub-Saharan Africa, 
are employing CBCA to evaluate improvements (or declines) in the quality of obstetrical 
care. However, the review also demonstrated that little attention has been paid to the 
measurement properties of CBCA and that only two studies correlated CBCA scores with 
health outcomes, notably maternal and perinatal deaths (139). We thus concluded that the 
current state of the literature did not allow us to determine whether CBCA was a valid and 
reliable measure of obstetrical quality of care, though we were reassured of its feasibility 
in low-income settings. 
 
Despite the knowledge gaps in the literature, we still felt that CBCA was the most 
promising method to measure intrapartum obstetrical care, but that we would need to 
develop our own instrument to address the limitations identified by the review. We 
describe the development process and efforts to validate the instrument in the next several 
chapters. In the first of these chapters, we describe the initial development and piloting of 
the instrument. During the pilot study we evaluated the content validity and inter-rater 
reliability of the instrument. In the following chapter, we assess the possibility of selection 
bias related to our sampling strategy. In this chapter, we are particularly interested in the 
availability of records for audit. Following our assessment of selection bias, we present a 
short communication on the importance of good recordkeeping practices for quality health 
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care. This communication was published by the International Journal for Quality in Health 
Care. Finally, we present the results of our assessment of content validity in the form of a 
peer-reviewed article. In this work, we assess whether our measure of quality, as obtained 
through the CBCA questionnaire, can predict key outcomes, such as perinatal mortality. 
This article has been published by BMC Pregnancy and Childbirth. 
 
 
Chapter 7: Development of CBCA Instrument and Pilot Study 
 
In this chapter, we describe the development of the CBCA questionnaire for the 
QUARITE trial. We also present pilot study results. These were used to evaluate the 
content validity of the questionnaire and inter-rater reliability. 
 
Objectives 
1) Develop a CBCA questionnaire to measure process-level intrapartum quality of 
care 
2) Evaluate the content validity and inter-rater reliability of the CBCA 
 
Methods 
Definition of the Measurement Construct   
The construct we are attempting to measure is intrapartum quality of care at the process 
level
15
. We focus on quality of care during the intrapartum period- labour, delivery, and 
the first 24 hours postpartum- because most maternal deaths occur during this time (57). 
By focusing on process-level quality of care, we are attempting to evaluate whether 
medicine in being properly practiced (75). This entails considerations of the 
appropriateness and completeness of information obtained through clinical history, 
physical examination and diagnostic tests; justification of diagnosis and therapy; technical 
                                                          
15
 In order to streamline the text from this point on, we will refer to process-level intrapartum quality of care 
as intrapartum quality of care, only. In the instances that we refer to structural-level quality of care, we will 
explicitly state this.  
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competence of staff; primary prevention where possible; early detection and management 
of problems; and coordination and continuity of care (57, 75).  
 
Generation of the Item Pool 
We compiled a pool of criteria generally accepted to represent best-practices in obstetrics. 
Criteria were selected by reviewing the literature (peer reviewed articles, Cochrane 
reviews, and the WHO Reproductive Health Library), best-practice guidelines from the 
Royal College of Obstetricians and Gynaecologists, and expert opinion. Criteria selection 
was consistent with WHO methods for conducting an obstetrical CBCA (79). Once a 
comprehensive item pool was compiled, the researchers removed criteria impossible to 
verify by using only medical records or criteria that were not relevant to the West African 
setting. For example, empirical evidence supports the presence of a family member during 
labour, as this reduces the probability of birth by caesarean section (140). However, 
family members are rarely allowed in the delivery room of most referral hospitals and this 
information is not recorded in either Senegalese or Malian medical records. Because of 
this, we removed this criterion from the item pool. 
 
Review of the Initial Criteria Pool with Experts 
Reviewing a criteria pool with experts is important to maximizing content validity (141). 
Once we had selected a criteria pool, a draft questionnaire was constructed and circulated 
to two Canadian, one French, one Malian, and one Senegalese expert. We asked the 
reviewers to evaluate the questionnaire for relevance and clarity. We also asked them if 
we had omitted any important criteria. The CBCA questionnaire was refined based on 
their suggestions and modifications.  
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Format of the scale 
In a typical CBCA, auditors review patients’ medical records to ascertain whether pre-
specified criteria have been met (58, 79). In many ways, a CBCA is a checklist of pre-
specified standards of good quality care. For example, the auditor may “check-off” if a 
patient’s blood pressure, pulse, and temperature were taken. A typical format for a CBCA 
questionnaire is given below.  
 
Is the following information available from the patient’s medical record? 
Blood pressure  ___ Yes  ___Non 
Pulse    ___ Yes  ___Non 
Temperature   ___ Yes  ___Non 
 
For each yes response, a point is given. In the example above, a total of three points are 
possible.  
 
Our CBCA questionnaire follows the above format but also requests additional data to 
improve data entry and interpretation. Using the example above, in addition to asking if 
blood pressure, pulse, and temperature had been taken, we required the auditor to record 
the actual value of each of these criteria. Thus, the format of much of the questionnaire 
was:   
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Check the yes box if this section of the patient medical record was completed, otherwise 
check no. If yes, copy the information given in the patient medical record onto the line 
provided.   
a) Pulse   □Yes ________________  □No 
b) Blood pressure  □ Yes________________  □No 
c) Temperature  □ Yes________________  □No 
 
A copy of the pilot version of the CBCA questionnaire can be found in appendix 5. The 
questionnaire contained ten sections. Four of the sections were intended for all patients. 
Another six sections applied to special situations: use of the partograph, caesarean section, 
and obstetrical complications. Contained in these five sections was an identification 
section (essential to linking this database with that of broader QUARITE CRT); a section 
describing the completeness of the patient record; a section on patient history; and sections 
on delivery management and follow-up after birth. Under these five sections, there were 
21criteria that applied to all patients. Additionally, there were sections for women in 
which a partograph was employed (7 criteria), for women who had had a caesarean (4 
criteria), and for those who had had pre-eclampsia or eclampsia (5 criteria), haemorrhage 
(6 criteria), and/or HIV/AIDS (2 criteria). For each yes response to a criterion, a point was 
awarded. For vaginal births without a partograph, the total possible score was 21. When 
additional sections were applicable, the total score was higher. For example, the total 
possible score for a woman with HIV/AIDS was 23. For a woman who delivered vaginally 
but also had a partograph in her medical record, the total possible score was 28. 
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Data Entry Form and Validity Checks 
Once a paper version of the CBCA questionnaire was completed, an electronic version of 
the questionnaire was programmed in Structured Query Language (usually referred to as 
SQL) and placed onto three notebook computers with long battery lives. We programmed 
additional internal validity checks to improve data entry. Continuing with the example 
above, if the auditor clicked yes next to the blood pressure criterion, she could not 
complete the questionnaire without also typing the blood pressure value found in the 
medical record. We did this to limit missing values and to assure that the auditors did not 
mindlessly click yes or no boxes in the questionnaire. Additionally, the questionnaire 
contained a few validity checks to prevent impossible responses (for example, maternal 
ages below 10 and above 65 were not allowed). By entering the data directly into an 
electronic database, there was less risk of lost data collection forms and illegible data 
recording. Data entered into the electronic questionnaire were exportable to Microsoft 
Excel and other statistical software. 
 
Pilot CBCA Questionnaire on a Development Sample 
The final step in developing the CBCA questionnaire was to administer it to a 
development sample. We used the development sample to assess content validity and 
inter-rater reliability. The methods employed to deliver the CBCA questionnaire to the 
development sample are described in detail below. 
 
Study design: To assess content validity and inter-rater reliability, we conducted a pilot 
study at four sites in each capital (Dakar, Senegal and Bamako, Mali), or eight sites in 
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total. To determine inter-rater reliability, two auditors reviewed an identical sample of 
patient medical records at each site. To assess content validity, auditors carefully noted 
difficulties encountered during the audit.  
 
Training of audit assistants: The candidate trained a midwife research assistant in each 
capital to conduct the CBCA. Each assistant received a procedures manual and two days 
of training. The first day of training was in the classroom and devoted to describing the 
study purpose, the CBCA instrument, and practicing with the notebook computers and the 
electronic questionnaire. The second day of training was onsite and consisted of a mock 
audit of 20-25 medical dossiers. After completing all audits in each capital, a meeting was 
held with each research assistant to discuss problem sections in the questionnaire and 
potential improvements to the CBCA. 
 
Sample & Data Collection: We aimed to select 32 patient records per site (the eight most 
recent births and the eight most recent cases of the following complications: haemorrhage, 
(pre) eclampsia, and HIV/AIDS). Cases were identified from admissions’ birth registers 
and corresponding medical records were sought. Because of quality controls put in place 
by the QUARITE trial, most medical records were stored in the delivery room or the 
examination room of the head midwife. Certain records were also stored in the surgical 
block. When a case’s medical record could not be found, the next most recent birth was 
selected. A three-month window was used to sample cases. Once all patient medical 
records were found in that three-month window, the candidate and research assistant 
extracted data into the electronic questionnaire.   
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Data Analysis: Data were analysed in SPSS 16 and STATA 9. Descriptive analyses were 
conducted using the candidate’s data to determine the frequency that each criterion was 
met. We paid particular attention to criteria with very high (above 80%) and very low 
(below 20%) proportions of attainment.  
 
We also calculated a score for each patient based on the total proportion of criteria met. 
We used a proportion, because the number of possible criteria varied by woman (e.g. if 
she had a partograph, caesarean section, and/or complication). To calculate the proportion, 
we divided the total number of criteria met by the total possible for that patient. We 
calculated two scores. The first score, entitled full questionnaire, used all criteria. The 
second score entitled, core sections, included the four portions of the questionnaire 
applied to all women in the development sample (completeness of the patient medical 
record; clinical history of the patient; management of labour and delivery; immediate post-
partum follow-up). Because the same core questions were applied to all women sampled, 
the denominator (n = 21 criteria) for this score is identical for all women. However, for the 
sake of comparing descriptive statistics (mean, standard deviation, minimum and 
maximum values) with the full questionnaire score, we also present these scores as 
proportions. 
 
After having analysed the descriptive characteristics of the questionnaire, we assessed 
agreement between auditors. First, we evaluated inter-rater reliability for each criterion by 
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percent agreement and the Kappa coefficient. The inter-rater reliability for the three scores 
was assessed with the intra-class correlation coefficient.  
 
Results 
 
Table 7 shows the final criteria included in the CBCA questionnaire applied to the 
development sample, as well as the level of evidence supporting each criterion choice in 
the questionnaire.  
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Table 7: Selected criteria with an explanation and evidence for inclusion in the questionnaire 
Criterion Explanation and supporting evidence justifying criterion  
Identification: Items contained in this section allowed merge with full QUARITE database (not calculated in the CBCA score). 
Country n/a 
Hospital structure n/a 
Registration number n/a 
Admission date n/a 
Patient initials  This information was recorded instead of the patient’s name for confidentiality reasons 
Patient’s age n/a 
Completeness of Patient Medical Record 
Condition of mother at arrival Expert opinion; The quality of data recording in a medical record is in of itself an indicator of good care (75). 
Date of birth Expert opinion; The quality of data recording in a medical record is in of itself an indicator of good care (75). 
Name of the person who delivered the 
baby 
Expert opinion; The quality of data recording in a medical record is in of itself an indicator of good care (75). 
Exit date Expert opinion; The quality of data recording in a medical record is in of itself an indicator of good care (75). 
Condition of the mother at exit Expert opinion; The quality of data recording in a medical record is in of itself an indicator of good care (75). 
Condition of the child at exit Expert opinion; The quality of data recording in a medical record is in of itself an indicator of good care (75). 
Partograph available Moderately compelling evidence for the use of partograph (142). Results from meta-analyses of randomized control studies 
have been inconclusive (143) but expert opinion (144) supports use of the partograph. Systematic and correct use may lead to 
early diagnosis of prolonged obstructed labour and use of appropriate interventions when obstructed labour occurs (142, 144). 
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Clinical History of the Patient  
Number of prenatal visits Expert opinion expressed in peer-reviewed literature. In LMIC, the ideal number of antenatal visits is between 3 and 4 (142). 
Gravidity Expert opinion (145) 
Parity Expert opinion (145) 
Pulse Expert opinion (145) 
Blood pressure Expert opinion as expressed in the peer-reviewed literature (142, 145) 
Temperature Expert opinion (145) 
Level of Consciousness Expert opinion.  
Blood type Necessary should the woman need a blood transfusion. Expert opinion. 
Rhesus factor Avoid rhesus incompatibility between infant and mother. Expert opinion 
Obstetrical antecedents Expert opinion; observation studies (39) 
Management of the Labour and Delivery 
Birth supervised by a qualified 
attendant (doctor, nurse or midwife) 
It is widely accepted that birth with a skilled attendant (doctor, nurse, or midwife) protects against maternal mortality, but the 
evidence for this in not robust (142). The type of skilled attendant is important, the benefit is greater for doctors versus nurses 
and midwives (146).  
Prophylactic oxytocin given 
postpartum 
Meta-analysis of randomized control studies. Oxytocin is the utertonic of choice for preventing post-partum haemorrhage as it 
helps to prevent uterine atony (142, 145) 
Immediate post-partum follow-up 
Follow-up two hours after the birth Expert opinion. Follow-up is essential as most maternal deaths occur post-partum (142). 
Was there an exit exam Expert opinion. Follow-up is essential as most maternal deaths occur post-partum (142). 
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Partograph  
Time of first exam This is a component of a partograph. As mentioned above, there is moderately compelling evidence for the use of partograph 
(142). Results from meta-analyses of randomized control studies have been inconclusive (143) but expert opinion including 
ALARM international and the WHO (144) support use of the partograph. Systematic and correct use of the partograph may 
lead to early diagnosis of prolonged obstructed labour and use of appropriate interventions when obstructed labour occurs 
(142, 144). 
Time of expulsion See note about partograph above. 
Fœtal presentation See note about partograph above. 
Condition of membranes See note about partograph above. 
Colour of amniotic fluid See note about partograph above. 
Frequency of uterine contractions See note about partograph above. 
Medications See note about partograph above. 
Caesarean- This section applied to women who received a caesarean section. 
Was the reason for the caesarean 
given? 
Expert opinion. At present, there are no trials to assess the risks and benefits of caesarean section undertaken without a 
conventional medical indication (147). 
What was the delay between the 
decision to do a caesarean and its 
performance? 
Expert opinion agrees that the recommended decision to delivery window for caesarean section is 30 minutes (148). 
Prophylactic antibiotics administered? Meta-analyses of randomized control studies. This important to avert post-partum sepsis (142). 
Eclampsia 
Was magnesium sulphate given Meta-analyses of randomized control studies. Magnesium sulphate is the anti-convulsant of choice for the treatment of pre-
eclampsia and eclampsia (142). 
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Bleeding time Expert opinion (145). Some observational studies suggest that the recommended treatment (magnesium sulphate) for severe 
pre-eclampsia/eclampsia may prolong bleeding times and cause further complications(149 {Kynczl-Leisure, 1996 #254)}. 
Coagulation rate Expert opinion (145). Some observational studies suggest that the recommended treatment (magnesium sulphate) for severe 
pre-eclampsia/eclampsia may prolong bleeding times & cause further complications(149 {Kynczl-Leisure, 1996 #254)}. 
Complete blood count Expert opinion (145). 
Albumin test Expert opinion (150).  
Haemorrhage 
Clinical surveillance (pulse & blood 
pressure) every 15 minutes for 2 hours 
after the diagnosis? 
Expert opinion (145). 
Use of oxytocin Meta-analyses of randomized control studies (142). Stimulates rhythmic contractions of the uterus leading to vasoconstriction 
thereby reducing blood loss (145).  
Bleeding time Expert opinion. Bleeding time, coagulation rate and complete blood count are used to guide replacement therapy after 
significant blood loss (151) . Bleeding time and coagulation rate tests are used to assess clinical coagulopathy (152). 
Coagulation rate See above note.  
Complete blood count Expert consensus. In acutely bleeding patients, platelet counts should not fall below a critical threshold (50×10
9
 litre
–1
) (152).  
Albumin test Expert opinion.  
HIV/AIDS 
Antiretrovirals (AZT or NVP) 
administered before and during 
delivery? 
Randomized control trials (153, 154). Administration of antiretrovirals prior to delivery and immediately after delivery greatly 
reduce mother to child transmission of HIV.  
Antiretrovirals (AZT or NVP) 
administered to the child after birth? 
Randomized control trials (155). Administration of antiretrovirals to the baby reduce mother to child transmission of HIV 
through breast milk.  
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Problem criteria identified while piloting the questionnaire 
Here we discuss criteria for which modifications were necessary (table 8). 
Table 8: Problems associated with particular criteria and suggested modifications 
identified during piloting of the questionnaire 
Problem Explanation Suggestions/ Modifications 
Missing 
question 
For the identification section of the 
questionnaire, the hour of admission was 
missing. 
In the identification section, record 
the hour of the mother’s admission 
Missing 
criteria 
All pregnant women are supposed to be tested 
for both HIV and syphilis. Knowledge of status 
can assist in the early detection and management 
of problems, such as sepsis (142). 
Ask if the mother has been tested for 
HIV and syphilis. 
Condition of 
the mother at 
arrival 
When the condition of the mother was recorded, 
it was mostly “BEG” (bon état général) or good 
condition. For a minority of women (6%), 
another condition was recorded, but the terms 
used to describe the condition were variable. For 
example, in certain medical records, the 
condition was labelled, “assez bon état général” 
(decent general condition) and in others it was 
labelled “passable” (acceptable). Both of these 
terms represent approximately the same 
condition. In addition, the condition of the 
mother was used as a proxy for her level of 
consciousness. 
Create a drop-down menu in the 
electronic questionnaire for each 
woman with an available condition at 
arrival. The suggested choices for the 
drop down menu are: 
BEG, ABEC, Altération, Mauvais état 
(Good, decent, alternating, and bad 
condition) 
Remove the later criterion on the level 
of consciousness. 
Condition of 
the child at exit 
This information was rarely recorded (only 25 
times in both countries). Frequently, we were 
only able to respond to this criterion if the child 
was stillborn.  
Remove this criterion and instead ask 
about the condition of the child at 
birth (APGAR scores).  
Condition of 
the mother at 
exit 
This information was rarely recorded (only 58 
times in both countries). It was strongly 
associated with whether the woman had an exit 
exam or not. Of the 58 women for whom this 
criterion was met, only 1 did not have an exit 
exam.  
Remove this criterion but retain the 
question asking if the woman had an 
exit exam or not. 
Obstetrical 
antecedents 
This criterion is too vague. On some medical 
records, there was a check box for obstetrical 
antecedents. In others, this information was 
written down. The midwife auditors informed us 
that often, if there were no obstetrical 
antecedents, this information was not recorded. 
Because the audit is based on information 
Remove criterion. 
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available in the medical dossier, we could not 
distinguish a woman with no obstetrical 
antecedents from one in which this information 
was not sought. Further, this question is non-
applicable to nulliparous women.  
 
 
Birth 
supervised by a 
qualified 
attendant 
(doctor, nurse 
or midwife) 
This criterion could be more precise. Instead of 
whether the birth was supervised by a qualified 
attendant, the type of attendant who supervised 
the birth should be indicated. An additional 
choice of “unknown” should be given for 
instances in which the qualification of the 
attendant was not specified. Need to add an 
option for interns.  
Create a drop-down menu in the 
electronic questionnaire with the 
following options: 
No; Yes, doctor; Yes, midwife; Yes, 
intern; Yes, nurse; Yes, supervised 
birth but qualification of attendant 
unknown 
Prophylactic 
oxytocin given 
postpartum 
 
Need to clarify when and how the oxytocin was 
given. 
 
 
Change the question to: 
A dose of oxytocin (syntocinon) was 
administered parenterally 
(intramuscularly or intravenously) to 
the women either during the expulsion 
of the baby or immediately after.  
The auditor can select as responses to 
this criterion: 1) Yes, AMTSL; 2) 
Yes, oxytocin only; 3) No 
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In addition to the above-noted difficulties related to specific criteria, two sections of the 
CBCA questionnaire proved particularly problematic: the caesarean section and 
partograph portions. In the caesarean section portion of the CBCA, the auditors struggled 
to determine the delay between the decision to do the caesarean and when it was 
performed. In the actual questionnaire, this criterion was addressed by two questions: 1) 
When was it decided to perform a caesarean? and 2) When was the caesarean actually 
performed? We found that medical records rarely contained information on when medical 
staff decided a caesarean was necessary. Further, the question on when the caesarean was 
performed turned out to be vague as auditors were uncertain as to what counted as 
performing the caesarean (entering the operating block, beginning the caesarean, 
extracting the baby, or completing the caesarean). In Mali, one auditor recorded decision 
times for 89 percent of the women who had had a caesarean section. It turned out that 
most of these decision times were for when the woman entered the operating room and not 
for when an obstetrical problem was detected
16
.   
 
For the partograph section, it was difficult to determine what constituted a completed 
partograph. In many cases, while an insert in the medical dossier containing a blank 
partograph graph was available, the curve of the graph was not completed despite the 
recording of other information on this insert (such as contraction frequency and 
medications). The most difficult situation for auditors was when a woman arrived just 
prior to giving birth, preventing completion of the partograph curve. There were also 
                                                          
16
 In the CBCA questionnaire, we asked if the reason for the caesarean section was given and then asked the 
auditor to record the reason. By doing so, we could assess if the caesarean section was performed for 
maternal indication or if it was elective. Based on our sampling scheme and confirmed by our findings, none 
of the women included in the development sample had elective caesarean sections.  
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concerns about the veracity of data entered into the partograph as the auditors witnessed 
interns completing partographs for women having already given birth.  
 
Sampling and case retrieval:  
We were unable to meet sampling goals (185 dossiers versus the intended 256 dossiers), 
largely because of an insufficient number of complications in the three-month sampling 
period and to a certain extent, poorly maintained archives. According to the first year of 
QUARITE data collection, we expected approximately 0-33 percent (median 4%) of 
obstetrical admissions to consist of (pre-) eclampsia and 0-21 percent (median 6%) to 
consist of ante- and post-partum haemorrhage
17
. Given QUARITE eligibility criteria and 
these frequencies, we should have had at least eight cases of haemorrhage per site and 12 
cases of (pre-)eclampsia per site 
18
. Because of the poor organisation of record archives, 
we believe that these cases existed, but their files were irretrievable. Additionally, at sites 
with poorly maintained archives, much of the day was spent searching for case records 
and there was insufficient time to perform the full audit. When there were insufficient 
complications, we oversampled vaginal births to obtain larger overall sample sizes at each 
site. In all, we were able to sample 30 cases of (pre) eclampsia out of 64; 34 haemorrhage 
cases out of 64, and 25 HIV cases out of 64. Most of the cases of HIV were from Mali 
(21/25). 
 
                                                          
17
 It is important to highlight again that these are referral hospitals and some of the sites, especially in the 
capital, have very high numbers of complication because they receive references from other sites. 
18
 The QUARITE trial only included hospital sites with a minimum of 800 births per year. Thus, the 
minimal number of women passing through the study at a single site, during a three-month window, would 
be 200.  
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Frequency of criterion attainment 
Table 9 shows the frequency that each criterion was met by country, based on results from 
the candidate’s audit.  
Table 9: Frequency and percent each criterion was met by country 
Core sections Senegal (n=95) Mali (n=89) 
Mother’s condition at arrival 76 (80.0%) 25 (28.1%) 
Date of birth 95 (100.0%) 89 (100.0%) 
Name of person who assisted delivery 49 (51.6%) 78 (87.6%) 
Exit date 56  (58.9%) 25 (28.1%) 
Mother’s condition at exit 39 (41.1%) 19 (21.3%) 
Child’s condition at exit 10 (10.5%) 15 (16.9%) 
Partograph available 22 (23.2%) 63 (70.8%) 
Number of prenatal visits 70 (73.7%) 87 (97.8%) 
Gravidity 95 (100.0%) 89 (100%) 
Parity 90 (94.7%) 89 (100%) 
Pulse 24 (25.3%) 74 (83.1%) 
Blood pressure 74 (77.9%) 85 (95.5%) 
Temperature 10 (10.5%) 80 (89.9%) 
Consciousness 77 (81.1%) 25 (28.1%) 
Blood type 64 (67.4%) 69 (77.5%) 
Rhesus factor 63 (66.3%) 69 (77.5%) 
Obstetrical antecedents 34 (35.8%) 68 (76.4%) 
Assisted birth  41 (43.2%) 59 (66.3%) 
Oxytocin 79 (83.2%) 54 (60.7%) 
2-hour follow-up 10 (10.5%) 79 (88.8%) 
Exit exam 47 (49.5%) 18 (20.2%) 
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Partograph Senegal (N=22) Mali (N=63) 
Time 1
st
 Exam 22 (100.0%) 63 (100.0%) 
Time Expulsion 20 (90.9%) 61 (96.8%) 
Presentation 21 (95.5%) 61 (96.8%) 
Ruptured membranes 22 (100.0%) 55 (87.3%) 
Colour amniotic fluid 13 (86.4%) 60 (95.2%) 
Contractions 21 (95.5%) 20 (31.7%) 
Medications 13 (86.4%) 60 (95.2%) 
Caesarean Senegal (N=22) Mali (N=16) 
Indication for CS 21 (95.5%) 13 (81.3%) 
Time Decision 7 (31.8%) 4 (25.0%) 
Time Realisation 4 (18.2%) 15 (93.8%) 
Antibiotics 11 (50.0%) 13 (81.3%) 
Eclampsia Senegal (N=14) Mali (N=13) 
Magnesium Sulphate 6 (42.9%) 3 (23.1%) 
Bleeding time 0 (0.0%) 0 (0.0%) 
Coagulation test 1 (7.1%) 0 (0.0%) 
Platelet Count 11 (78.6%) 0 (0.0%) 
Albumin test (proteinuria) 8 (57.1%) 1 (7.7%) 
Haemorrhage Senegal (N=16) Mali (N=9) 
15 min surveillance 0 (0.0%) 1 (11.1%) 
Oxytocin 12 (75.0%) 9 (100.0%) 
Bleeding time 0 (0.0%) 0 (0.0%) 
Coagulation test 0 (0.0%) 0 (0.0%) 
Platelet Count 11 (68.8%) 2 (22.2%) 
Albumin test (proteinuria) 3 (18.8%) 0 (0.0%) 
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HIV/AIDS Senegal (N=4) Mali (N=21) 
ART Mom 1 (25.0%) 3 (14.3%) 
ART Baby 3 (75.0%) 14 (66.7%) 
 
In the core sections of the questionnaire, there was high criterion attainment in both 
countries for date of birth (100%), gravidity (100%), and parity (nearly 100%). There was 
low criterion attainment (under 20%) for the child’s condition at exit. For temperature and 
two-hour follow-up, there was low criterion attainment in Senegal (11%) and high 
criterion attainment in Mali (about 90%). In the partograph section, there was limited 
variability in criterion responses. Each criterion had very high percent attainment (85% or 
above). The only exception was for the criterion on contraction frequency. In Senegal, 
attainment was 96% but in Mali it was 32%. For the complications of eclampsia and 
haemorrhage, criterion attainment for laboratory tests was low, especially in Mali.  
 
Table 10 presents descriptive statistics for the CBCA scores in each country. Scores are 
presented for the full questionnaire and the core sections of the questionnaire. There was 
higher average percent criterion attainment in Mali than Senegal, but there was also a 
greater range of values in Mali than Senegal. Percent attainment for the core sections was 
approximately the same as for the full questionnaire. In Mali, percent attainment was 
slightly higher for the core sections of the questionnaire than for the full questionnaire, 
indicating lower criterion attainment for cases of obstetrical complications in Mali. 
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Table 10: Percent criteria attainment by country 
Full Questionnaire 
 Senegal (n=95) Mali (n=89) 
Mean 0.52 0.65 
S.D. 0.11 0.14 
Min 0.26 0.19 
Max 0.79 0.90 
Core Sections 
Mean 0.52 0.68 
S.D. 0.11 0.16 
Min 0.29 0.19 
Max 0.81 0.90 
 
Auditor agreement for each criterion 
Tables 11 and 12 show auditor agreement for each criterion. Percent agreement and Kappa 
coefficients are presented. Cross tables are available in Appendix 6 for those criteria with 
an asterisk.  
Table 11: Percent agreement and Kappa coefficient for each criterion in Senegal 
Senegal (N = 96 patients) 
Criterion % Agreement Kappa 
Mother’s condition at arrival 88/96 = 91.7% 0.704 
Date of birth 96/96 = 100% 1.00 
Name of person who assisted in 
the delivery 
88/96 = 91.7% 0.833 
Exit date 90/96= 93.8% 0.873 
Mother’s condition at exit* 71/96= 74.0% 0.410 
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Child’s condition at exit* 88/96 = 91.7% 0.553 
Partograph available 90/96 = 93.8% 0.839 
Number of prenatal visits 90/96 = 93.8% 0.849 
Gravidity 95/96 = 99.0% 1.000 
Parity* 73/ 96 = 76.0% 0.224 
Pulse 88/96 = 91.7% 0.795 
Blood pressure 92/96 = 95.8% 0.878 
Temperature 93/96 = 96.9% 0.807 
Consciousness 86/96 = 89.6% 0.658 
Blood type 90/96 = 93.8% 0.859 
Rhesus factor 91/96 = 94.8% 0.884 
Obstetrical antecedents* 64/96 = 66.6% 0.357 
Assisted birth*  64/96 = 66.6% 0.458 
Oxytocin* 60/96 = 62.5% 0.196 
2-hour follow-up* 56/96 = 58.3% 0.259 
Exit exam 83/96 = 86.5% 0.728 
Partograph 
Time 1
st
 Exam 100% 1.000 
Time Expulsion 20/22 = 90.9% n/a; 100% attainment for one auditor 
Presentation 21/22 = 95.5% n/a; 100% attainment for one auditor 
Ruptured membranes 21/22 = 95.5% n/a; 100% attainment for one auditor 
Colour amniotic fluid* 14/22=63.6% 0.248 
Contractions 21/22 = 95.5% n/a; 100% attainment for one auditor 
Medications 21/22 = 95.5% 0.904 
Caesarean 
Indication for CS 100% 1.00 
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Time Decision 14/21 = 66.7% n/a; 100% non-attainment for one auditor 
Time Realisation 5/21 = 23.8% 0.023 
Antibiotics 12/21 = 57.1% 0.145 
Eclampsia 
Magnesium Sulphate 11/11 = 100% 1.000 
Bleeding time 11/11 = 100% 1.000 
Coagulation test 11/11 = 100% 1.000 
Complete blood count 7/11 = 63.6% 0.353 
Albumin test 11/11 = 100% 1.000 
Haemorrhage 
15 minute surveillance 7/12 = 58.3% n/a; 100% non-attainment for one auditor 
Oxytocin* 7/12 = 58.3% 0.000 
Bleeding time 12/12 = 100% 1.000 
Coagulation rate 11/12 = 91.7% 0.625 
Complete blood Count 10/12 = 83.3% 0.571 
Albumin test 10/12 = 83.3% 0.636 
HIV/AIDS 
ART Mom 3/4 = 75.0% 0.500 
ART Baby 3/4 = 75.0% 0.500 
 
For most criteria in the core section of the questionnaire there was high to very high 
agreement. For the child’s condition at exit, there was high percent agreement (92%) but a 
moderate Kappa (0.55). Similarly, for the parity criterion, percent agreement was 76%, but 
the Kappa was 0.22. For both, marginals in the cross-table were imbalanced (see appendix 
6). Lowest agreement was found for: obstetrical antecedents, birth with a qualified 
assistant, prophylactic oxytocin, and two-hour follow-up after birth. For both the child’s 
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condition at exit and 2-hour follow-up, information on these criteria was only available in 
a handful of medical records (11.0%, see table 9). The Kappa statistic is often unreliable 
for rare findings; it tends to be low when the prevalence of a finding is low (156). This 
may help explain the low Kappa coefficients for each of these criteria.  
 
For a handful of criteria in Senegal, most notably, the mother’s condition at arrival, parity, 
and oxytocin, it appears that auditor one was more likely to indicate that a criterion was 
present than auditor two (see appendix 6). Auditor one was the candidate. She feels that 
she was more thorough at inspecting the records than the audit assistant. As is presented 
below, reliability scores are better in Mali. Hospitals in Mali were sampled after Senegal 
by a second audit assistant and the improved scores reflect, in part, improved training and 
a more conscientious audit assistant.  
 
For the partograph section of the questionnaire, there was very little disagreement, but 
there was also virtually 100% criterion attainment and thus little response variability. 
There was very low agreement for the caesarean section portion of the questionnaire. For 
criteria in the complication section, except the 15-minute surveillance and oxytocin 
criteria of the haemorrhage section, there was relatively high agreement, but sample size 
was small. 
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Table 12: Percent agreement and Kappa coefficient for each criterion in Mali 
Mali (N = 89 patients) 
 % Agreement Kappa 
Core Sections 
Mother’s condition at arrival 76/89 = 85.39 0.667 
Date of birth 87/89 = 97.75 100% attainment for one auditor 
Name of person who assisted delivery 84/89 = 94.38 0.750 
Exit date 75/89 = 84.27 0.601 
Mother’s condition at exit 80/89 = 89.89 0.667 
Child’s condition at exit* 75/89 = 84.27 0.332 
Partograph available 78/89 = 87.64 0.676 
Number of prenatal visits* 77/89 = 86.51 0.110 
Gravidity 89/89 =100% 1.00 
Parity 89/89 =100% 1.00 
Pulse 82/89 = 92.13 0.712 
Blood pressure* 85/89 = 95.51 0.577 
Temperature 84/89 = 94.38 0.752 
Consciousness 84/89 = 94.38 0.752 
Blood type 83/89 = 93.26 0.792 
Rhesus factor 83/89 = 93.26 0.792 
Obstetrical antecedents* 69/89 = 77.52 0.070 
Assisted birth  79/89 = 88.76 0.756 
Oxytocin 75/89 = 84.27 0.674 
2-hour follow-up* 55/89 = 61.80 0.130 
Exit exam* 76/89 = 85.39 0.557 
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Partograph 
Time 1
st
 Exam 61/61 = 100% 1.00 
Time Expulsion 60/61 = 98.4% n/a 
Presentation 59/61=96.7% 0.783 
Ruptured membranes 61/61=100% 1.000 
Colour amniotic fluid 54/61 = 88.5% 0.736 
Contractions* 57/61 = 93.4% 0.315 
Medications 56/61 = 91.8% 0.663 
Caesarean 
Indication for CS 16/16 = 100% 1.00 
Time Decision 6/16 = 37.5% 0.09 
Time Realisation 16/16 = 100% 1.00 
Antibiotics 15/16 = 93.8% 0.765 
Eclampsia 
Magnesium Sulphate* 10/13 = 0.77 0.264 
Bleeding time 12/13 = 0.92 100% non-attainment for on auditor 
Coagulation rate 12/13 = 0.92 100% non-attainment for on auditor 
Complete blood count 11/13 = 0.85 100% non-attainment for on auditor 
Albumin test* 5/13 = 0.38 0.071 
Haemorrhage 
15 min surveillance 8/9 = 0.89 0.609 
Oxytocin 7/9 = 0.77 100% attainment for one auditor 
Bleeding time 9/9 = 1.00 n/a 
Coagulation rate 9/9 = 1.00 n/a 
Complete blood count * 6/9 = 0.66 -0.174 
Albumin test 8/9 = 0.89 100% non-attainment for one 
auditor 
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HIV/AIDS 
ART Mom 18/19 = 94.7% 0.771 
ART Baby 16/19 = 84.7% 0.659 
 
In Mali, there was good agreement for nearly all the criteria in the core section. Only the 
criteria of obstetrical antecedents and two-hour follow-up had low inter-rater agreement. 
Child’s condition at exit, the number of prenatal visits, and blood pressure all had high 
percent agreement but moderate to low Kappa coefficients. The marginals for all three of 
these criteria are imbalanced (see appendix 6) and in the case of the child’s condition at 
exit, this information was rarely recorded in the medical record. As mentioned above, 
when a finding is rare, Kappa also tends to be low (156). Like in Senegal, the criteria for 
the partograph portion of the questionnaire had high agreement, but little variability. In 
caesarean section portion of the questionnaire, agreement for the time of decision for the 
caesarean was low. Once again, sample size for specific complications was low leading to 
unstable estimates of agreement.  
 
Agreement on partograph, caesarean section, and complications 
The agreement statistics presented above for the partograph, caesarean, eclampsia, 
haemorrhage, and HIV/AIDS sections are for those women in which both auditors had 
data. In other words, in order for the above-presented statistics to be calculated, 
preliminary agreement as to which women had received a partograph or caesarean or had 
a complication was necessary. In fact, there was some disagreement between auditors in 
regards to each. Tables 13 and 14 present the agreement between auditors for each section. 
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Table 13: Agreement between auditors in Senegal on additional sections 
Section Frequency by auditor Percent 
agreement 
Kappa 
coefficient 
Partograph available 22 versus 28 90/96 = 93.8% 0.839 
Caesarean section conducted 22 each 92/94 = 97.9% 0.941 
Experienced eclampsia 14 versus 11 93/96 = 96.9% 0.862 
Experienced  haemorrhage 14 versus 16 90/96 = 93.8% 0.763 
Infected with HIV/AIDS 4 each 4/4 = 100% 1.000 
 
Table 14: Agreement between auditors in Mali on additional sections 
Section Frequency by auditor Percent 
agreement 
Kappa 
coefficient 
Partograph available 63 versus 70 78/89 = 87.6% 0.676 
Caesarean section conducted 16 versus 19 86/89 = 96.6% 0.893 
Experienced eclampsia 16 versus 14 85/89 = 95.5% 0.840 
Experienced  haemorrhage 18 versus 11 78/89 = 87.6% 0.552 
Infected with HIV/AIDS 19 versus 21  87/89 = 97.8% 0.936 
 
Agreement for total scores (full questionnaire and core sections) 
Table 15 presents the ICC for the full questionnaire and the core sections of the 
questionnaire for each country. 
 96 
 
Table 15: ICC for scores  
 ICC- Senegal  
(n=96) 
ICC- Mali  
(n=96) 
Score for full questionnaire 0.646  
 
0.762  
Score for core sections 0.658   0.840  
 
 
The ICC based on scores from the full questionnaire and core sections of the questionnaire 
was higher in Mali than in Senegal. In Mali, the ICC was higher for the core section than 
for the full questionnaire. This is because there was low agreement for many of the criteria 
contained in the haemorrhage and eclampsia sections. 
 
Because of problems encountered with the partograph and caesarean section portions of 
the questionnaire, as a form of sensitivity analysis, we calculated a third score by 
removing these sections from the questionnaire.  Removal of these sections did not 
improve inter-rater reliability. The ICC for this reduced score was 0.634 in Senegal and 
0.774 in Mali. These ICC values are approximately the same as for the full questionnaire.   
 
Conclusions 
Based on the pilot study, the researchers identified a number of obstacles to implementing 
the CBCA. Before applying the CBCA to all sites in the QUARITE study, they suggested 
a number of changes specifically to improve access to patient records and the quality and 
reliability of data obtained by the questionnaire. 
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Operational changes to improve access to patient records 
It was difficult to access a sufficient number of complications, specifically haemorrhage 
and eclampsia. While this may in part, be due to an over-estimate of the number of 
complications during the three-month sampling window, we believe that the major 
problem was the quality of data recorded in the delivery register. Not all complications 
were recorded in the delivery register. To circumvent this problem in the future, the 
researchers should synchronize their data collection with the national coordinator’s visit to 
all study sites. During this visit, the coordinator compares a random sample of QUARITE 
data collection sheets with patient medical records to verify the quality of data collection. 
To facilitate the coordinator’s visit, staff at each site typically pull out and organise all 
medical records for the past three months. Coinciding data collection for the CBCA 
questionnaire with that of the national coordinator’s visit would improve access to medical 
records, hopefully reducing the number of missing records. Furthermore, the QUARITE 
data sheets record obstetrical complications and the researchers can triangulate 
information obtained from the medical registers with that of the QUARITE data sheets to 
assure that all cases of obstetrical complication are included. However, it is worth noting 
that the incomplete nature of records experienced during the pilot study is more similar to 
the actual conditions a clinician would encounter when performing an audit than the 
conditions supported under a well-resourced randomized trial. As one researcher put it, 
“the time required to retrieve records should not be underestimated. Indeed, the 
elusiveness of medical records may well be a valuable subject for audit” (157 p650).  
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Operational changes to facilitate understanding of the medical records 
We found that most information contained in the medical records of patients was recorded 
with abbreviations. Without a working knowledge of these abbreviations, it is difficult to 
understand the content of records and thus to complete the CBCA questionnaire. The 
researchers and research assistants compiled a list of common abbreviations. These 
abbreviations and definitions are presented in appendix 7. We suggest that auditors 
memorize this lexicon prior to data collection, as well as bring it with them as a reference 
tool during the audit. When possible, we also suggest that auditors request clarifications 
from midwives or doctors if they encounter unfamiliar abbreviations or terms and then 
make a note of these clarifications in order to update the lexicon.  
 
Precision of definitions of eligibility 
During the pilot study, we noted that occasionally, there was confusion as to when to 
apply certain subsections of the questionnaire. As discussed previously, the most frequent 
source of confusion concerned the partograph section of the questionnaire. We decided to 
eliminate the partograph section and replace it with a section containing criteria on the 
monitoring of women during labour. We did this because, at some sites, they did not have 
partograph charts but nonetheless monitored the labour; we did not want to unjustly 
penalize these sites. In this new section, we continue to ask if a partograph is available in 
the medical records and include many of the same questions that were previously included 
under the partograph section of the piloted questionnaire. 
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The section on monitoring the labour only applies to women who were at the hospital for 
four or more hours. During the pilot study, we noted that a substantial number of women 
arrived at the hospital just prior to giving birth and staff had little time to complete a 
partograph or perform other clinical exams typical to monitoring the labour (taking 
woman’s blood pressure, pulse, temperature, etc.). The four-hour threshold is based on the 
clinical expectation that blood pressure be taken every four hours (145); all other clinical 
measures are expected to be taken more frequently. To eliminate confusion concerning 
when to apply this section or not, the computer program prompts the auditor to check off 
whether the woman gave birth four or more hours after entering the hospital. The 
computer will only allow the auditor to complete this section if they have clicked yes to 
this prompt. 
 
There was also some uncertainty as to whether it was appropriate to apply quality criteria 
contained in the (pre)eclampsia and haemorrhage sections to certain women labelled as 
having these complications. Obstetrical complications are no different from other disease 
states; they exist on a continuum between mild and severe. On several occasions, the 
midwife research assistants felt that the quality criteria were too strict for milder 
complications. For the revised CBCA questionnaire, we were more restrictive as to whom 
the (pre)eclampsia and haemorrhage sections applied.  
 
Pre-eclampsia/ eclampsia: In the revised questionnaire, the eclampsia section only applied 
to women with severe pre-eclampsia or eclampsia. For women with mild to moderate pre-
eclampsia, it was felt that close monitoring of the patient is often sufficient and that care 
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was not always sub-optimal if criteria such as “was magnesium sulphate given?” were not 
met. When the medical records did not specify the severity of pre-eclampsia, we 
considered the woman as having severe pre-eclampsia if, in addition to high blood 
pressure (>15/9), she had high levels of albumin (recorded in the records as albumin +++), 
had severe oedema (recorded as OMI +++)
19
 and/or was experiencing convulsions.  
 
Haemorrhage: In the revised questionnaire, we only included cases of post-partum 
haemorrhage. Our decision was based on the following considerations. First, we 
considered the relationship between PPH and maternal mortality. Haemorrhage accounts 
for around 25% of global maternal deaths and PPH is the most common form of 
haemorrhage (158). Any important reduction in the number of PPH deaths will lead to 
significant declines in maternal mortality. Our second consideration was the link between 
PPH and intrapartum quality of care. PPH is considered largely preventable and when it 
does occur, clinically manageable (158). As most PPH occurs in the immediate 
postpartum period (159), during which the mother should be under the care a watchful 
attendant (57), there should be an association between quality of care and mortality due to 
PPH. The final consideration behind the decision to sub-sample PPH was practical. In the 
first year of the QUARITE trial, 4% of women in Mali had haemorrhage and 8% of 
women in Senegal had haemorrhage. As PPH is the most common form of haemorrhage, 
we believed we would have a sufficiently large sample of women with this obstetric 
complication. 
 
                                                          
19
 Oedema is no longer considered a valid indication of pre-eclampsia or eclampsia in most Northern 
settings. However, in West Africa, it is frequently used to indicate cases of pre-eclampsia or eclampsia. 
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Modifications to CBCA questionnaire 
Based on the results of this pilot study, we modified the CBCA questionnaire. All 
modifications were reviewed by experts (2 members of the Society of Obstetricians and 
Gynaecologists of Canada and 1 professor of obstetrics and gynaecology in Mali). The 
most important change to the questionnaire was an alteration of its structure to better 
correspond with the temporal flow of the care process during labour and delivery. Thus, 
we began with the initial interview and clinical exam and finished with the post-delivery 
follow-up. We believe such a structure is more intuitive but also, allows us to assess 
whether certain periods of the care process receive more attention relative to others. The 
ameliorated CBCA is presented in appendix 8 where we discuss clarifications, additions, 
and deletions made to the questionnaire. We note all modifications made to the 
questionnaire in red.  
 
 
Chapter 8- Assessment of Selection Bias Associated with Obstetrical 
Record Archiving 
 
In this chapter, we take a detailed look at the potential for selection bias related to the 
sampling strategies used to select obstetrical records for audit. We are particularly 
interested in evaluating selection bias because no previous work using CBCA has 
attempted to quantify how poor-recordkeeping may threaten study results (139), even 
though CBCA is entirely dependent on record availability. Specifically, we are concerned 
that medical records may go missing in a non-random fashion.  
 
The retreivability of medical records may confound any observed associations found 
between the ALARM intervention and quality of care and quality of care and patient 
outcomes. There may be an association between the availability of obstetrical records for 
audit and QUARITE’s ALARM intervention, as medical death reviews may oblige staff to 
more thoroughly maintain and archive records. The retreivability of a record may also be 
associated with obstetrical quality of care. Conceptually, the two should be correlated 
because recordkeeping is in of itself an indicator of quality (75, 160). Good recordkeeping 
is a sign of professional conscientiousness; it is also necessary to assure the continuity of 
patient care (160, 161). Furthermore, tools for monitoring labour, such as the partograph, 
are a part of the recordkeeping process. Finally, it is conceivable that the records of 
patients with near miss obstetrical events, or maternal deaths, go missing more frequently 
than the records of patients with minor or no complications. This may occur when the files 
of maternal deaths are archived separately from general records [13] or when women with 
severe complications pass through several hospital services and providers. The more staff 
that handle obstetrical records, the more likely they are to go missing. 
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We can indirectly assess if the retreivability of medical records raises concern for 
selection bias by looking at patient characteristics. Easily obtainable patient information, 
such as age and delivery method, can provide clues as to the representativeness of the 
populations for which records are available and for which they are not. For example, if 
missing records were associated with complicated deliveries, then we would expect a 
higher percentage of missing records in women receiving caesarean sections than in 
women who gave birth vaginally. In other words, we might expect something to the effect 
of table 16. 
Table 16: Cross table demonstrating where we would be under-sampling should selection 
bias be an issue 
 Adverse Outcome (near 
miss or death) 
Normal outcome 
Many missing records +++  
Few missing records   
 
Age can also be a useful indicator of whether we are unduly selecting one cell over 
another. Age can loosely proxy many demographic variables including income and 
education (young pregnant women tend to have less education and income than women 
who give birth later in life) (162, 163). In obstetrics, age is also associated with adverse 
events. Women at the extremes of the reproductive spectrum are more at risk for maternal 
death (39, 164, 165). Thus, it is conceivable that if there were significant age differences 
between samples for which records were available and for which they were not available, 
then selection bias would be a concern. Overall, we would like to avoid the below 
situation (table 17). 
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Table 17: Cross table of demonstrating where we would be over-sampling should selection 
bias be an issue 
 Adverse Outcome (near 
miss or death) 
Normal outcome 
Good Care  +++ 
Poor Care   
 
This situation would occur if the retrievability of a record was associated with the quality 
of care and with maternal outcomes. We believe that conceptually, there is no way to 
disassociate quality of care from the retrievability of records (good archiving is a sign of 
good quality care). But, the retreivability of records may not be associated with patient 
outcomes. In such a case, there would be less concern about selection bias.  
 
Objectives 
1) Assess the possibility of selection bias in the consecutive sample due to missing 
obstetrical records 
2) Assess the possibility of selection bias in the complicated sample due to messy 
and/or incomplete medical archives 
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Methods 
Sampling Strategy 
At each hospital, the birth registry was located and information about the last 30 
consecutive women who gave birth from September 30, 2010 was noted down
20
. Using 
the registry, we recorded each woman’s registration number, age, and if she had a vaginal 
or surgical birth
21. After, we attempted to locate the corresponding woman’s obstetrical 
record and we took note of which records were retrievable.  
 
We next conducted the CBCA audit on files that we were able to retrieve using the list of 
women described above. Beginning with the last woman who gave birth on September 
30
th
, we aimed to audit, consecutively, the previous 20 retrievable obstetrical records. We 
refer to this as the consecutive sample; it is a random snap-shot of the women treated at a 
given hospital as seen through their obstetrical records. When there were less than 20 
retrievable records from the list above (e.g. there were lots of missing records), we 
completed the sample with obstetrical records not included on the list, but consecutively 
sampled in reverse order until we reached at least 20 records.  
 
We also sub-sampled cases of severe (pre-) eclampsia, post-partum haemorrhage (PPH), 
and HIV/AIDS. Pre-eclampsia /eclampsia and haemorrhage are direct obstetrical 
complications that, according to the first year of QUARITE data collection at the 46 
participating centres in the trial, were recognized and treated approximately 0-33% 
                                                          
20
 At one hospital in Dakar, this was not possible because obstetrical records were only available until 
September 15. We therefore started the consecutive sample at September 15.  
21
 Surgical birth refer mostly to caesarean sections but also include hysterectomies 
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(median =4%) of the time for (pre-) eclampsia and 0-21% (median =6%) of the time for 
ante- and post-partum haemorrhage
22
. Given these frequencies, we aimed to sample eight 
cases of each complication per site in the three-month sampling frame. HIV/AIDS is an 
indirect obstetrical complication that occurs in 1-3% of the female population of 
reproductive age in Senegal and Mali (11, 166). We sampled all cases of HIV/AIDS in the 
three-month sampling frame, expecting around one case of HIV per month. This sample of 
(pre-) eclampsia, PPH, and HIV/AIDS is referred to as the complicated sample. The 
complicated sample includes cases of complication identified in the consecutive sample 
and additional cases sought out in the three-month sampling frame. In sampling 
complicated cases, we started with those that occurred closest in calendar time to 
September 30, 2010 and finished with those furthest from that date. 
 
Measures 
Patient variables: From the birth registry, we collected data on the patients’ ages and 
modes of delivery. The mode of delivery was categorized dichotomously: surgical birth 
(caesarean section and/or hysterectomy versus vaginal delivery). 
 
Hospital variables: These variables included whether the hospital was an ALARM or 
control site, whether it was located in the capital or outside of the capital (regional or 
district hospitals), and the hospital’s Complexity Index Score (see chapter 5). 
                                                          
22
 It is important to highlight again that these are referral hospitals and some of the sites, especially in the 
capital, have very high numbers of complication because they receive referrals from other sites. 
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Ease of locating files: This variable was used in the analysis of cases of obstetrical 
complication. For these analyses (described below), we consider the “ease of auditing”, as 
the dependant variable, and a function of the actual frequency of a particular complication 
in the population, the ability of health providers to recognise the complication, and the 
retrievability of records concerning that complication (Figure 1). 
 
Figure 1: Factors affecting the ease of retrieving and auditing cases of obstetrical complication 
 
Data Analysis and Hypotheses 
Consecutive sample: To assess the possibility of selection bias due to non-randomly 
missing obstetrical records, we used our list of 30 consecutive births at each site as 
obtained from the birth registry. Descriptive frequencies were calculated for the variables: 
1) missing record; 2) surgical birth; and 3) age of patient. Cross-tabs were used to 
determine if there was an association between missing records and having been sent to the 
surgical theatre. We did the same thing for missing records and country. A t-test for 
independent means was used to determine if there was an association between missing 
records and the patient’s age. For each hospital and country, we calculated the percent of 
irretrievable files (number of missing files / number of files searched). In addition, we 
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assessed if there was an association between missing files and ALARM sites, hospital 
location (capital versus regional), and hospital complexity score.  
 
Complicated sample: Given the more complex sampling strategy used to locate cases of 
complication and the greater risk of selection bias in this sample (e.g. cases of very severe 
complication and/or death may go missing because more personnel handled their records, 
their information is stored apart, interns use these records for case studies, etc.), we were 
interested in study characteristics (ALARM site, location of hospital, complexity score, 
percent missing records) associated with selecting cases of obstetrical complication. We 
hypothesize that in the absence of selection bias, we should find it easier to retrieve cases 
of complication at hospitals in the capital and at hospitals with higher complexity scores 
because women with obstetrical complications are referred to these types of sites. We also 
hypothesize a greater ease of locating cases of complication at ALARM hospitals because 
of better quality of care (staff should better recognise complications) and improved 
recordkeeping.  
 
For the categorical variables we looked at the association of percent complications 
retrieved at each site using a Chi-square test. For the continuous variables, we used 
Student’s t-test. All data were analyzed in SPSS 17 and Excel 2003. 
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Results 
Consecutive sample 
We quantified the number of missing records as well as factors associated with 
missingness at both patient and hospital levels. To do so, we used the list obtained from 
the birth registry of the previous 30 consecutive births starting September 30, 2010. From 
this list, we identified a total of 880 women who gave birth on the 30
th
 of September or 
before. The average number of women assessed by site was 29 in Mali and 27 in Senegal. 
We did not always reach a total of 30 women because, upon later inspection of the 
obstetrical record, some women were not eligible (e.g. they had a prophylactic caesarean 
sections, a miscarriage, or post-partum admission). Because information in the birth 
registry is not comprehensive, it was not always possible to determine the eligibility of the 
patient a priori from this data source.   
 
Patients ranged in age from 12 to 47. The mean age of women in the sample was 26; the 
median was 25. Women sampled in Senegal (mean 26.5) were slightly older than those in 
Mali (mean 25.5). A total of 185 (21.9%) women were sent to the surgical block for 
caesarean section and/or for post-partum hysterectomy. The percentages of women sent 
for surgery were similar in Mali and Senegal (22.1% in Mali and 21.8% in Senegal).  
 
We were able to retrieve 739 (84.0%) of obstetrical records. In Mali, we were able to 
retrieve 305 (82.0%) and in Senegal, we were able to retrieve 434 (85.4%) of obstetrical 
records. For both countries, there was no association between the patient’s age or type of 
birth (vaginal versus surgical) and the retrievability of the obstetrical record. This suggests 
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that records were missing at random, as patient characteristics in the retrieved and non-
retrieved records were similar.  
 
The number of missing records varied from zero to 21 (0-83%) depending on the site. The 
average number of missing records per site was four (16.0%). There was a significant 
association between the hospital and the retrievability of the obstetrical record. There were 
five hospitals with especially high numbers of missing records when compared to 
recorded admissions (greater than 35%). When these hospitals were removed from the 
sample, the average number of missing records per site dropped to 8% (7.7% in Senegal 
and 8.3% in Mali; no significant difference between countries). In this sample, with only 
8% missing records, the average patient age was 26 and 22% of women had caesarean 
section. These frequencies are the same as for the total samples indicating that patient 
characteristics are similar in hospitals with high and low numbers of missing records. The 
highest levels of missing records were found in the capital (24% versus 12% at regional 
hospitals). This difference was significant. There were significantly more missing records 
at ALARM sites than non-ALARM sites (19% versus 13%), but there was no difference in 
the number of missing records according to complexity score. 
 
Sampling Complicated Cases 
We assessed if there were differences in the number of cases of complication audited by 
region (capitals versus regions), by ALARM, by hospital complexity scores (Tables 18 
and 19). It is important to note that these statistics do not reflect the actual proportions of 
complications at each site, because both the consecutive and complicated samples were 
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included for these calculations. Rather, the frequencies shown in these tables reflect the 
ease by which we were able to retrieve and audit cases of complication.  
 
Table 18: Frequency and proportion of records of complication that were retrieved and 
audited by categorical variables (ALARM and location)  
  Severe 
(Pre)Eclampsia 
PPH HIV 
ALARM 
   Intervention  
  Control  
Senegal  
44 (16.4%) 
37 (17.9%) 
 
40 (16.2%) 
35 (15.6%) 
 
20 (8.1%) 
4  (1.8%)* 
   Intervention  
  Control  
Mali 24 (14.2%) 
33 (14.4%) 
18 (10.7%) 
29 (12.7%) 
12 (7.1%) 
8  (3.5%) 
Location 
   Capital  
   Regional  
Senegal  
22 (15.4%) 
59 (18.0%) 
 
20 (14.0%) 
55 (16.7%) 
 
4  (2.8%) 
20 (6.1%) 
   Capital  
   Regional  
Mali 17 (11.8%) 
40 (15.7%) 
22 (15.3%) 
25 (9.8%) 
13 (9.0%) 
7  (2.8%)* 
*Significant difference at α=0.05 
Table 18 shows that it was easier to retrieve cases of HIV at ALARM intervention 
hospitals than control hospitals in both Mali and Senegal. In Mali, it was significantly 
easier to locate cases of HIV in the capital than in the regions. Table 18 also showed a 
tendency suggesting that complications were easier to locate and audit at regional 
hospitals than hospitals in the capital in Senegal. Higher complexity scores were 
associated with more retrieved cases of severe (pre)eclampsia in Senegal and PPH and 
HIV in Mali (table 19).  
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Table 19: Mean complexity score for records of obstetrical complication compared to 
records without complication 
 Complexity Score (mean and SD) 
 Senegal Mali 
Severe (Pre) Eclampsia 
   Yes 
   No 
 
74.1 (7.8)
¥ 
 
72.3 (9.2) 
 
63.8 (9.52) 
63.3 (8.66) 
PPH 
   Yes 
   No 
 
71.6 (9.1) 
72.8 (9.0) 
 
67.1 (8.08) * 
62.9 (8.76) 
HIV 
   Yes 
   No 
 
73.0 (5.8) 
72.6 (9.2) 
 
68.8 (5.57) * 
63.9(8.83) 
* P-value for difference < 0.05, * 
¥ 
P-value for difference < 0.10 
 
Discussion 
In this study, we documented that an average of 16% of medical records were missing. In 
most hospitals, the number of missing records was lower (less than 10%). However a 
handful of sites had a very high number of missing records (greater than a third of records) 
and this had an undue influence on the average number of missing records per site. In two 
hospitals in Mali, over half of records were missing. Both of these sites were located in the 
capital and had very high caseloads. Additionally, these were the last sites to be audited 
and thus, more time had passed for records to go missing (about six months). It is possible 
that limited space available at the hospital, very high caseload (over 200 births per month), 
and a lack of recordkeeping culture resulted in the misplacement of many records. It is 
likely that more records would have been located if the auditor had more time at the site 
(she spent between 6 and 10 hours at each site, depending on the availability and quality 
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of obstetrical records). However, it is unlikely that in a real-world situation an audit 
assistant would spend any more time looking for records than the auditor did. 
 
Selection Bias due to Missing Records 
We were also able to address concerns that records were missing in a non-random manner 
and thus could constitute a form of selection bias. In our systematic review of CBCA in 
low- and middle-income countries (167), we demonstrated that at the time of publishing 
the article, only two peer-reviewed studies had considered the possibility of selection bias 
due to irretrievable obstetrical records and that none of these studies had attempted to 
quantify this possibility. This study showed that, at the patient level, records were most 
likely missing at random, as there was no association between the retrievability of the 
record and the age of the patient or the delivery mode. This finding suggests that the 
population of women audited was not systematically different than the population of 
women not audited because of missing records.  
 
There was a significant association between certain structure-level characteristics and 
missing records. Missing records were significantly associated with structures located in 
the capital and with ALARM sites. We hypothesize that there are more missing records at 
sites in the capital because of the case mix, heavy case load, and the presence of interns. 
We believe that at sites with a high number of obstetrical records and poor archiving, it is 
very easy to misplace a record and very difficult to retrieve it once misplaced (e.g. it is 
much easier to retrieve a misplaced record when there are only 100 records to sort through 
compared to 1000). Further, capital-level hospitals are sinks for the most difficult 
obstetrical complications. These are women who have complications that require 
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hospitalization, multiple diagnostic tests, and several health providers, etc. The records of 
such women are handled by multiple health professionals and may pass through several 
services of the hospital (e.g. the maternity, the operating bloc, the post-operating room, the 
room for hospitalizations, etc.). The more a record travels, the more likely it is to get lost. 
Finally, capital-level hospitals tend to make up for health personnel shortages with 
medical interns who are concomitantly writing their theses. At several sites, hospitals staff 
blamed missing medical records on interns who take the records home for use in their 
theses.  
 
While we were not surprised that there were significantly more missing records at 
hospitals in the capital, we were surprised that there were more missing records at 
ALARM sites. We expected that quality improvement efforts at these sites would lead to 
better recordkeeping. In particular, given that maternal death enquiries use patient medical 
records to make suggestions for quality improvements, we expected that ALARM sites 
would be more vigilant in their archiving efforts than non-ALARM sites. Three of the five 
sites with very high numbers of missing records were ALARM intervention sites. When 
these sites were removed from the sample, the significant association between ALARM 
and missing records disappeared, but the tendency remained. After removal of these sites, 
the average percent of missing records at ALARM sites was 9.3 whereas this percentage 
was 6.7 at non-ALARM sites.  
 
One possible explanation for why there was more missing records at ALARM sites is that 
records at these sites get more use. That is, workshops given under the ALARM program 
teach staff to better exploit the medical records, particularly the partograph. In Senegal, 
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there is some evidence of this. Partograph use at ALARM sites in Senegal is double that of 
non-ALARM sites (44.0% versus 21.4%) and this difference is significant (p = 0.001). 
This association is not found in Mali. While the ALARM program explicitly teaches better 
recordkeeping, there is no equivalent for archiving. Thus, it is possible that records may be 
more complete at ALARM sites but because they are used for more than just 
administrative purposes, they also go missing more often.  
 
Selection Bias in Sampling Complicated Cases 
Consistent with our hypotheses, bivariate analyses showed that it was easier to retrieve 
cases of complication at hospitals with greater complexity scores. This was especially true 
in Mali. In the bivariate analyses, for the most part, we did not see the expected 
relationship between ALARM and capital location with the percent of complicated cases 
retrieved. ALARM did not appear to affect the ease of locating cases of severe (pre-) 
eclampsia or PPH. It was, however, associated with a greater ease of locating the records 
of HIV-positive cases. The ALARM International Program dedicates a section of its 
teaching activities to the care and treatment of HIV. Staff at ALARM sites may therefore 
be more conscientious about HIV. Finally, we retrieved more cases of HIV in Bamako 
compared to elsewhere. This is expected given the epidemiology of HIV in Mali and the 
concentration of HIV/AIDS services in the capital.  
 
Other considerations 
The number of missing records at a site may be indicative of the quality of care. Poor 
recordkeeping may directly influence quality of care by, for exampling, impeding the 
continuity of care such as when a patient’s previous medical records cannot be retrieved. 
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Poor medical recordkeeping and archiving may also be indirectly linked to quality of care. 
It may proxy medical professionals’ attitudes about their jobs and in places where 
recordkeeping is especially insufficient, it may indicate a lack of professional discipline. 
In the following chapter, we present a short communication that discusses the importance 
of good medical recordkeeping and quality of care. This communication was published in 
the International Journal for Quality in Health Care (161).
 
 
Chapter 9: Medical recordkeeping, essential but overlooked aspect of 
quality of care (article 2) 
 
AUTHORS: Catherine M Pirkle, Alexandre Dumont, and Maria-Victoria 
Zunzunegui 
Abstract 
Medical recordkeeping is essential to assuring quality health care. Records aid in the 
medical management of patients while serving epidemiological purposes. Medical 
recordkeeping is often inadequate in resource-limited settings, which threatens the quality 
of care. In this paper, we present examples of the challenges that poor medical 
recordkeeping has posed to researchers across a variety of resource-limited settings. We 
then discuss our experiences conducting a cluster-randomized trial in West Africa, which 
further demonstrates the challenges caused by inadequate recordkeeping. By way of 
example, we make the case for increased attention to medical recordkeeping by illustrating 
how poor recordkeeping can threaten the quality of care. The examples provided pertain to 
both medical charting and archiving. Finally, we make suggestions to improve the 
adequacy of medical recordkeeping emphasizing recent technological innovations applied 
to resource-limited settings. 
 118 
 
Medical recordkeeping, which comprises both the charting and archiving of medical 
information, is essential to evaluating, ensuring, and improving the quality of health care. 
Records aid in the medical management of individual patients while serving vital 
educational and epidemiological purposes (160, 168). When recordkeeping is adequately 
performed, it supports quality of care by improving the coordination and continuity of 
care, reinforcing decision-making capacities, augmenting staff accountability, and 
achieving more accurate district, regional and national statistics (169, 170).  
 
Our experiences conducting a cluster randomized trial to improve the quality of obstetrical 
care in West Africa illustrate some of the problems that inadequate medical recordkeeping 
can pose to quality of care. These challenges are not unique to the QUARITE trial and 
have been faced by other researchers in divergent resource-limited settings (168, 170, 
171). In this paper, we begin by presenting examples of the challenges of that poor 
medical recordkeeping has posed to other researchers in resource-limited settings. Next, 
we use experiences from the QUARITE trial to flesh out some of the mechanisms by 
which poor recordkeeping can threaten the quality of care. Finally, we make suggestions 
to improve the adequacy of medical recordkeeping.  
 
Brief glimpse of the literature 
Incomplete charting in Iran 
Pourasghar et al. (2008) draw a broad portrait of the quality of paper medical records at a 
university hospital in Tabriz. The authors focus mostly on the completeness of medical 
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records. Their work documented that nearly all medical records in the hospital were 
incomplete and incompatible with standards set by the Ministry of Health and Medical 
Education. Incomplete charting was largely attributed to poor handwriting, lack of 
documentation of requested information (e.g. administrative information, laboratory 
results, etc.), and missing pages. The authors concluded that they believed doctors and 
nurses at the hospital to be unaware of the importance of medical records to the treatment 
and follow-up of patients (168). 
 
Registries to improve quality of care in Egypt 
Safavi et al. (2010) describe the creation and implementation of a registry for acute 
coronary syndrome. In this paper, they highlight the importance of registries, which are 
detailed case report forms, to strengthening hospital care. They point out that health 
structures in resource-limited settings are often incapable of evaluating the quality of care 
because they lack sufficient health information infrastructure, both in terms of technology 
and human capital. In their intervention, the authors were able to implement a registry for 
acute coronary syndrome, but doing so required additional data collection activities 
because complete medical records were unavailable (171).  
 
Improved archiving in Ethiopia 
Wong and Bradley (2009) report on an intervention to improve medical record 
management in a rural hospital in Ethiopia. The intervention aimed to reduce the number 
of missing records and improve the accessibility of archived records. The authors 
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described a context in which patient registration numbers were often replicated, records 
were lost and patients were assigned new registration numbers, clinical information was 
recorded on loose scraps of paper, medical records were poorly stored, and physicians 
were generally unsatisfied with the existing medical record system. The researchers 
implemented a computer database to manage the archiving of patient records, created 
standardized medical records’ forms, and increased human resource management efforts. 
The intervention was largely a success, as there was greater record retrieval and more 
complete records post intervention. The authors emphasized the importance of articulating 
the link between accessible medical records and the quality of care (170). 
 
The examples presented above demonstrate that inadequate medical recordkeeping poses 
problems to health personnel and researchers in a variety of resource-limited settings. 
They demonstrate that recordkeeping problems can include charting difficulties 
(incomplete, illegible, or inaccurate records) and archiving issues (missing or irretrievable 
records) and that these are widespread. All of the works cited above either explicitly or 
implicitly recognised the link between adequate recordkeeping and quality healthcare. 
While conducting hospital-based research in West Africa, we encountered many of the 
same obstacles described above. In the next section, we provide a detailed description of 
some of the challenges we encountered and by way of example, demonstrate the 
mechanisms by which flawed recordkeeping systems can threaten care.  
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QUARITE trial in West Africa 
In September 2007, we began a CRT at 46 hospital sites in Mali and Senegal. This trial, 
known as QUARITE, is in the process of evaluating whether a multifaceted quality 
improvement program, known as ALARM 
(http://www.sogc.org/alarm2005/english/index.shtml), can significantly reduce in-hospital 
maternal mortality (results forthcoming). Throughout the trial, we have encountered 
important obstacles to proper medical recordkeeping. When we began the trial, few sites 
systematically maintained medical charts and fewer yet, had designated areas to archive 
these charts. Almost none of our study sites stored confidential patient medical 
information under lock and key. Archiving was in such disarray at the beginning of the 
trial that we were obligated to use external resources to manage and store charts, as we 
needed access to patient medical records for verification of data collected by the trial. 
Consequently, every three months national coordinators, often accompanied by several 
graduate students, visit all 46-study sites to compare data recorded in the trial against 
various patient medical records (obstetrical charts, birth and death registries, surgical 
protocols, etc.). However, even with considerable financial and human resources support 
from the trial, we continue to struggle to retrieve patient charts.  
 
Tables 20 and 21 provide concrete examples from the field as to how recordkeeping can 
threaten various facets of quality of care. In table 20, we concentrate on charting while in 
table 21, we draw attention to archiving.   
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While quality of care is broad, multidimensional construct (75), the examples provided in 
tables 21 and 22 focus specifically on the continuity of care, decision-making, 
accountability, and epidemiological data. Convincing arguments exist linking record-
keeping to other facets of quality of care such as satisfaction (e.g. when a patient retains 
outpatient records and becomes more involved in his or her health (160)), but we believe 
that the facets of quality we focus on provide the clearest examples of the mechanisms 
linking recordkeeping to the quality health care. For example, the charting process can 
bolster quality by improving the continuity of care and decision-making process (160). 
Demonstrating with an example from obstetrics, partographs are graphical tools used to 
monitor the progression of labour. In West Africa, they typically form a part, or the 
entirety, of the obstetrical chart of a patient. Systematic and correct use of the partograph 
can assist in the early diagnosis of prolonged obstructed labour and the use of appropriate 
interventions, such as caesarean section (142, 144).  
 123 
 
Table 20: Examples from the field of how poor charting can threaten quality of care and why these examples are important 
Aspect of quality 
affected  
Example from the field Explanation of threat 
Coordination and 
continuity of care 
Health personnel argued that incomplete patient 
obstetrical charts are acceptable because recording case 
notes is time-consuming and they are able to remember 
all pertinent medical information anyway.  
Medical charts are a written means of sharing information. Multiple 
personnel and shifts of personnel attending a patient require some 
form of information transmission. Verbal transmission of case notes 
is not reliable and does not reach all staff. 
Decision-making 
capacity 
Partographs were often jokingly referred to as 
postographs. This is because they are frequently and 
inaccurately completed after childbirth. They are often 
used as learning tools for interns and almost never 
completed by more experienced staff. 
Medical charts are decision-making tools. They help professionals 
synthesize divergent clinical information to make informed 
decisions. When charts are incomplete or inaccurate, they negatively 
affect decision-making capacities. 
Health personnel 
accountability 
At one site, three different sources of medical records 
(the birth registry, the death registry, and the 
partograph) all recorded different complications and 
survival outcomes for the same woman.  
Promising quality improvement programs, such as death enquiries 
and clinical audits, are reliant on patient charts to assess patient care 
and to make quality improvement recommendations. When charts 
are incomplete or unreliable, so are any recommendations based on 
them, including what staff could have done better. 
Accurate statistics In both Mali and Senegal, almost all cases of recorded 
postpartum haemorrhage were in women who returned 
for care. Postpartum haemorrhage was almost never 
identified in patient medical charts during the 
immediate post-partum period, although detailed 
inspection of the case notes often revealed unmentioned 
cases of postpartum haemorrhage. 
Postpartum haemorrhage is an example of an obstetrical 
complication that can almost entirely be prevented or effectively 
treated, but when treatment is delayed, it has a high case-fatality 
rate. By not explicitly recording occurrences of postpartum 
haemorrhage, trends cannot be assessed that would be useful for 
widespread quality improvements (e.g. improvements in medical 
education and patient follow-up). 
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Table 21: Examples from the field of how poor archiving can threaten quality of care and why these examples are important 
Aspect of quality 
affected 
Example from the field Explanation of threat 
Coordination and 
continuity of care 
When women with postpartum complications return to 
the same hospital for additional treatment, a new chart 
is created. Hospital staff do not append new notes to the 
patient’s old chart. We have witnessed hospital 
personnel search vainly through unorganized piles of 
patient charts only to give-up and start a completely 
new file. 
Archiving in often so poor that time-constrained personnel cannot 
reasonably retrieve a patient’s previous chart. This limits the 
understanding of the aetiology of many conditions, if previous 
treatments had been administered, and if other conditions had 
previously presented.  
Health personnel 
accountability 
At one hospital, we were confronted with an 
unexpectedly low number of maternal deaths. Enquiries 
at the hospital and in the community to explain the low 
number of recorded maternal deaths suggested that the 
files of a substantial number of maternal deaths were 
misplaced. We were forced to spend extra time 
interviewing staff and searching morgue records.  
When the files of adverse events go missing, then health personnel 
cannot be held accountable for their actions vis à vis those missing 
cases. It is impossible to know if care was suboptimal and in cases 
where it may have been, to make necessary changes.  
Accurate statistics 15%  and 8% of medical records were missing from 
archives in Senegal and Mali, respectively. In our 
study, we deemed these records to be missing at 
random, but this may not always be the case.  
Missing data is a form of selection bias and even with advanced 
forms of statistical adjustment, statistical correction for bias is 
almost impossible for levels of missing data greater than 10%. Any 
statistics based on archival research will risk bias with high 
numbers of missing records. Trends in quality of care and health 
outcomes cannot easily be assessed based on such data. 
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The charting process can also play a role in quality improvement, as it can help in clinical 
decision-making and in assuring staff accountability. One of the most important 
components of the intervention arm of the QUARITE trial is the use of maternal death 
enquiries. These enquiries are a form of audit in which maternity personnel look through a 
deceased patient’s medical record, as well as interview staff and the family, to determine 
aspects of care that may have contributed to her death and what health personnel can do to 
improve practice. Unfortunately, poorly filled-out medical records compromise the 
effectiveness of maternal death enquiries and thus a potentially powerful quality 
improvement tool.  
 
Suggestions to improve medical recordkeeping 
There are examples of innovative programs from a variety of resource-limited settings 
evaluating the use of electronic medical records (EMR) and Open-Source software (172, 
173) to improve medical recordkeeping. For example, Partners in Health and Zanmi 
Lasante implemented a web-based EMR system in rural Haiti to assist in the clinical 
management of HIV patients. This system used a satellite internet connection and a single 
secure server to create a database of core information to track individual patients and to 
monitor the progress of groups of patients (174). In Malawi, the Kamuzu Central Hospital 
implemented a touch-screen patient management information system. This program 
demonstrated that EMRs can be user-friendly, even in poor countries where staff may 
have limited IT skills (173). Similarly, handheld devices, such as personal digital 
assistants (PDA), may be useful tools for improving the quality of medical charts and for 
transmitting patient medical records from health centre to health centre (175, 176).  PDAs 
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may be especially useful for community health care, as they are simple and easy to 
transport, have good battery life, and are lower in cost than most other electronic systems 
(173). Finally, given the preponderance of mobile phones in most resource-limited  
settings, it may be conceivable to create cell phone medical chart applications. For 
example, in Thailand, smart phones were used to keep track prenatal care and 
immunization appointments for women in the coverage area and to update information 
regarding the antenatal care and immunization status of these patients (177). 
 
No matter their form, EMRs eliminate the need to find space to store medical records, 
improve the legibility of entered data, and facilitate the retrieval of previous patients’ 
records. Certain forms of EMR facilitate the transfer of information for epidemiological 
and planning purposes, as data entered on systems with Internet access can be sent directly 
to Ministries of health, funders, and research institutions.  As an additional benefit, 
validity checks can be programmed into EMRs to assure that health personnel do not 
forget to record vital patient information such as age and diagnosis.  
 
Equally important as technological improvements are efforts to instil a “culture” of 
recordkeeping. In discussions with hospital staff at each QUARITE hospital site, the link 
between recordkeeping and quality of care was never mentioned. Many staff felt that both 
charting and archiving wasted time and prevented them from performing more important 
medical activities. Those who supported medical recordkeeping almost exclusively 
discussed the legal importance of records in protecting against litigation. Other studies 
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have also documented this preoccupation with the legal aspects of medical documentation 
(168). 
 
Medical leaders, from university professors to hospital chiefs, need to reinforce the 
importance of recordkeeping (170). Research has indicated that many health professionals 
believe that medical and nursing students should receive additional training about 
recordkeeping (168). We would suggest that such training stress the link to quality of care, 
emphasizing that recordkeeping is more than an administrative exercise. In the QUARITE 
trial, it was apparent that top hospital personnel had rarely looked through patient medical 
records nor discussed the quality of these records with their staff. Without hospital leaders 
showing an interest in patient medical records, there was little incentive to complete them 
correctly. This logic has been echoed elsewhere, as successful interventions required 
support from hospital senior management and the inclusion of all staff in training 
programs (170). 
 
We would also make the following suggestions. If paper records are to be used, then 
physical space needs to be allocated to archive records and a system to retrieve records 
needs to be implemented. As seen in Ethiopia, this system can be a computer database 
(170) and/or it can include personnel specifically employed to archive medical records. 
The system does not need to be overly complex. At one hospital in Senegal, a head 
midwife took it upon herself to organise the obstetrical records of her maternity. She used 
an Excel spreadsheet to record the patient registration number, name and address, age, and 
reason for admission. When she needed to find a patient, she performed a search of the 
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Excel file, obtained the patient registration number, and then located the record using the 
registration number.  
 
Additionally, we feel that public health workers and officials from the Ministry of Health 
should likewise reinforce the importance of recordkeeping as health information systems 
are dependent on the collection of data from medical records. Such officials could 
periodically audit hospital records to assess the completeness and retrievability of records. 
In the QUARITE trial, regular audits of the medical records are believed to have improved 
the completeness of patient registries and the archiving of records (Dumont, unpublished 
data). Further, while the Ministries of Health have provided standardized obstetrical 
records and partograph forms to both Mali and Senegal, many hospitals choose not to use 
these forms. Charting at centers that do not use the standardized forms tends to be more 
haphazard and patient specific, limiting the exploitability of data as there are no standard 
requirements. Enforcing the use of standardized medical records may remind healthcare 
providers to assess certain patient characteristics that may have been overlooked had they 
not been required for completion of the form (in QUARITE, the vital signs of pulse and 
temperature were infrequently recorded on forms which did not have specific sections for 
this information). 
 
Conclusion 
In our trial, we witnessed important challenges to recordkeeping, which without 
significant external support, would have threatened the validity of data collected during 
the trial. While staff at most hospitals in the resource-limited settings are not supported by 
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large international research teams, complementary research conducted by the QUARITE 
trial has shown that investments of less than 1% of state subsidies to public hospitals 
could significantly improve recordkeeping (Dumont, unpublished data). Similar work in 
Ethiopia calculated that an initial investment of 2% of the hospital budget and 1% of the 
budget in subsequent years would substantially improve medical recordkeeping (170). 
Given the importance to quality of care, there is no reason not to make such investments.  
 
 
 
 
Assessment of Construct Validity 
In the chapter to follow, we present an article describing the development and validation 
of the CBCA questionnaire. This article has been published in BMC Pregnancy and 
Childbirth. While some of the steps taken to develop the CBCA questionnaire were 
already described in the chapter on the pilot study, most of this article is devoted to the 
assessment of construct validity. Using data collected from over 600 obstetric admissions, 
we show that patient CBCA scores can significantly predict stillbirth and early neonatal 
mortality. As one would hypothesize, poor quality of care scores are associated greater 
rates of adverse perinatal outcomes. Overall, our results indicate that the questionnaire 
performs according to theory and is a valid and reliable measure of intrapartum quality of 
care. 
 
 
Chapter 10: Validity and reliability of criterion based clinical audit to 
assess obstetrical quality of care in West Africa (article 3) 
 
AUTHORS: Catherine M Pirkle; Alexandre Dumont; Mamadou Traore; Maria-Victoria 
Zunzunegui and the QUARITE research team 
 
Abstract 
Background: In Mali and Senegal, over 1 percent of women die giving birth in hospital. 
At some hospitals, over a third of infants are stillborn. Many deaths are due to substandard 
medical practices. Criterion-based clinical audits (CBCA) are increasingly used to 
measure and improve obstetrical care in resource-limited settings, but their measurement 
properties have not been formally evaluated. In 2011, we published a systematic review of 
obstetrical CBCA highlighting insufficient considerations of validity and reliability. The 
objective of this study is to develop an obstetrical CBCA adapted to the West African 
context and assess its reliability and validity. 
Methods: Criteria were selected based on extensive literature review and expert opinion. 
Early 2010, two auditors applied the CBCA to identical samples at 8 sites in Mali and 
Senegal (n = 185) to evaluate inter-rater reliability. In 2010-11, we conducted CBCA at 32 
hospitals to assess construct validity (n = 633 patients). We correlated hospital 
characteristics (resource availability, perinatal and maternal mortality) with mean hospital 
CBCA scores. We used generalized estimating equations to assess whether patient CBCA 
scores were associated with perinatal mortality. 
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Results: Results demonstrate substantial (ICC = 0.67, 95% CI 0.54; 0.76) to elevated 
inter-rater reliability (ICC = 0.84, 95% CI 0.77; 0.89) in Senegal and Mali, respectively. 
Resource availability positively correlated with mean hospital CBCA scores and maternal 
and perinatal mortality were inversely correlated with hospital CBCA scores. Poor CBCA 
scores, adjusted for hospital and patient characteristics, were significantly associated with 
perinatal mortality (OR 1.84, 95%CI 1.01-3.34). 
Conclusion: Our CBCA has substantial inter-rater reliability and there is compelling 
evidence of its validity as the tool performs according to theory.  
 
Keywords: Criterion-based clinical audit, questionnaire development, quality of care, 
validity, reliability, resource-limited settings 
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Background 
Worldwide, approximately 1000 women die each day during pregnancy or of childbirth-
related causes. More than half of these occur in sub-Saharan Africa (178). Further, an 
estimated three million babies are stillborn every year; stillbirths account for the majority 
of perinatal deaths in developing countries (14). One in three stillbirths occur during 
delivery and in most cases, could have been prevented with improved intrapartum 
management of the mother (14) . Stillbirth and maternal mortality are strongly correlated; 
both decline with improved access to caesarean section and skilled attendance (179). 
Experts agree that one way to reduce maternal and perinatal mortality is to encourage 
women to routinely deliver in health facilities (43, 57, 178, 180). For such a strategy to 
work, women must have confidence in the health system (59) and the system itself should 
not contribute to mortality. 
 
In Mali and Senegal, over one percent of women die giving birth in referral hospitals 
(114). National rates of perinatal mortality are estimated at 50 per 1000 births (14), but 
levels at referral hospitals may be much greater.  Such high case fatality suggests poor 
medical practice. Gross deficiencies in the quality of care provided to women during 
childbirth are widely recognized in West Africa (64). Insufficiencies in health personnel 
training, shortages of basic obstetrical equipment, and dramatic, even violent interactions 
between care givers and parturients have been reported (64, 66). Limited quantitative 
work supports these results; up to 70 percent of in-hospital maternal deaths may be 
avoidable with improved quality of care (71). Nonetheless, maternal mortality is still a 
rare event and estimators are often unstable (181). This makes it difficult to directly link 
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maternal mortality to quality of care. Perinatal mortality, however, is more common and 
frequently directly related to the care episode (182). 
 
At present, we have little indication of the amplitude of the quality problem or which 
aspects of medical practice to target. One of the reasons for this knowledge gap is the 
difficulty inherent to measuring the quality of obstetrical practice at the patient level. 
There are several methods for measuring medical practice: standardized patients, direct 
observation, vignettes, and chart abstraction. Standardized patients require a trained actor 
to engage medical professionals in a clinical examination related to a topic of research 
interest. For obvious reasons, it is impossible for an actor to convincingly recreate the 
birth process. It is also possible to measure quality of care through direct observation, but 
this method is subjective and risks the Hawthorne effect. Finally, there are vignettes and 
chart abstraction. Vignettes are written scenarios involving a fictitious patient (77). Work 
in high-income countries show that vignettes have promising measurement properties 
(78), but there are limitations: they measure individual provider knowledge versus team 
practice, no validation studies have been conducted in low-income countries, and current 
tools target physicians versus midwives or other lower-cadre staff. 
 
Chart abstraction is a general term for when researchers retrieve predefined information 
from patient medical records and compare that information against agreed-upon standards 
of care. A criterion-based clinical audit (CBCA) is a specific type of chart abstraction that 
can be effectuated by non-medically qualified audit assistants. Assistants screen the 
medical records of patients and extract relevant data. Standardized criteria for evaluating 
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good quality care are predetermined and then compared against extracted data to evaluate 
whether or not a minimal standard of care has been met [5, 14]. CBCA are gaining 
traction in the domain of obstetrical care in resource-limited settings, as they can dually 
serve to measure and improve care [5, 14-22].  
 
In 2011, we published a systematic review of obstetrical CBCA in resource-limited 
settings (183). The review highlighted insufficient considerations of CBCA reliability and 
validity. This article has two objectives. The first objective was to report on the 
development a CBCA instrument for West Africa. The second objective was to address 
the gaps identified through the systematic review, namely to evaluate inter-rater reliability 
and construct validity. To assess construct validity, e.g. whether the instrument is 
performing according to theory, we followed Donabedian’s conceptualization of quality of 
care: 1) Given an adequate setting and equipment (structure), quality medical care 
(process) will follow and 2) In the absence of proper medical procedures (process), good 
health outcomes will not be achievable (75). If our instrument is valid, we hypothesize 
that we will observe the following: 1) A positive correlation between structure and process 
measures of quality of care 2) A negative correlation between process measures of quality 
of care and adverse maternal and perinatal outcomes.  
 
Methods 
Background: This is a sub-study within a cluster randomized trial called QUARITE 
(114). The trial assessed a multifaceted quality improvement intervention known as the 
ALARM International Program (114). The aim of the ALARM intervention is to reduce 
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facility maternal mortality. QUARITE began in September 2007 and was completed in 
December 2012. It took place in 46 out of 49 eligible referral hospitals in Mali and 
Senegal. Referral hospitals in both countries treat complicated deliveries and receive 
evacuations from lower order health centres. Hospitals were considered eligible for study 
if their maternity registered a minimum of 800 births per year and could provide 
comprehensive emergency obstetrical care (87). The primary endpoint measure of 
QUARITE is overall facility-based maternal mortality (number of maternal deaths divided 
by the number of women giving birth in the facility). The trial also measured (described in 
subsequent sections): (i) resource availability; (ii) intrapartum quality of care; and (iii) and 
perinatal mortality (114).  
 
Description of the CBCA questionnaire: From 2008 to 2010, we developed a CBCA 
adapted to the West African context to measure intrapartum quality of care. We focus on 
quality of care during labour, delivery, and the first 24 hours postpartum because most 
maternal deaths occur during this period (57) and because the duration of hospital stay for 
normal deliveries is usually less than 24 hours after birth in the region. The CBCA is 
organized in five domains: history taking, clinical examination, laboratory analyses, 
monitoring during birth, and postpartum follow-up. The organization of the audit reflects 
the basic steps expected of a medical team following a woman through delivery and birth. 
 
Generation of the item pool: Criteria were generated by reviewing the literature (peer 
reviewed articles, Cochrane reviews, and the WHO reproductive health library), best-
practice guidelines from the Royal College of Obstetricians and Gynaecologists, and 
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expert opinion. Criteria selection was consistent with WHO methods for conducting an 
obstetrical CBCA (79). Once a comprehensive item pool was compiled, the C. Pirkle and 
A. Dumont removed criteria impossible to verify in a West African setting. C. Pirkle is a 
public health researcher with extensive experience in West African maternities and A. 
Dumont, an obstetrician/gynaecologist with 15 years of clinical practice and research 
experience in Senegal.  
 
Review of initial criteria pool with experts: Using the criteria selected in the previous 
step, a draft CBCA instrument was constructed and circulated to two Canadian and three 
West African obstetrician/gynaecologists. We asked the reviewers to evaluate the criteria 
included (or excluded) for relevance and clarity. The CBCA instrument was refined based 
on their suggestions and modifications (inclusions, exclusions, clarifications). All experts 
agreed on the final version of the CBCA instrument used during data collection (table 22).  
 
CBCA questionnaire format and scoring: In a typical CBCA, auditors review patients’ 
medical records to ascertain whether pre-specified criteria have been met (58, 79). A 
CBCA is a checklist of pre-specified standards of good quality care. For example, the 
auditor may “check-off” if a patient’s blood pressure, cardiac frequency, and temperature 
were taken. For each affirmative response related to an expected standard care, a point is 
given. Our questionnaire contained 26 criteria. The CBCA questionnaire was scored 
according to the percentage of criteria attained. Thus, if 20 criteria were attained during 
the audit of a given medical record, then the score for that record would be 20/26 or 
76.9%.   
 138 
 
Table 22: Final criteria (n=26) for the obstetrical CBCA questionnaire 
Domain Criteria 
History taking  Condition of the mother at arrival 
 Number of prenatal visits 
 Age 
 Gravidity 
 Parity 
Clinical examination  Uterine height 
 Cardiac frequency 
 Blood Pressure 
 Temperature 
 Foetal presentation 
 Foetal heart beat 
 Membranes/amniotic fluid 
 Cervical dilation 
Laboratory analyses  Blood type 
 Rhesus factor 
 HIV test 
 Syphilis test 
Monitoring during birth  Name of birth attendant 
 Qualification of birth attendant 
 Time of placental expulsion 
 Oxytocin given 
 Time of birth given 
Postpartum monitoring  Follow-up examination 
 Exit examination 
 Date of discharge 
 Vital status of the infant at birth 
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Language: The CBCA questionnaire and all supporting documents (e.g. the procedures 
manual and lexicon of common medical abbreviations) were written in French. An 
English translation of the final CBCA questionnaire can be found in the supplementary 
materials (the French version can be obtained upon request from CP). The English CBCA 
questionnaire was translated by the first author (CP) who is a native English-speaker. The 
translation was verified by the second author (AD), a French-speaking obstetrician-
gynaecologist. Both CP and AD were involved in all phases of CBCA development.  
 
Data Entry Form and Validity Checks: An electronic version of the CBCA 
questionnaire was installed onto notebook computers with long battery lives. Validity 
checks were programmed to limit missing data and improve accuracy by detecting 
impossible responses (e.g. 77 versus 17 for maternal age). Auditors entered data directly 
into the electronic questionnaire. Data were exported to Microsoft Excel and other 
statistical software.  
 
Data collection and sampling strategy: Figure 2 shows the different steps and dates in 
the CBCA development and validation. There were two phases of data collection. The first 
phase took place at 4 hospitals in Bamako, Mali and 4 hospitals in Dakar, Senegal. In this 
phase, we used a development sample of patient records to evaluate inter-rater reliability 
between two auditors and improve content validity. The second phase of data collection 
used a finalized version of the questionnaire and took place at 32 hospitals in Mali and 
Senegal (13 in Mali and 19 in Senegal). For logistic and financial reasons were not able to 
include all 46 eligible QUARITE sites. Of the 32 included hospitals, 11 were located in 
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the country capitals, 11 were regional and 10 were district hospitals. Data from the second 
phase of data collection were used to assess construct validity.  
 
During the first phase of data collection, we audited 185 obstetrical records. Cases were 
identified from delivery-room birth registries and corresponding obstetrical records were 
sought. Most medical records were stored in the delivery room or the examination room of 
the head midwife. We audited, in reverse consecutive order, the most recent 20-25 
deliveries having occurred at a given site. When a case’s medical record could not be 
found, the next most recent birth was selected. During the second phase of data collection, 
we followed essentially the same sampling strategy. In both countries, we used the 
delivery-room birth registry to locate and audit the last 15-20 women who gave birth 
starting with September 30, 2010. As during the first phase of data collection, when we 
could not find a woman’s record, the next consecutive record was retrieved. We 
corresponded the second phase of data collection with the national QUARITE 
coordinators’ trimestral visit of the hospital sites. During the coordinator’s visit, he/she 
verified data recorded on trial data collection sheets with information retrievable in 
various hospital registries and patient obstetrical records. This allowed us to triangulate 
multiple patient registries to maximize the number of retrievable patient records. We 
audited 661 medical records, of which 633 had complete data to calculate CBCA scores. 
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Figure 2: Schema showing questionnaire development steps and validation phases  
 
 
Patient inclusion criteria: Because we are measuring intrapartum obstetrical care, we 
included the obstetrical records of all women admitted to hospital in labour with a foetus 
of at least 500gms. Thus, women admitted for elective caesarean section were not 
included.  
 
Measures 
Facility maternal and perinatal mortality: We calculated hospital maternal and perinatal 
mortality for the three-month period around when the audits were conducted (July 1-
September 30, 2011 in Senegal and September 1- November 30, 2011 in Mali). Maternal 
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and perinatal mortality was calculated based on information recorded on a data sheet 
collected for every patient giving birth at QUARITE hospitals (see patient demographic 
and obstetric variables below). These dates correspond to the national coordinators’ 
trimestral visit to the hospitals in each country and provide a large enough window to 
calculate reliable estimates of facility maternal and perinatal mortality. Facility perinatal 
mortality is defined as the number of newborn deaths (including stillbirths) occurring prior 
to the woman’s discharge divided by the number of livebirths occurring at the hospital 
during the eligible three-month study window. Here, facility maternal mortality is defined 
as the number of maternal deaths occurring at a given hospital during the study period 
divided by the total number of livebirths during that same period. Both ratios are given per 
1000 livebirths.  
 
Indicator of facility resource availability: The QUARITE trial annually collects data on 
hospital material and human resources. The Complexity Index we employed is derived 
from the WHO Global Survey on Maternal and Perinatal Health (136). It is comprised of 
eight categories describing: 1) basic services, 2) screening tests, 3) basic emergency 
obstetrical resources, 4) intrapartum care, 5) general medical services, 6) anaesthesiology 
resources, 7) human resources and, 8) academic resources and clinical protocols. We used 
an Africa-specific grading scheme for the Index (137). A list of services under each of the 
categories described above is classified as essential, comprehensive, or advanced. Each 
service classified as essential receives one point, each comprehensive service receives two 
points, and each advanced service gets 3 points. Points for the Complexity Index were 
summed up for each hospital. Scores vary from 0 to 100.  
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Patient demographic and obstetrical variables: As part of the larger QUARITE trial, a 
data sheet was completed for every woman who gave birth in participating hospitals; it 
includes the mother’s survival outcome, age, parity, number of prenatal visits, and 
previously diagnosed maternal conditions. The vital status of the infant at birth and at 
discharge was recorded in the QUARITE trial data sheet and verified by the auditor during 
the CBCA audit. For each patient, we merged audited data with that collected by the 
QUARITE trial using a unique patient identifier. During the CBCA audit, the data 
collector did not find the vital status of 23 infants at birth. According to the QUARITE 
database, all 23 infants were alive at discharge, but four had very low birth weights (less 
than 1500 grams). Given uncertainty between databases and the very low probability of 
the infants’ survival, we treated these four infants as perinatal deaths (though we 
conducted additional analyses treating the infants as alive).  
 
Statistical analyses- reliability and validity: Analyses were conducted in STATA 11 
and SPSS 17. We stratified most analyses by country because assessments of reliability 
and validity are context specific (184) and because of differences between Malian and 
Senegalese health systems in terms of user fees and hospital decentralization. We 
calculated the mean, standard deviation, minimum and maximum CBCA scores. Using 
data from the first phase of data collection, we calculated the intra-class correlation 
coefficient to determine inter-rater reliability.  
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To assess construct validity, we followed Donabedian’s conceptualization of quality of 
care according to structure, process, and outcome (see introduction) (75). The CBCA 
questionnaire measures the quality of obstetrical care at the process level (e.g. medical 
procedures and practice) while the Complexity Index measures structure. We first 
evaluated hospital-level associations. We expected a positive correlation between the 
Complexity Index and CBCA questionnaire. To look at correlations between CBCA 
scores and the Complexity index, we aggregated patient CBCA scores to calculate a mean 
quality of care score for each hospital (hospital CBCA scores). We used scatterplot graphs 
to visually assess the relationship between Complexity Index and hospital CBCA scores. 
Spearman’s rho, with one-tailed tests of significance, was used to evaluate the correlation 
between the two scores.  
 
We also looked at the correlation between hospital CBCA scores and hospital rates of 
maternal and perinatal mortality. We expected a negative correlation between the CBCA 
questionnaire and adverse maternal and perinatal outcomes. We did this analysis in the 
same manner as we did for the Complexity Index and CBCA scores.  
 
We also looked at patient-level correlations. It is possible that a hospital may provide an 
overall high level of quality of care but that individual episodes of poor quality care could 
be correlated with adverse patient outcomes (stillbirth and early neonatal mortality). We 
selected a score of 70% to represent good quality of care; this was the upper quartile of 
scores for women treated in Senegal. For each section of the questionnaire, we calculated 
the percentage of stillbirths and early neonatal mortality in women with CBCA scores 
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above and below 70%. For the full questionnaire, we also conducted sensitivity analyses 
looking at different thresholds of good quality care (scores of 60, 70, and 80). We used 
generalized estimating equations with an exchangeable matrix to evaluate the association 
between CBCA score and stillbirth and early neonatal mortality. We adjusted for country, 
Complexity Index score, and capital versus regional facility location. We also assessed 
potential confounding by patient characteristics including maternal age, parity, number of 
prenatal visits, and previously diagnosed maternal condition. If the coefficient for CBCA 
score changed by 10% or more, the variable was considered a confounder.  
 
Sample size: Estimates are given for an alpha of 0.05 and a beta of 0.20. For the 
estimation of inter-rater reliability, 40 medical charts per country were sufficient to 
estimate an intraclass correlation coefficient of 0.80, given a minimum acceptable level of 
reliability of 0.60  (185). For the hospital level correlations (n=32), we calculated study 
power with the statistical package pwr of R. Based on a null hypothesis of a correlation 
coefficient of 0 against an alternative of 0.50, our power to detect a significant result is 
0.84. 
 
Results:  
Mean patient CBCA scores differed significantly by country (p=0.000). In Senegal, mean 
patient criterion attainment was 60.0% (SD 11.4). In Mali, mean attainment was 73.4% 
(SD 12.0). Hospital complexity index scores varied from 50.0-89.0.  Significantly more 
patients in Senegal were treated at hospitals with higher mean complexity scores than 
patients in Mali (72.7 vs. 63.1%). Average hospital perinatal mortality was 135/1000 in 
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Mali (range 25-270/1000) and 168/1000 in Senegal (range 13-390/1000). For maternal 
mortality, these numbers were 13/1000 (range 0-30/1000) in Mali and 12 (0-30/1000) in 
Senegal.  
 
Inter-rater reliability: According to the classification scheme proposed by Landis and 
Koch (1977), inter-rater reliability for the CBCA questionnaire was substantial to high 
(186). Using data from the first phase of data collection, we sampled 96 obstetrical records 
in Senegal and obtained an ICC of 0.66 (95% CI 0.54-0.76). We sampled 89 obstetrical 
records in Mali and obtained an ICC of 0.84 (95% CI 0.77-0.89). Note that the upper limit 
of the confidence interval in Senegal is below the lower limit of the interval in Mali.  
 
Construct Validity: 
Correlation between hospital CBCA scores and hospital Complexity Index score 
Figure 3 shows the relationship between the Complexity Index and CBCA score by 
country. As hypothesized, there is a positive correlation between the two scores. This 
relationship is significant in Mali (Spearman’s Rho = 0.632, p = 0.010), but not in Senegal 
(Rho=0.293, p=0.112). In Senegal, there are three hospitals that appear to be 
outperforming, in terms of CBCA scores, hospitals with similar or greater Complexity 
Index scores. All three are rural, district-level hospitals (e.g. lowest level of referral 
hospital). When the three outliers are removed from the analysis, there is a significant 
linear relationship between Complexity Index and CBCA scores in Senegal (Spearman’s 
rho = 0.438, p= 0.045). 
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Figure 3: Complexity Index by CBCA scores according to country 
  
 
Correlation between hospital CBCA scores and hospital perinatal mortality  
Perinatal mortality was high in both countries. There were negative correlations between 
hospital CBCA scores and perinatal mortality (figure 4). In Mali, the correlation 
coefficient was -0.35 (p=0.12); in Senegal, it was -0.18 (p=0.23). Because case mix is an 
important confounder between CBCA score and mortality outcome, we redid the analysis 
with only hospitals with at least 10% of patients with obstetrical complications. We thus 
removed 3 hospitals that were receiving and treating a population more akin to that of a 
community health centre than a referral site. Removing these sites, in Mali, the correlation 
coefficient was -0.57 (p=0.03) and in Senegal, it was -0.37 (p=0.07). 
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Figure 4: CBCA scores by facility perinatal mortality according to country 
 
 
Correlation between hospital CBCA scores and hospital maternal mortality  
In both countries there were negative correlations between the hospital CBCA scores and 
facility maternal mortality (figure 5). In Mali, the correlation coefficient was -0.25 
(p=0.20) while in Senegal, it was -0.14 (p=0.28). As with the perinatal mortality analysis, 
we removed the three sites with very low levels of complication. With the restriction, the 
correlation between hospital CBCA scores and facility maternal mortality was -0.51 
(p=0.045) in Mali and -0.25 (p=0.17) in Senegal. 
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Figure 5: CBCA scores by facility maternal mortality according to country 
 
Association between patient CBCA scores and perinatal outcomes  
For this analysis, we merged the QUARITE and CBCA databases, pairing on the mother’s 
hospital registration number. In Mali, we had a 94.2% merging success and in Senegal, we 
had 91.9% merging success.  In Mali, there were 44 (15.3%) cases of stillbirth and early 
neonatal death. In Senegal, there were 48 (14.3%) adverse perinatal outcomes but we 
could not calculate CBCA scores for two because of missing information in the medical 
charts. There were four cases of maternal deaths; all four had stillbirths. 
 
Table 23 shows the number and percentage of stillbirths and early neonatal deaths for each 
section of the questionnaire according to those with good quality of care (>70% criterion 
attainment) versus moderate to poor care (≤ 70% criterion attainment). It also shows the 
total number of women with criterion attainment above 70% for each questionnaire 
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section. In Mali, for all sections of the questionnaire, there was a smaller proportion of 
stillbirths and early neonatal mortality in those patients with greater than 70% criterion 
attainment. In Senegal, the same is true for the first three sections of the questionnaire. 
Also, in Senegal, there were substantially fewer women (N=51) with greater than 70% 
criterion attainment than in Mali (N=171). 
 
We did sensitivity analyses looking at different cut-offs for good quality of care (60, 70, 
and 80%). Our results suggest that the choice of 70% is adequate. In both countries, there 
was a smaller proportion of perinatal deaths in women with CBCA scores above 70% 
compared to 60%. No important change occurs after that cut-off, particularly in Senegal 
where very few women had CBCA scores above 75%.  
 
In table 24 we present the results of the generalized estimating equations adjusting for 
hospital and patient characteristics. In this analysis, age, parity, and number of prenatal 
visits were not confounders and we did not adjust for them. In all analyses, moderate to 
poor quality of care was significantly associated with stillbirth and neonatal mortality. 
Women with CBCA scores below 70% were approximately two times more likely to have 
a stillbirth or neonatal death (adjusted OR 1.84, p=0.05).  
 
.
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Table 23: Number and percentage of stillbirths and early neonatal deaths according to good (≥70% attainment) and moderate/poor (<70% 
attainment) quality of care 
 Mali  Senegal  
 Records indicating 
good quality of care 
(≥70%) 
Records indicating 
poor quality of care 
(<70%) 
P Records indicating 
good quality of care 
(≥70%) 
Records indicating poor 
quality of care (<70%) 
p 
 N  
 
% stillbirths & 
neonatal 
deaths  
N % stillbirths & 
neonatal 
deaths  
 N % stillbirths 
& neonatal 
deaths 
N % stillbirths & 
neonatal 
deaths 
 
Patient History 273 14.7 14 28.6% 0.24 284 13.7 34 20.6 0.30 
1
st
  Clin exam 277 15.2 10 20.0% 0.65 245 12.2 89 20.2 0.08 
Laboratory  49 6.5 238 17.2% 0.05 93 7.5 238 17.2 0.02 
Delivery 220 13.2 67 22.4% 0.08 56 19.6 278 13.3 0.22 
Post-partum 74 10.8 213 16.9% 0.26 89 16.9 243 13.6 0.48 
Total 171 11.1 116 21.6% 0.02 51 9.8 259 15.8 0.39 
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Table 24: Association between CBCA score and stillbirth and early neonatal mortality adjusted for hospital and patient characteristics using 
generalized estimating equations 
 Block 1- Crude score Block 2- Adjusted for hospital 
characteristics 
Block 3- Adjusted for hospital 
and patient characteristics 
 OR, P-value 95% CI OR, P-value 95% CI OR, P-value 95% CI 
CBCA score 
   Good ≥70%  
   Poor <70% 
 
- 
1.85, p= 0.04 
 
- 
1.03-3.34 
 
- 
2.03, p=0.01 
 
- 
1.17-3.54 
 
- 
1.84, p=0.05 
 
- 
1.01-3.34 
Country 
   Mali 
   Senegal 
 
- 
 
- 
0.56, p=0.11 
 
- 
0.28-1.13 
 
- 
0.59, p=0.11 
 
- 
0.31-1.12 
Capital location 
   Capital 
   Region 
 
- 
 
- 
2.59, p=0.00 
 
- 
1.59-4.23 
 
- 
2.67, p=0.00 
 
- 
1.54-4.62 
Complexity index - 1.02, p=0.21 0.99-1.06 1.01, p=0.66 0.98-1.04 
Maternal condition 
   No 
   Yes 
 
- 
 
- 
 
- 
8.00, p=0.00 
 
- 
5.16-12.40 
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Discussion 
To our knowledge, this is the first study to comprehensively assess the measurement 
properties of obstetrical CBCA. Our CBCA has elevated inter-rater reliability and there is 
compelling evidence of its validity; the tool performs according to theory at both hospital 
and patient levels of analysis. Average hospital CBCA scores positively correlate with 
Complexity Index scores and negatively correlate with hospital maternal and perinatal 
mortality. At the patient level, women with moderate to poor care had about 2 times the 
odds of perinatal death compared to women with good quality obstetrical care. 
 
There are a number of strengths to this study. CBCA development was comprehensive and 
involved multiple revisions with international experts. Data collection was conducted by 
trained auditors using an electronic CBCA questionnaire with internal validity checks in 
order to reduce random error related to issues such as lost questionnaires and illegible 
writing. It is also one of the largest and most detailed audits conducted in a resource-
limited setting. Finally, given concerns that obstetrical records could be missing in a non-
random fashion, we systematically recorded the numbers of missing records and patient 
characteristics associated with missing obstetrical records. In Mali, we were able to 
retrieve 82.0% and in Senegal, we were able to retrieve 85.4% of obstetrical records. For 
both countries, there was no association between the patient age or type of birth (vaginal 
versus surgical) and the retrievability of the obstetrical record. This suggests that records 
were missing at random, as patient characteristics for retrieved and non-retrieved records 
were similar.  
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While this was a very large audit, there were sample size limitations related to the number 
of hospitals included (n=32). Estimates for the hospital-level analyses are unstable 
especially as considerable inter-country differences necessitated stratified analyses and 
thus reduced study power. In Mali, we observed significant associations while in Senegal, 
we mostly observed trends. Further, the hospital-level analyses did not adjust for 
confounding, such as differing levels of obstetrical complication. In theory, all hospitals 
are referral sites and should treat relatively similar proportions of complicated deliveries. 
However, certain hospitals appeared to receive a disproportionately low number of 
complications (less than 10%). These sites have serious organizational dysfunctions that 
place in question their categorization as comprehensive obstetrical referral sites. When we 
excluded these outlying hospitals, all correlations intensified. 
 
In this paper, our definitions for perinatal and maternal mortality reflected the fact that this 
was a hospital-based study and the goal of the larger QUARITE trial was to reduce facility 
mortality rates. Thus, we only followed women and their newborns until discharge. We 
did not include cases perinatal and maternal deaths that occurred after leaving the hospital. 
In the case of perinatal mortality, the fact that we could not follow newborns for a full 
week after birth entailed that our sample size for perinatal mortality was lower than 
expected because of few recorded early neonatal deaths (n=11). Based on previous studies 
(187, 188), we expected similar numbers of stillbirths and early neonatal deaths. We 
believe that a lack of postpartum monitoring (on average, less than 50% of criteria for this 
section were attained) meant that cases of early neonatal mortality were not detected 
and/or recorded. Despite this limitation, we observed that perinatal mortality was between 
1.5 and 2.0 times higher in women with lower than 70% criterion attainment. This result is 
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consistent with the odds ratio obtained by the generalized estimating equations that 
adjusted for both hospital and patient characteristics and also accounted for the clustering 
effect of the study design.  
 
We dichotomized the CBCA score based on recommendations by the WHO which suggest 
that a threshold, or target, be selected to represent an acceptable and obtainable quality of 
care score (79). The idea behind this recommendation is to encourage healthcare providers 
to obtain or beat the target at the next audit, when the CBCA is used as part of the audit 
cycle. However, there are limitations to dichotomizing the CBCA score, such as the 
possible introduction of misclassification bias. On the other hand, care during the 
intrapartum period is a process and the individual ascertainment of criteria is less 
important than the total package of care and a minimal standard of care should be 
expected for the treatment of any woman during delivery. 
 
Another limitation of the study was the small number of neonatal deaths. Our study 
outcome for the patient analyses consisted mostly of stillbirths, as we could not remove 
cases of intrauterine death from this outcome variable. By not taking away cases of 
probable intrauterine death, we likely introduced non-differential misclassification, which 
typically biases the estimate towards the null. We did not remove cases of intrauterine 
death because this information was inconsistently recorded by the study. In Senegal, the 
foetal heart rate was not evaluated in 16% of women while this was only the case for 2% 
of women in Mali.  
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The most important weakness of using CBCA is that the instrument is dependent on what 
is recorded in patient medical charts. If this information is incomplete or inaccurate, it can 
introduce measurement error. For example, during the audit, we could not find the vital 
status of 23 infants at birth. We were fortunate to have a second database to recuperate 
missing data but, nevertheless, made the assumption that four cases of recorded livebirths 
were in fact perinatal deaths given their very low birth weights. This assumption was also 
based on CBCA results indicating that these four women had no postpartum monitoring. 
To assure that we had not introduced error, we did two additional analyses treating these 
four cases as livebirths and as missing data; in all analyses, we obtain adjusted point 
estimates for CBCA score within two tenths of each other. Overall, we noted that the 
quality of data recording was generally poorer in Senegal compared to Mali, as evidenced 
by the lower reliability score and the non-overlapping confidence intervals. Reliability and 
validity coefficients are interlinked. The reliability of a test puts a cap on the possible 
validity for that test. Poorer data recording in Senegal introduced random error that 
reduced the precision of the CBCA instrument.  
 
Conclusion 
Overall, in conjunction with the elevated reliability coefficients, we feel that the 
converging evidence from the multiple assessments of construct validity in this article 
provide compelling evidence of the utility of this instrument to measure intrapartum 
quality of care. CBCA has the advantage of measuring the actual obstetrical practice 
received by a patient (compared to provider knowledge with vignettes) and is less 
subjective than expert observation. It was originally developed as a quality improvement 
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tool, but has promising research applications and can thus benefit both researchers and 
clinicians in measuring and improving obstetrical quality of care. As we have previously 
argued (183), recommendations  based on clinical audits need to be based on valid and 
reliable instruments. This tool helps fill that gap. 
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SUPPLEMENTARY MATERIALS 
(English Translation- CBCA questionnaire) 
 
IDENTIFICATION 
Complete the sections below. 
 
Country________________________________________________ 
 
Health Structure__________________________________________ 
 
Patient Registration Number______________________________________ 
 
Patient admission date_____________________________________ 
 
Time of admission________________________________________ 
 
Patient initials___________________________________________ 
 
 
FOR ALL WOMEN- PATIENT HISTORY 
Select one of the options below. If the information is not available in the patient record, 
select no.  
 
1) Condition of the mother at admission 
□ Not provided 
□ Good physiological condition 
□ Medium physiological condition 
□ Critically-ill 
□ Very critically ill 
 
Check yes if the information is available in the medical record and no if it is unavailable. 
If it is available, provide the corresponding information (e.g. the number of recorded 
prenatal exams, etc.). 
 
2) Number prenatal visits □YES________________□NO 
3) Age    □YES________________□NO 
4) Gravidity    □YES________________□NO 
5) Parity   □YES________________□NO 
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FOR ALL WOMEN- FIRST CLINICAL EXAMINATION 
These questions pertain to the first clinical examination of the patient. Check yes if the 
information is available in the medical record and no if it is unavailable. If it is available, 
provide the corresponding information (e.g. measure of uterine height, etc.). 
 
6) Uterine height   □YES________________□NO 
7) Cardiac frequency (pulse)   □YES________________□NO 
8) Blood pressure    □YES________________□NO 
9) Temperature   □YES________________□NO 
10) Fœtal presentation  □YES________________□NO      
 
These questions pertain to the first clinical examination of the patient. Check yes if the 
information is available in the medical record and no if it is unavailable. 
 
11) Fœtal heart beat       □YES  □NO 
12) Integrity of the membranes and/or colour of the amniotic fluid  □YES  □NO  
13) Measure of cervical dilation      □YES  □NO 
  
 
FOR ALL WOMEN- LABORATORY EXAMINATIONS 
Check yes if the laboratory result is available and recorded in the medical record and no if 
this information is not available.  
 
14) Blood type       □YES  □NO 
15) Rhesus factor       □YES  □NO 
16) HIV test        □YES  □NO 
17) Syphilis test       □YES  □NO 
 
       
FOR ALL WOMEN- DELIVERY AND BIRTH 
These questions apply to the time of delivery and birth. Check yes if the information is 
available in the medical record and no if it is not available.  
 
21) Name of the birth attendant     □YES  □NO 
22) Time of the placental expulsion     □YES  □NO 
 
 
 
 
 
 
Select one of the options below. If the information is not available, select no. 
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23) Birth assisted by a skilled attendant 
□No 
□Yes- doctor 
□Yes- midwife 
□Yes- resident in obstetrics/gynaecology 
□Yes- nurse 
□Yes- birth assisted but qualification not recorded 
 
24) Intramuscular or intravenous oxytocin administered to the woman during delivery or 
immediately post-partum? 
 □No     
  □Yes- as part of the active management of the third phase of labour (AMTSL)     
  □Yes- oxytocin only 
 
25) Time of birth  □Yes (write in the time) _____________ □No 
 
 
 
FOR ALL WOMEN- FOLLOW-UP AFTER BIRTH 
 
Select one of the options below. 
 
26) Was there clinical follow-up of the woman after birth (including the height of the 
uterine fundus and at least one vital sign)? 
□Yes, within the two hours following birth 
□Yes, between two and four hours after birth 
□Yes, four or more hours after birth 
□No, follow-up not noted recorded 
 
Check yes if the information is available in the medical record and no if the information is 
not available.  
 
27) Was a medical examination conducted prior to the woman’s hospital discharge? 
          □YES 
 □NO 
28) Was the woman’s date of discharge recorded?   □YES  □NO 
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Select one of the options below. 
 
29) Was the vital status of the newborn recorded in the medical record? 
□No 
□Yes, live-born in good health 
□Yes, live-born in poor health 
□Stillborn 
 
30) Was the APGAR score recorded? 
Score at 1-minute      □YES  □NO 
Score at 5 minutes      □YES  □NO 
 
 
 
 
 
 ALARM is associated with greater CBCA scores 
 
In the previous chapters we presented results regarding the development and validation of 
a CBCA instrument for the QUARITE trial. The instrument was specifically created for 
the West African context, proved to be reliable and demonstrated construct validity. 
Further, the availability, or lack thereof, of obstetrical records for audit does not appear to 
raise concerns for selection bias, as the population of women audited does not differ 
systematically from the population of women not audited. All in all, we are confident that 
we have developed a useful tool for measuring obstetrical quality of care at hospitals in 
West Africa. In appendix 9, we make some final suggestions on how to further improve 
the questionnaire, as well as how to modify it to meet specific research needs.  
 
Having developed a valid instrument with which to measure obstetrical quality of care, we 
were able to apply it in order to evaluate whether the randomized ALARM intervention 
was associated with better obstetrical quality of care scores in women giving birth at those 
sites. This chapter has been published by BMC Pregnancy and Childbirth.  
 Chapter 11: Effect of a facility-based multifaceted intervention on the 
quality of obstetrical care: A cluster randomized controlled trial in Mali 
and Senegal (article 4) 
 
AUTHORS: Catherine M Pirkle, Alexandre Dumont, Mamadou Traore, and Maria-
Victoria Zunzunegui 
 
Abstract 
Background: Maternal mortality in referral hospitals in Mali and Senegal surpasses 1 
percent of obstetrical admissions. Poor quality obstetrical care contributes to high 
maternal mortality; however, poor care is often driven by insufficient hospital resources. 
One promising method to improve obstetrical care is maternal death review. The 4-year 
QUARITE cluster randomized trial assessed whether the ALARM International Program 
(AIP), based on maternal death review, can improve obstetrical quality of care and reduce 
maternal mortality. Here, we evaluate the effect of the AIP on intrapartum obstetrical 
quality of care, as it is the causal mechanism by which the intervention is believed to 
function.  
Methods and Findings: The trial began with a pre-intervention year in 2007, followed by 
two years of AIP activities and a post-intervention year. We measured obstetrical quality 
of care in the post-intervention year using a criterion-based clinical audit (CBCA). We 
collected data from 32 of the 46 trial hospitals (16 in each trial arm) and included 658 
patients admitted in the maternity unit with a trial of labour. The CBCA questionnaire 
contained 26 criteria that measure 5 dimensions of care- patient history, clinical 
examination, laboratory examination, delivery care and postpartum monitoring. We used 
adjusted mixed linear regression models to evaluate differences in CBCA scores by trial 
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arms and examined how levels of hospital human and material resources affect quality of 
care differences associated with the AIP.  
Results and Discussion: For all women, the mean percentage of care criteria met was 66.3 
(SD 13.5). There were significantly greater mean CBCA scores in women treated at AIP 
hospitals (68.2) compared to control hospitals (64.5). After adjustment, women treated at 
AIP sites had 5 points’ greater scores than those at control sites. This difference was 
mostly attributable to greater clinical examination and post-partum monitoring scores. The 
association between the AIP intervention and quality of care was the same no matter how 
many resources a hospital had available to it; however, as resources increased, so did 
quality of care scores in both arms of the trial, especially in Mali. 
Conclusions: Patients treated at AIP hospitals had greater CBCA scores suggesting that 
the intervention is improving quality of care. Results indicate that the intervention mostly 
improves clinical examination at admission and postpartum monitoring, as well as key 
care aspects for post-partum haemorrhage. Results also indicate that quality of care scores 
can be maximized through interventions targeting clinical care, such as the AIP, and 
through increases in human and material resource availability at hospitals in the region.  
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Background 
Each day, 800 women worldwide die during pregnancy or of childbirth-related causes. 
Most maternal deaths occur in sub-Saharan Africa (189). Globally, it is recognized that 
significant inroads in maternal mortality cannot be made without dramatically increasing 
access to emergency obstetrical care (EmOC) (42). Hospitals capable of basic EmOC 
should provide parental antibiotics, anticonvulsants, and oxytocics, as well as be able to 
manually remove the placenta and retained uterine products, and perform assisted 
deliveries. Comprehensive EmOC sites also perform caesarean sections and blood 
transfusions (87). Yet, in many places, the numbers of maternal deaths occurring in health 
facilities providing EmOC are unacceptably high. In Mali and Senegal, over one percent 
of women die giving birth in referral hospitals across the region, in places where 
comprehensive EmOC is available (114). Such high case fatality suggests that poor 
medical practice may contribute to maternal mortality, along with other factors such as 
long travel times and late recognition of obstetrical complications. 
 
While elevated facility maternal mortality indirectly suggests deficiencies in quality of 
care, little work in the region has directly measured the problem. Anthropologists working 
in five West African capital cities have documented shocking departures from quality 
obstetrical care. These ranged from gross neglect to physical violence against patients 
(64). Additionally, limited quantitative evidence has indicated that over 70% of maternal 
deaths in the region could be avoided with better quality care (71). While sobering, this 
work does not quantify the amplitude of the quality problem nor give health professionals 
concrete suggestions on how to improve obstetrical practice.  
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Recently, there has been substantial interest in employing maternal death review (MDR) 
to improve obstetrical quality of care and reduce maternal mortality (190-192). MDR are 
audits of maternal deaths in which all healthcare staff involved in the management of a 
particular patient discuss the circumstances of the death and how care could have been 
improved. During the audit, recommendations to improve future patient care are made 
(79). In Senegal, a pilot study using MDR showed a 50% reduction in maternal mortality 
(80). MDR are believed effective at improving obstetrical care because they draw hospital 
staff attention to the problem of maternal mortality, highlight quality gaps, and emphasize 
finding solutions that are realistic in a given setting. Overall, they are believed to increase 
provider accountability. 
 
In September, 2007, the QUARITE cluster randomized trial was initiated to assess the 
effect of a multifaceted intervention, the ALARM International Program, on reducing 
facility maternal mortality (114). The hallmark of the intervention is MDR. Other aspects 
of the intervention include workshops on obstetrical best practices and periodic visits to 
ALARM sites by international experts. It is believed that the workshops and international 
visits facilitate MDR by providing health care professionals with the knowledge and 
confidence to make quality improvement suggestions during the reviews. In all, the 
ALARM program targets heath professionals in maternity units and is believed to reduce 
maternal mortality by improving quality of care, through better obstetrical practice. For 
the trial, we randomly allocated the ALARM intervention to referral hospitals in the 
region. To avoid contamination between health professionals, and because the intervention 
targets teams of professionals, a cluster design was deemed more appropriate than an 
individual randomized controlled trial. 
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Methods 
The QUARITE trial began in September 2007 and was completed in December 2011. It 
consisted of a one-year pre-intervention period, a two-year intervention period, and a final 
year post-intervention period. A detailed description of the trial design and objectives has 
been described elsewhere (114). The trial received ethics committee approval from Sainte 
Justine Hospital in Montreal (ref. 2425), the Ministry of Health and Preventive Medicine 
in Senegal (ref. 0869), and the National Ethics Committee for Health and Life Sciences in 
Mali (ref. 034/MS-SG-CNESS). Informed consent was obtained from each hospital 
included in the trial.  
 
Setting: 
The QUARITE trial took place in referral hospitals in Mali in Senegal. Referral hospitals 
are evacuation sites for complicated deliveries and in theory, should have sufficient 
infrastructure to provide comprehensive EmOC including caesarean section and blood 
transfusion (87). In both countries, there are sufficient numbers of comprehensive EmOC 
facilities for the population, though rural areas are underserved (86). In Mali, 
approximately 45% of women give birth in a basic or comprehensive health facility and of 
those whose births were assisted by a health professional, 2% received a caesarean section 
(193). In Senegal, the respective proportions are 62% and 3% (194).  
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Participants: 
As this is a cluster design, eligibility criteria apply to both the hospital and patient levels 
of analysis. To be eligible for the QUARITE trial, the referral hospital needed to have 
comprehensive EmOC capacity (i.e. a functioning surgical theatre and blood transfusion 
capacity) and at least 800 births per year. We focused on high volume hospitals in order to 
have enough maternal deaths (main trial outcome) and because the health system is 
organized in a pyramidal fashion. That is, lower order health centres refer cases of 
complication up to higher level, larger facilities that, in theory, should be able to able to 
treat life-threatening obstetrical complications. QUARITE’s eligibility criteria have been 
described in detail elsewhere, and a total of 46 of the 49 eligible referral hospitals were 
included in the trial (114). For the present study and analyses, all women admitted to 
hospital with a trial of labour and a foetus of at least 500gms were eligible for this sub-
study. Women admitted for elective caesarean section were not included, because they did 
not have a trial of labour. Elective caesarean section accounted for two percent of all birth 
in the trial (195).  
 
We sampled the charts of two populations of women. Providers were not aware of which 
charts would be sampled until the day of data collection which was after all care had been 
provided to the obstetrical patient. The first sample, called the consecutive sample, 
included the last 20-25 births having occurred at a hospital as of September 30, 2010. It 
was a random snap shot of the population of women attending a given hospital on an 
arbitrary date and included some of the women in the second sample. The second sample, 
called the complicated sample, included only women with severe pre-eclampsia and/or 
eclampsia and post-partum haemorrhage (defined below). We only looked at pre-
  169 
eclampsia and haemorrhage, because these were the two most frequent and lethal 
complications of women treated in trial hospitals, according to data collected during the 
baseline year of QUARITE. Women in the complicated sample were selected within a 
three-month sampling frame: July-September, 2010 in Senegal and September-November, 
2010 in Mali. We aimed for 10-15 complications per hospital, starting in September and 
working backwards in Senegal (and forwards in Mali) until the desired sample size was 
achieved or the sampling frame was exhausted. The dates of the sampling frames differ 
slightly because of when data was collected and the availability of records for audit (Mali 
was sampled after Senegal). 
 
To locate cases of severe (pre-) eclampsia/ eclampsia and post-partum haemorrhage, we 
used three data sources: the delivery register, the patient medical chart, and the QUARITE 
trial data sheet (records basic information on all women giving birth in trial hospitals, 
including diagnoses of obstetrical complication). Prior to QUARITE trial commencement, 
staff at both intervention and control sites received training on the diagnosis of obstetrical 
complications according to international guidelines. This was done to ensure consistency 
in the definitions of complication used across sites.  
 
For this sub-study, we assessed the care of patients with severe pre-eclampsia/ eclampsia 
and post-partum haemorrhage. To locate cases of severe pre-eclampsia or eclampsia, we 
searched the three forms of medical records described above. We looked for a diagnosis of 
pre-eclampsia, toxaemia, or eclampsia, as recorded by a healthcare professional (usually a 
midwife or doctor). Since many pre-eclampsia patients had mild to moderate pre-
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eclampsia, we also looked for the following indications of severe pre-eclampsia: mention 
of severity, convulsions, albumin laboratory scores of +++, and vomiting. For post-partum 
haemorrhage, in addition to an express diagnosis of the complication, we looked in depth 
at patients with antenatal haemorrhage (placenta praevia, abruptio-placentae) continuing 
into the post-partum period. We looked for indicators of postpartum haemorrhage such as: 
an important postpartum drop in blood pressure and/or post-partum blood pressure below 
90/50 (145); a postpartum drop in haemoglobin levels (158), retained placental fragments 
or incomplete expulsion of the placenta, mention of uterine atony, intravenous post-
partum administration of oxytocin or post-partum blood transfusion. We did not include 
blood loss because this was not recorded in the patient medical records and because 
physiological change may be more appropriate in this context, as there is a high 
prevalence of anaemia (159). The case notes for each obstetrical complication were 
verified by an obstetrician gynaecologist (AD) in order to reduce the inclusion of false 
positives.   
 
Intervention:  
The ALARM International Program was developed by the Society of Obstetricians and 
Gynaecologists of Canada. It combines clinically-oriented and evidence-based outreach 
visits with facility-based MDR. Specifically, the intervention included the following 
activities: 1) A six-day workshop to train and certify opinion leaders (one physician and 
midwife from each intervention site) in EmOC best practices, audit techniques, and sexual 
and reproductive rights; 2) the creation of a multidisciplinary audit committee (physicians, 
midwives, nurses, and administrators) at each site; 3) commencement of a once-monthly 
audit cycle according to WHO guidelines; 4) the training of qualified staff in obstetrical 
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best practices with 4-8 training sessions during the intervention period organized by local 
opinion leaders and external facilitators; 5) Educational outreach every three months by 
external facilitators including a national opinion leader and an ALARM international 
coordinator to support local opinion leaders in their activities and; 6) Recertification of 
local opinion leaders a year after initial certification with an accelerated training 
workshop. A more detailed description of the intervention has been published elsewhere 
(114). The control group did not receive any intervention by the research team after the 
baseline year. In other words, normal practice continued at the control sites including 
infrequent training courses (mostly related to HIV care) for obstetricians and midwives 
and some oversight by regional and national governments regarding the numbers of 
maternal deaths and prevention of mother to child transmission of HIV. It should be noted 
that these same activities were also carried out at ALARM sites. The ALARM program 
was implemented in addition to existing activities in the region.  
 
Objectives: 
The primary objective of the trial was to reduce facility maternal mortality (results 
forthcoming). Secondary objectives of the trial included: 1) reducing stillbirth and 
neonatal mortality; 2) reducing severe maternal morbidity; 3) improving quality of care 
and 4) increasing health professional job satisfaction (114). In this paper, we address the 
secondary objective of improving quality of care, as it is the mechanism by which the 
ALARM intervention is believed to reduce maternal mortality. In other words, we did not 
expect significant reductions in facility maternal mortality without first seeing 
improvements in obstetrical care. 
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Here, we evaluate the effect of ALARM on obstetrical quality of care during labour, 
delivery and the immediate post-partum period. It is during this period that most maternal 
deaths occur (57).  We assess whether quality of care at the patient level differs according 
to trial arms (ALARM versus control sites) and whether certain aspects of the care process 
have been differentially affected by the intervention. 
 
Outcomes: 
The primary outcome of this study was patient intrapartum quality of care, as measured 
with chart abstraction (see below). Secondary outcomes for this study were: scores for 
different dimensions of quality, quality scores for severe pre-eclampsia and eclampsia, and 
quality scores for postpartum haemorrhage.  
 
Quality of care was assessed with a form of chart abstraction known as criterion-based 
clinical audit (CBCA) (79). When using CBCA, standardized criteria for evaluating good 
quality of care are predetermined, usually with medical literature and expert opinion, and 
then compared against data extracted from medical records to evaluate whether or not a 
minimal standard of care has been met [5, 14]. CBCA is formatted to look like a checklist 
of pre-specified standards of good care. For example, the auditor may “check-off” if a 
patient’s blood pressure, cardiac frequency, and temperature were taken. For each 
affirmative response related to an expected standard of care, a point is given. The points 
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are tallied up and divided by the total possible in order to assign a quality of care score to 
each patient.  
 
The CBCA that we used has been described extensively elsewhere (196) and is both a 
valid and reliable tool for measuring obstetrical quality of care. Prior to conducting the 
audit, we piloted the questionnaire on 185 medical charts to assess inter-rater reliability 
and to maximize content validity. Additional analyses of the CBCA instrument showed 
that low scores (less than 70% criterion attainment) predict perinatal mortality; this 
strongly indicates construct validity (196). Additionally, because of concerns that missing 
patient obstetrical charts might lead to selection bias (183), we systematically recorded the 
numbers of missing records and patient characteristics (patient age; vaginal birth versus 
caesarean section) based on data collected from the delivery register. We assessed if there 
was an association between patient characteristics and missing obstetrical records and 
found no association. This suggests that records were missing at random, as patient 
characteristics for retrieved and non-retrieved records were similar (196).  
 
The CBCA contains 26 unweighted criteria that measure 5 dimensions of care: patient 
history, clinical examination, laboratory examinations, labour management (partograph), 
delivery care and postpartum monitoring. These sections apply to all women sampled. A 
quality of care score was attributed to each woman based on the number criteria met. For 
example, if 20 criteria were attained during the audit of a given medical record, then the 
score for that record would be 20/26 or 76.9%. In accordance with previous studies (79), 
we also defined a binary outcome to assess quality of care as follows: good care defined as 
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greater than 70% criterion attainment versus moderate to poor care defined as 70% or less 
attainment (196). Finally, two sections of the questionnaire applied only to women with 
severe pre-eclampsia/eclampsia and postpartum haemorrhage. These were scored 
separately (denominator of 7 for each). Table 25 shows the criteria included for each 
section.  
Table 25: Criteria included in the CBCA to measure obstetrical quality of care 
Dimension Criteria 
History taking  Condition of the mother at arrival 
 Number of prenatal examinations 
 Age 
 Gravidity 
 Parity 
Clinical examination at admission  Uterine height 
 Pulse 
 Blood Pressure 
 Temperature 
 Foetal presentation 
 Foetal heart beat 
 Membranes/amniotic fluid 
 Cervical dilation 
Laboratory analyses  Blood type 
 Rhesus factor 
 HIV test 
 Syphilis test 
Monitoring during birth  Name of person who assisted the 
birth 
 Qualification of the birth attendant 
 Time of placental expulsion 
 Oxytocin given 
 Time of birth given 
Postpartum monitoring  Follow-up examination 
 Exit examination 
 Date of exit 
 Condition of the infant at birth 
 
 
 
Severe pre-eclampsia and eclampsia 
(specific to women with this diagnosis 
only) 
 Anticonvulsant administered 
 Blood pressure recorded every four 
hours after birth 
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 Urinary output measured at least once 
in 24 hours 
 Test of bleeding time 
 Test of coagulation rate 
 Platelet count 
 Albumin test 
Post-partum haemorrhage (specific to 
women with this diagnosis only) 
 Pulse and blood pressure every 15 
minutes for 2 hours after diagnosis 
 Injection of oxytocin or egometrine 
 Intravenous oxytocin perfusion 
 Placenta expulsed 
 Test of bleeding time 
 Test of coagulation rate 
 Platelet count 
 
Sample size:  
We used Hayes and Moulton’s (2009) formula for cluster randomized trials with a 
quantitative endpoint (197). Our endpoint was mean patient CBCA score. Previous work 
in low- and middle- income countries has shown post-audit improvements in quality of 
care scores of 15-35% (183). We conservatively estimated that mean patient CBCA scores 
at ALARM hospitals would be 15% greater than at control sites. We assumed that 
standard deviations around the CBCA score would be the same in both groups and 
estimated them to be 0.15. We expected a high degree of within cluster correlation in 
CBCA scores, because facility institutional culture would likely lead similar obstetrical 
care and recording practices. We thus used a highly conservative intra-class correlation 
coefficient of 0.50. Given that we planned to sample 20 medical charts per hospital for the 
consecutive sample, 9 hospitals per trial arm would be necessary to detect a significant 
difference between intervention and control groups, with 80% power and an alpha of 0.05. 
For the subsamples of post-partum haemorrhage and severe pre-eclampsia and eclampsia, 
which used only 10 medical charts per site, we would need 10 hospitals per trial arm to 
detect a significant difference between arms. 
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Randomization: 
Centres were included on the basis of formal, informed consent on the part of the hospital 
director and the person in charge of maternity services. After a one-year pre-intervention 
data collection phase, each hospital was randomly assigned (August 2008) to either an 
intervention group, in which ALARM was implemented, or a control group. 
 
The participating hospitals were stratified into six strata corresponding to the combination 
of two countries (Mali and Senegal) and three hospital types: hospitals in the capital, 
regional hospitals, and district hospitals outside the capital. We attempted to ensure 
optimal balance between the hospitals assigned to the intervention and the control groups 
in terms of their number and size (number of deliveries per year). Therefore, within each 
stratum, we first ranked the hospitals with respect to size, and then used blocked 
randomization, with each block of size two, containing two hospitals with adjacent ranks, 
i.e., of similar size. All participating hospitals were randomized simultaneously, after their 
list was provided, which eliminated any risk of allocation bias. 
 
Blinding: 
Patients attending the study facilities were blinded to group assignment. For obvious 
reasons, those administering the intervention and health professionals implementing the 
intervention were not blinded. 
 
Statistical Methods: 
All statistical analyses were conducted in SPSS 17.0. We used t-tests to assess if there 
were statistically significant differences in CBCA scores according to arms of the 
QUARITE trial (ALARM versus control). We used mixed linear regression models with 
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restricted likelihood estimation and a random intercept. These take into account clustering 
by hospital when examining predictors of CBCA score. Because of the limited number of 
clusters in most CRTs, it is not unusual to find imbalances in covariates between trial arms 
(197). Thus, at the cluster level, we adjusted for country, material and human resources 
available for obstetric care (see below), and capital versus regional location. At the patient 
level, we assessed for confounding by age, parity and the number of prenatal 
consultations. We entered each patient variable one at a time to evaluate changes in the 
coefficient for ALARM. Changes of greater than 10% were considered potential 
confounding.  
 
For each site, we collected information on material and human resources allowing us to 
score the structural capacity of each centre. This score, called the Complexity Index Score, 
was derived from an instrument used in the WHO Global Survey on Maternal and 
Perinatal Health (136). It is comprised of eight categories describing: 1) basic services 
(e.g. water, electricity, etc.), 2) screening tests (proteinuria, urine culture, etc.), 3) basic 
emergency obstetrical resources (antibiotics, hysterectomy, transfusion, etc.), 4) 
intrapartum care (partograph use, skills in forceps, etc.), 5) general medical services (e.g. 
medical laboratory, sterilization equipment, etc.), 6) anaesthesiology resources 
(anaesthesiologist present 24h, equipment for general anaesthesiology, etc.) 7) human 
resources (nurse, midwife, etc.) and, 8) academic resources and clinical protocols (medical 
library, internet, etc.). We used an Africa-specific grading scheme for the Index proposed 
by Shah (137). A list of services under each of the categories described above is classified 
as essential, comprehensive, or advanced. Each service classified as essential receives one 
point, each comprehensive service receives two points, and each advanced service gets 3 
points. Points for the Complexity Index were summed up for each hospital. Scores can 
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vary from 0 to 100. For the Complexity index score, we centred the values around the 
mean to make the results more easily interpretable.  
 
Because the Malian and Senegalese health systems are organized differently, we also 
assessed for effect modification by country. Similarly, we assessed for effect modification 
by Complexity Index Score, hypothesizing that ALARM would be most effective at sites 
with greater resources. 
 
RESULTS  
Cluster (hospital) flow: Figure 6 shows the numbers of clusters followed through each 
stage of the study. Because of logistical and financial limitations, for this study on quality 
of care, we only analyzed 32 of the 46 study hospitals.  
Figure 6: Flow diagram of clusters and medical charts included in the study 
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Numbers analysed: This is an intention to treat analysis. In each trial arm, there were 16 
clusters (hospitals). We analyzed data from two samples: the consecutive (N=658) and 
complicated samples (N= 209). Figure 6 shows the numbers of clusters and charts 
analysed in each trial arm. 
 
Baseline data: Table 26 shows that the hospital and patient characteristics were very 
similar at the AIP and control sites. There were, however, more district and regional sites 
among those not sampled; parity in patients from these hospitals was higher.  
 
Table 26: Baseline characteristics of AIP, control, and excluded sites 
 AIP Sites* Control Sites* Not sampled
¥
 
Mali 
Senegal 
6 
10 
7 
9 
9 
5 
No. Capital sites 
No. Regional/District 
5 
11 
6 
10 
1 
13 
Mean patient age (SD) 25.7 (6.8) 25.8 (6.6) 25.2 (6.7) 
Mean patient parity (SD) 2.3 (2.3) 2.1 (2.3) 3.3 (2.4) 
Mean no. prenatal visits 
(SD) 
3.1 (1.7) 3.0 (1.6) 2.8 (1.8) 
*
Calculated from the consecutive sample 
¥
Data obtained from QUARITE trial database for same three-month study period (N=5764 for age, 
5776 for parity, and 5774 for prenatal visits). 
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Observations in the consecutive sample were well-distributed according to the 
intervention (48.5% at AIP sites and 51.5% at Control sites) and by location (33.4% in the 
capital versus 66.6% at district or regional hospitals). In the complicated sample, there 
were slightly more observations in the control arm than the AIP arm (see figure 6). When 
we centred the Complexity index score around the mean, 45.4% of observations in the 
consecutive sample were below the mean while 54.6% were above it. In the complicated 
sample, 39.2% of observations were below the mean Complexity index score while 60.8% 
were above it. This is expected, as higher-level hospitals attract more cases of obstetrical 
complication. 
 
Outcomes and estimation: For the consecutive sample (N=658), the mean CBCA score 
was 66.30 (SD 13.46) and the mean Complexity index score was 68.27 (SD 10.21). For 
the complicated sample (N=209), the respective means were 69.11 (SD 12.42) and 68.54 
(SD 9.36).  For 27 (4.1%) women we could not calculate a CBCA score due to missing 
information in the consecutive sample. A slightly higher proportion (6.7%) could not be 
calculated for the complicated sample.  
 
In both samples, there were significantly greater mean CBCA scores in women treated at 
AIP hospitals compared to women treated at control hospitals. This difference was mostly 
attributable to greater clinical examination at admission and post-partum monitoring 
scores (table 27).  
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We also looked at differences in the proportions of women receiving good quality care 
(greater than 70% criteria attainment) versus moderate to poor care (70% or fewer criteria 
attained). In the consecutive sample, significantly more women at AIP sites received good 
quality care compared to women at control sites (44.1% versus 29.7%, p=0.000). In the 
complicated sample, a similar difference between AIP and control sites was observed 
(50.0% at AIP sites versus 37.4% at control sites, p=0.08).  
 
Table 27: CBCA sores according to sample and AIP intervention 
 Consecutive Sample Complicated Sample 
 N AIP(% ) Control 
(%) 
N AIP (%) Control 
(%) 
Initial interview  639 82.3% 81.1% 203 81.8% 81.4% 
First clinical exam 657 86.4%* 80.5% 209 84.6% 80.7% 
Laboratory exams 654 33.3% 31.7% 204 40.2% 33.6% 
Delivery and birth  657 63.3% 62.8% 207 68.1% 71.0% 
Postpartum 
monitoring  
655 56.2%* 46.1% 208 63.0%* 49.8% 
Total  631 68.2%* 64.5% 195 71.5%* 67.1% 
*p-value for t-test ≤ 0.05 
 
For the subsections of the CBCA questionnaire pertaining to the direct complications of 
severe pre-eclampsia and eclampsia and post-partum haemorrhage, there were no 
significant differences in total scores between arms of the QUARITE trial. Overall, 
criteria attainment for these sections of the questionnaire was very low (tables 28, 29). 
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However, there were notable differences between trial arms for specific criteria within 
each section. While not statistically significant for most criteria, overall, AIP sites tended 
to have greater individual criterion attainment with the exception of criteria related to 
laboratory tests.    
 
Table 28: Criterion attainment for women with pre-eclampsia/eclampsia according to AIP 
Criterion AIP (n, %) 
N=68 
Control (n, %) 
N=70 
p-value 
Anticonvulsant administered 
     Magnesium sulphate 
     Valium 
     None 
 
26, 38.2% 
7, 10.3% 
35, 51.5% 
 
20, 28.6% 
7, 10.0% 
43, 61.4% 
 
 
 
0.455 
Blood pressure recorded every four 
hours after birth 
     Yes 
     No 
 
 
15, 22.1% 
53, 77.9% 
 
 
13, 18.6% 
57, 81.4% 
 
 
 
0.675 
Urinary output measured at least 
once in 24 hours 
     Yes 
     No 
 
 
22, 32.4% 
46, 67.6% 
 
 
22, 31.4% 
48, 68.6% 
 
 
 
1.000 
Test of bleeding time 
     Yes 
     No 
 
5, 7.4% 
63, 92.6% 
 
10, 14.3% 
60, 85.7% 
 
 
0.275 
Test of coagulation rate 
     Yes 
     No 
 
5, 7.4% 
63, 92.6% 
 
9, 12.9% 
61, 87.1% 
 
 
0.346 
Platelet count 
     Yes 
     No 
 
22, 32.4% 
46, 67.6% 
 
17, 24.3% 
53, 75.7% 
 
 
0.346 
Albumin test 
     Yes 
     No 
 
18, 26.5% 
50, 73.5% 
 
18, 26.1% 
51, 73.9% 
 
 
1.00 
 
Total severe (pre-) eclampsia score 
 
25.2% 
 
23.2% 
 
0.621 
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Table 29: Criterion attainment for women with post-partum haemorrhage according to AIP  
Criterion AIP (n, %) 
N= 58 
Control (N, %) 
N=64 
p-value 
Pulse and blood pressure every 15 
minutes for 2 hours after diagnosis 
     Yes 
     No 
 
 
8, 13.8% 
50, 86.2% 
 
 
6, 9.4% 
58, 90.6% 
 
 
 
0.57 
Injection of oxytocin or egometrine 
     Yes 
     No 
 
18, 31.0% 
40, 69.0% 
 
9, 14.1% 
55, 85.9% 
 
 
0.03 
Intravenous oxytocin perfusion 
     Yes 
     No 
 
27, 46.6% 
31, 53.4% 
 
23, 35.9% 
41, 64.1% 
 
 
0.27 
How the placenta was expulsed 
     Spontaneously 
     Manually 
     Not recorded 
 
10, 17.5% 
43, 75.4% 
4, 7.0% 
 
13, 21.3% 
35, 57.4% 
13, 21.3% 
 
 
 
0.05 
Test of bleeding time 
     Yes 
     No 
 
7, 12.3% 
50, 87.7% 
 
19, 29.7% 
45, 70.3% 
 
 
0.04 
Test of coagulation rate 
     Yes 
     No 
 
7, 12.3% 
50, 87.7% 
 
18, 28.1% 
46, 71.9% 
 
 
0.06 
Platelet count 
     Yes 
     No 
 
28, 49.1% 
29, 50.9% 
 
35, 54.7% 
29, 45.3% 
 
 
0.48 
Total post-partum haemorrhage 
score 
 
36.7% 
 
34.9% 
 
0.586 
 
Predictors of CBCA score: We used the larger consecutive sample to assess predictors of 
CBCA score. Table 30 presents results from the mixed linear regression model. After 
adjusting for all relevant covariates, AIP was significantly associated with CBCA score. 
Women treated at AIP sites have, on average, 5 percentage points’ greater CBCA scores 
than those treated at control sites. Country predicted CBCA score better than any other 
variable; women treated at sites in Senegal have lower average CBCA scores than women 
treated in Mali. Complexity score was associated with better CBCA score in Mali but not 
in Senegal.  The number of patient prenatal visits was not significantly associated with 
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CBCA score but it was a potential confounder and thus, we preferred to retain it in the 
final model. 
Table 30: Mixed linear regression model of predictors of CBCA score (N=618) 
Variable Estimate 95% confidence 
interval 
P-value 
Intercept 0.756 0.706 – 0.806 0.000 
AIP 
     Intervention 
     Control 
 
0.052 
- 
 
0.003 – 0.102 
- 
 
 
0.040 
Country 
      Senegal 
      Mali 
 
-0.184 
- 
 
-
0.240 – -0.128 
- 
 
 
0.000 
Centred complexity score 0.006 0.002 – 0.011 0.005 
Prenatal visits 
     3 or less 
    4 or more 
 
-0.012 
- 
 
-
0.028 – 0.003 
- 
 
 
0.108 
Country-Complexity 
interaction 
     Senegal*Complexity 
     Mali*Complexity 
 
 
-0.005 
- 
 
 
-
0.011 – 0.000 
- 
 
 
0.055 
 
Figures 7 and 8 show relationship between AIP and CBCA scores for three difference 
scenarios of Complexity index score (10 points below the average score, the average 
score, and 10 points above the average score) for a woman with the recommended number 
of prenatal visits (4 or more).  
 
In Mali, a ten-point increase above the average Complexity index score has a slightly 
more important effect on CBCA score than the AIP intervention (6% improvement for 
Complexity index score versus 5% for AIP). In Senegal, however, a ten-point increase 
above the average Complexity index score has a less important effect on CBCA score than 
AIP (1% improvement for Complexity index score versus 5% for AIP). 
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Figure 7: Relationship between CBCA and Complexity Index score according to AIP 
in Mali 
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Figure 8: Relationship between CBCA and Complexity Index score according to AIP 
in Senegal 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
-10 Complexity score Ave +10 Complexity score
Hypothetical Hospital Senegal
AIP
Control
 
 
 
  186 
Discussion 
This was a sub-study of data from the QUARITE cluster randomized controlled trial. In 
this study, we attempted to parse out potential mechanisms of effect for the ALARM 
intervention.  By doing so, we hoped to better understand how the intervention worked 
and what aspects of the intervention can be modified for future quality improvement 
efforts. Analyses from this study indicate that women treated at hospitals with the 
ALARM intervention have modestly greater mean CBCA scores. This suggests that the 
intervention is having the desired effect; it is associated with better obstetrical quality of 
care. Further, 15% more women are receiving good care (70% or greater criterion 
attainment) at ALARM hospitals when compared to control hospitals.  
 
Results indicate that the intervention mostly improves clinical examination at admission 
and postpartum monitoring. There is also a trend suggesting that ALARM may be 
associated with increased use of magnesium sulphate in women with severe pre-
eclampsia/ eclampsia. Finally, there was significantly greater administration of oxytocin 
for women with post-partum haemorrhage at ALARM sites and a greater proportion of 
women with post-partum haemorrhage at these sites were recorded as having had the 
placenta removed manually. 
 
This study looks at the potential mechanisms of a complex quality improvement 
intervention and points to areas for future focus, specifically laboratory tests and birth and 
delivery care. It goes beyond simply assessing efficacy. By attempting to better elucidate 
what worked and why, we “look more closely inside the ‘black box’ of an intervention” 
  187 
(198 p792), in order to better guide the development of future quality improvement 
programs. It takes a comprehensive look at quality of care evaluating both structure- 
(Complexity Index score) and process-level (CBCA score) components of care (75). 
Quality of care is frequently proxied by the availability of hospital infrastructure and 
human resources based on the assumption that medical practice will improve as these 
resources increase (75). We take a more nuanced view, acknowledging that context may 
determine the relative importance of each component of quality of care. In Senegal, for 
example, we saw that the ALARM intervention, which focused on medical practice, had 
more influence on intrapartum quality of care than resource availability. However, in 
Mali, where resources are lower than in Senegal, both the ALARM intervention and 
resource availability were important predictors of quality.  
 
There are several strengths to this study. To our knowledge, this is the first validated 
CBCA to be used in a resource-limited setting to measure obstetrical care (183). This was 
a very large audit of over 800 women (both samples) across 32 hospitals. Because of this, 
we were able to document the extensive variability in care that women received at referral 
facilities across the region. The breadth of the study, and the use of a validated CBCA 
instrument to quantitatively measure obstetrical care, gives us confidence that ALARM is, 
in fact, a promising quality improvement tool that can be applied in a wide variety of 
settings. In a trial of this size, one would expect effect dilution due to factors such as 
incomplete implementation of the program (199). Given the inevitability of effect dilution, 
significant results showing quality of care improvements are encouraging and may suggest 
that the ALARM intervention can be generalized in low-income settings. 
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We sub-sampled women with direct complications that are both prevalent and have high 
case-fatality rates in West African hospital settings (200). We were surprised to find that 
the ALARM intervention had a limited effect on the care of women with severe pre-
eclampsia/ eclampsia. The care of this complication may be strongly influenced by 
resource availability. For example, in Mali, most district hospitals did not have sufficient 
laboratory resources to detect biological signs of severe pre-eclampsia, such as tests of 
proteinuria. These signs are frequently used as indicators for the use magnesium sulphate.  
However, even at sites with sufficient resources, complications appeared to go 
unrecognized. For both of the complications sampled, we were not able to rely exclusively 
on provider diagnoses. Sometimes, complications were simply not detected or 
euphemisms were employed (e.g. “endometriosis” following caesarean section instead of 
postpartum haemorrhage). As a result, we used multiple signs of complication (see 
participants section of methods) to detect cases severe pre-eclampsia/eclampsia and 
postpartum haemorrhage. By doing so, we increased the sensitivity of our case definition 
but may have reduced specificity (e.g. more false positives). Nonetheless, it is obvious that 
medical care for a complication cannot be improved if that complication is not 
acknowledged/ detected. Thus, future efforts need to improve the recognition of 
obstetrical complications.  
 
There are limitations to this study. By not sampling all 46 hospitals in the QUARITE trial, 
we may have broke-down the initial randomization. For this reason, we considered 
potential confounders at both the hospital and patient levels. Given that hospitals in our 
sample were well-balanced by trial arm and by level (capital, regional, district) and that 
patient variables, such as age and parity, were not confounders, suggests that we did not 
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introduce bias with the smaller sample. However, the proportion of district-level hospitals 
was greater in those sites not sampled (table 26) and results from this study may be less 
generalizable to lower-level referral hospitals.  
 
An additional limitation is related to the sample size for both of the direct obstetrical 
complications sampled. It is possible that we would have observed a significant result for 
the administration of magnesium sulphate at ALARM sites had we had a larger sample of 
clusters in both trial arms. There was very large variability at both the patient and hospital 
levels for the treatment of these complications. This reduced precision around the effect 
estimate and thus, our ability to detect a significant result. A larger sample would have 
allowed us to better interpret the laboratory results, as very few women received 
recommended laboratory tests for both complications. It should be noted that no patients 
in Mali were recorded as having tests of bleeding time or coagulation rate. Estimators for 
these criteria are thus very unstable.  
 
Finally, the greatest weakness of CBCA is that it is dependent on what is recorded. In 
applying this tool, one assumes that what is recorded in the medical chart has actually 
been done and what has not been recorded, has not been done. This assumption may be 
flawed. For example, in Senegal, the name and qualification of the person who assisted the 
birth was recorded about a quarter of the time and in 80% of these cases, information was 
only recorded when the woman was seen by a medical doctor. Incomplete recording 
practices in Senegal may partially explain why CBCA scores were significantly lower 
there, compared to Mali. Nonetheless, charting is itself an indicator of quality of care. 
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Good charting is necessary because the medical team following a woman may change 
over the course of a day and important decisions, such as when to conduct a caesarean 
section, are best made with the aid of tools such as the partograph (161).  
 
CONCLUSION 
The ALARM intervention appears to improve certain aspects of the care process (clinical 
examination and post-partum monitoring), but other aspects (laboratory tests, delivery 
care) need further programmatic targeting. There is evidence suggesting that the program 
improves the care of women with post-partum haemorrhage, but that it is less effective for 
cases of severe pre-eclampsia/ eclampsia. Resource limitations, particularly in Mali, may 
be slightly more influential in determining the care of these patients (especially those with 
direct complications) than interventions targeting medical practice. Overall, these analyses 
demonstrate that future efforts in the region need to continue to target medical practice, 
but that a greater effect can be expected if resource availability is also improved.  
.  
 
 
 
 
 
 Components of PMTCT programs are associated with greater CBCA 
Scores 
 
In the previous chapter, we showed that the randomized ALARM program was 
significantly associated with greater CBCA scores. These results indicate that the program 
is having the desired effect; it is improving the medical procedures and practices of health 
professionals. In the following chapter, we assess which PMTCT programs are associated 
with CBCA scores. As the chapter will show, specific components of PMTCT programs 
are significantly associated with greater CBCA scores. This means that aspects of these 
programs may lead to better intrapartum quality of care and this information can be used 
to better integrate divergent programs such as ALARM with PMTCT. The results of this 
chapter also show that there is no effect interaction between the programs. That is, both 
significantly improve quality of care, but not above what would be expected based on the 
independent contribution of each. This chapter has been submitted to Health Policy and 
Planning. 
 Chapter 12: Training and nutritional components of PMTCT programs 
are associated with improved intrapartum quality of care in Mali and 
Senegal (article 5) 
 
AUTHORS: Catherine M Pirkle, Alexandre Dumont, Mamadou Traoré, and Maria-
Victoria Zunzunegui 
 
Abstract 
Introduction: Widespread scale-up of prevention of mother to child transmission 
(PMTCT) of HIV programs in sub-Saharan Africa has stimulated interest to assess 
whether these programs can indirectly affect other health priorities. In countries with high 
maternal mortality and weak health systems, evaluating whether and how PMTCT 
programs improve maternal healthcare could be informative to developing linkages 
between the two types of programs. This study assesses whether PMTCT programs, or 
components of these programs, are associated with better obstetrical quality of care and 
how PMTCT may reinforce existing maternal health programs.  
Methods: This is a cross-sectional analysis of data from 31 referral hospitals and 612 
patients included in a cluster-randomized trial called QUARITE conducted in Mali and 
Senegal. The exposure variable of interest was PMTCT, measured with a scale containing 
10 components describing different prongs of a hospital PMTCT program. The outcome 
variable of interest was obstetrical quality of care measured through a previously validated 
chart abstraction tool. Other variables of interest included: presence of a quality of care 
improvement program, hospital resources, and patient demographic characteristics. 
Statistical analyses included mixed linear regression models and generalized estimating 
equations. 
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Results: Out of 45 points, the mean hospital PMTCT score was 26.1 (SD: 6.7). Total 
PMTCT scores were not significantly associated with quality of care, but certain program 
components were. After adjustment for known predictors of quality of care, staff training 
in PMTCT (p=0.03) and complementary nutritional services (p=0.03) were significantly 
associated with better quality obstetrical care. A point increase in scores for both of these 
components was associated with 40% greater odds of good obstetrical care. 
Conclusions: PMTCT training and nutritional components are significantly associated 
with better quality intrapartum care. In particular, health professionals’ training in 
maternal care and PMTCT could be combined to improve the quality of obstetric care in 
the region. 
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Introduction: 
International initiatives have vastly scaled-up HIV/AIDS treatment programs and more 
than tripled the number of patients receiving antiretrovirals in sub-Saharan Africa since 
2006 (201). Prevention of mother to child transmission of HIV, or PMTCT, has been of 
particular interest in HIV/AIDS program scale-up because it can bring transmission of the 
virus to below 5%, even in low resource settings (108). Recently, there have been 
dramatic increases in the numbers of women benefitting from PMTCT programs. 
Coverage more than doubled in the three year period from 2005 to 2007, going from 14% 
to 33% (96). As of 2010, this number was estimated at 48% (201). 
 
HIV/AIDS program scale-up may lead to wider health systems improvements (100). The 
substantial funds backing HIV/AIDS programs may bolster weak and underfunded health 
systems, such as those throughout much of sub-Saharan Africa. Funds for these programs 
may indirectly benefit other health initiatives by renovating health facilities; improving the 
reliability of supply chains; increasing the availability of well-trained health professionals; 
and augmenting health service utilisation (94, 96, 101, 102). Beneficial changes to health 
services attributed to implementation of HIV programs have been linked to improvements 
in maternal and child health (101, 103), although neither health priority was directly 
targeted by the HIV programs. While much focus has been paid to the positive spill-over 
from HIV/AIDS scale-up, there has also been concern that the verticality of these 
programs could negatively impact funding for other health concerns, as well as lead to 
untenable administrative burdens for fragile health systems (202-204). 
 
  195 
PMTCT programs provide a fascinating lens through which to analyse how HIV/AIDS 
interventions may contribute to overall health system strengthening (or weakening). Many 
PMTCT programs offer continuing education courses to maternity staff, provide resources 
such as medications, gloves and bleach, as well as construct or renovate maternity, 
laboratory and pharmaceutical infrastructures (104, 112, 205). These inputs may lead to 
overall health facility improvements that benefit all mothers, not just those who are HIV 
positive. For example, Delvaux
 
et al. (2008) provided evidence from Côte d’Ivoire 
suggesting that PMTCT programs improve the quality of antenatal and delivery services 
used by both HIV-positive and negative women (104). Thus, scale-up of PMTCT 
programs may lead to better hospital infrastructure, especially in the maternities where 
program components are carried-out, and to greater healthcare provider training and skills. 
These changes may, in turn, indirectly improve maternal care.  
 
Improving the care of pregnant women, especially during childbirth and delivery, is 
essential in sub-Saharan Africa where almost half of all maternal deaths occur (206). Poor 
quality obstetrical care is a significant contributor to these maternal deaths; most maternal 
deaths occur during the intrapartum period, when a woman should be under the 
supervision of a trained birth attendant (68, 71, 207). Several authors have raised the 
possibility of linking HIV/AIDS programs, especially PMTCT programs, to maternal 
health initiatives in order to benefit both programs (116, 117, 120, 208). Others have 
stressed the importance of determining whether HIV programs can benefit obstetrical 
quality of care (209), as there is growing consensus that reductions in maternal mortality 
cannot occur in the absence of wider health systems improvements and better quality of 
care (68, 99, 210). Despite the theoretical linkages between the two health priorities, little 
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empirical research exists to assess whether PMTCT programs improve (or harm) 
obstetrical care. A recent systematic review only found three studies that attempted to 
address this question and the results were inconclusive (211). This knowledge gap is 
particularly acute for sub-Saharan African countries with weak health systems and 
moderate to low HIV epidemics, such as Senegal and Mali (211). Further, how PMTCT 
programs may lead to improvements in general obstetrical care is largely unexplored. 
PMTCT programs are multi-pronged and have differential levels of integration into 
hospital maternity units. Consequently, we do not know what specific components of 
PMTCT programs are associated with better care, or how PMTCT and maternal health 
programs may realistically be linked. To respond to these knowledge gaps, we examine 
the indirect effects of PMTCT on obstetrical quality of care in Mali and Senegal.  
 
An additional consideration when trying to examine the association between PMTCT 
programs and the quality of obstetrical care is accounting for the role of multiple global 
health programs at once. This is of particular concern because, at the same time that 
massive HIV/AIDS scale-up was occurring (2006 to present), several important initiatives 
directly targeting maternity care were also launched including: the QUARITE trial in Mali 
and Senegal (114); the Audobem trial in Niger, Burkina Faso and Benin (trial registration 
number: ISRCTN67206260); and the MaiMwana Project in rural Malawi (115). Evidence 
demonstrating a link between HIV/AIDS programs and other health outcomes has 
insufficiently attempted to dissociate the effects of concomitant programs. Thus, it is 
possible that previously observed associations between HIV/AIDS programs and maternal 
and child health are partially or entirely due to the effects of other initiatives.  
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The primary objective of this study is to assess whether PMTCT programs offered at 
referral hospitals in Mali and Senegal are associated with improved obstetrical quality of 
care, in and above other factors correlated with care in the region. We assess associations 
between PMTCT components and quality of care. By looking at program components, we 
aim to better understand how a PMTCT program may or may not lead to improved 
maternal quality of care. Finally, we are interested in evaluating whether any observed 
associations are maintained after adjusting for the effects of a regional obstetrical quality 
of care improvement program called ALARM. This program consisted of maternal death 
reviews and training in evidence-based practices and is believed to reduce facility 
maternal mortality. It was ongoing at the same time as PMTCT programs in the region 
were scaling up. Previous work has demonstrated an association between ALARM and 
better average obstetrical quality of care (212). Before any conclusions can be drawn 
about the associations between PMTCT and quality of care, the potential role of ALARM 
needs to be accounted for. Further, assessing the possible interrelationship between 
PMTCT and ALARM may help to draw conclusions about how to link up programs so as 
to exploit the strengths of each while limiting redundancies.  
 
Methods: 
Context and Background 
PMTCT: In recent years, massive scale-up of HIV/AIDS programs across West Africa has 
occurred. Despite the fact that both Mali and Senegal have relatively low HIV/AIDS 
population prevalences (1.3% in Mali and 0.7% in Senegal) in adults aged 15 to 49 (55, 213), 
they have been large beneficiaries of HIV/AIDS financing. For example, as of 2010, over 56 
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million US$ in HIV/AIDS funding had been disbursed to Mali by the Global Fund. In 
Senegal, the corresponding number was over 44 million US$. In both countries, funding by 
the Global Fund has steadily grown over the past ten years, with approved funding for 
HIV/AIDS surpassing 80 million dollars in Mali and Senegal 
(http://portfolio.theglobalfund.org/en/Region/Index/WCA). These numbers do not include a 
myriad smaller donors, such as Solthis, ARCAD-SIDA, FMI, etc., who also support 
HIV/AIDS programs in West Africa. 
 
Increases in HIV/AIDS funding have driven PMTCT program scale-up in the region. At the 
31-referral hospitals that are the focus of this study (see participant section below), the earliest 
start date for a PMTCT program was 2000 and the latest was 2010. 14 of the 31 sites in 
this study started their PMTCT programs in 2006 or 2007. The timing of PMTCT scale up 
in the region coincided with regional quality improvement efforts directed at obstetrical 
care. 
 
PMTCT is a multifaceted intervention; the content of programs can vary dramatically. A 
holistic approach to PMTCT includes: 1) primary prevention of HIV among women of 
childbearing age; 2) preventing unintended pregnancy among HIV-positive women; 3) 
preventing vertical transmission of the virus; and 4) providing appropriate treatment and 
care to HIV-positive women and their families (214). In practice, most PMTCT programs 
focus on points three and four by providing voluntary testing and counselling to pregnant 
women, ARV prophylaxis to HIV-positive pregnant women and their infants, infant 
feeding and counselling, and postnatal follow-up until the infant’s HIV status is 
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determined. Some programs also provide opportunistic infection prophylaxis, screening 
and treatment of other diseases such as tuberculosis, nutritional and psychological support, 
adherence counselling and clinical and laboratory monitoring. In both Mali and Senegal, 
official guidelines focus mostly on voluntary testing and counselling, ARV prophylaxis, 
breastfeeding, and infant testing. However, some sites, particularly in Mali, provide more 
comprehensive programs with nutritional support, extensive clinical and laboratory 
monitoring, and neonatal follow-up beyond HIV testing.  As will be demonstrated later, 
there was extensive diversity in the PMTCT program components offered at referral 
hospitals in the region.  
 
An additional complexity when describing PMTCT programs in the region is the level of 
integration they have within existing health services. We define full integration as harmonized 
service-delivery at a single point of care, in this case, the hospital maternity. Similar to 
findings from a recent review of the subject (113), most hospitals in this study could be 
classified as having a semi-integrated PMTCT program. That is, most PMTCT services were 
carried out in hospital maternities (which include prenatal consultation rooms) but were 
financed, managed, or supervised as additional services. 
 
ALARM: While scale-up of PMTCT programs was occurring in West Africa, programs 
directly targeting obstetrical quality of care were also being implemented. In Mali and 
Senegal, the most notable quality improvement program in the region was the Advances in 
Labour and Risk Management (ALARM) International Program. This program started in 
October 2008 and finished in October 2010 and was implemented at approximately half of all 
referral hospitals in both countries. ALARM targeted the health care professionals in 
  200 
participating hospitals and consisted of an initial interactive workshop and quarterly 
educational clinically oriented and evidence-based outreach visits focused on facility-based 
maternal death reviews and best practices implementation. The effectiveness of the ALARM 
International Program on maternal and perinatal mortality was assessed, using a cluster 
randomized control (CRT) trial Qualité des soins, gestion du risque et technologie obstétricale 
dans les pays en développement, or QUARITE (114). 
 
Design 
This is a cross-sectional analysis of data collected as part of the QUARITE trial. 
 
Participants 
To be eligible for the QUARITE trial, a referral hospital needed to be able to provide 
comprehensive emergency obstetrical care and have at least 800 births per year. There 
were 49 hospitals in the region eligible for QUARITE, of which 46 participated. An equal 
number of hospitals were allocated to each arm of the trial (23 intervention and control 
hospitals). More details about the eligibility requirements, sampling, and randomization 
can be found elsewhere (114). Due to logistic and budgetary restraints, we did not sample 
all QUARITE sites for this study. Instead, we selected a representative sample of 31 
hospitals from the QUARITE trial. The sample consisted of 15 intervention sites receiving 
the ALARM International Program and 16 controls sites; of these 31 study sites, 10 were 
district hospitals, 11 were regional hospitals, and 10 were located in the capitals. Among 
sampled hospitals, all women admitted with a trial of labour and a foetus of at least 
500gms were eligible. At each site in this study, we sampled the last 20-25 births having 
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occurred as of September 30, 2010 (at the end of the intervention period of the trial). Our 
sampling procedure provided a random snap shot of the population of women attending a 
given hospital on an arbitrary date. 
 
Sample size 
We used Hayes and Moulton’s (2009) formula for cluster randomized trials with a 
quantitative endpoint (197). Our endpoint was mean patient CBCA score. Previous work 
in low and middle income settings has shown improvements in quality of care scores of 
15-35% with tools, such as audit, that directly target obstetrical care (183). We would 
expect that the indirect effects of PMTCT would be less than the effects of programs 
directly targeting obstetrical care. We estimated that mean patient CBCA scores at 
hospitals with comprehensive PMTCT programs would be 10% greater than at sites with 
substandard programs. We assumed that standard deviations around the CBCA score 
would be the same in both groups and estimated them to be 0.10. Since a high degree of 
within cluster correlation in CBCA scores was expected, because facility institutional 
culture would likely lead similar obstetrical care and recording practices, we used a 
conservative intra-class correlation coefficient of 0.50. Given that we planned to sample 
20 medical charts per hospital, a sample size of 18 hospitals would be necessary to detect 
a significant difference between hospitals with comprehensive PMTCT programs versus 
sub-standard programs, based on 80% power and an alpha of 0.05.  
 
Measures 
Exposures: In order to describe the PMTCT program at each hospital, we used a modified 
version of Columbia University’s International Centre for AIDS Care and Treatment 
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Programs’ (ICAP) PMTCT/VCT site assessment tool (107). The questionnaire was 
modified based on feedback from two HIV experts experienced in the sub-Saharan 
context. It allowed us to characterize the comprehensiveness of each hospital’s PMTCT 
program and determine the level integration of that program into the maternity. It was 
administered to the head midwife and the lead maternity doctor at each site. This was done 
during an annual meeting (October 2010) held by the trial during which, the two 
respondents completed the questionnaire together. After completion of the questionnaire, 
CP verified it for inconsistencies and missing data. In such cases, CP sought out the 
respondents to fix the possible errors. CP later visited each site and further modifications 
were made to the questionnaire if inconsistencies were observed. 
 
The PMTCT questionnaire was piloted for feasibility and context-specificity in August 
2008 at 10 hospitals in Mali and Senegal, after which, final revisions were made. The final 
questionnaire described 10 components of a PMTCT program: training in PMTCT, 
counselling, testing for the virus, general physical evaluation, laboratory clinical 
evaluation, knowledge of prophylaxis for the mother, laboratory surveillance of the 
mother, knowledge of prophylaxis for the newborn, follow-up of the newborn’s health, 
and nutritional services. All questions were closed-ended except for those asking 
respondents to list the antiretroviral protocol given to HIV positive mothers and their 
infants. In appendix 10 is a summary of the questionnaire sections and scoring. Each 
question was worth one point and index scores were calculated for the questionnaire 
sections and for the total questionnaire. A total of 45 points was possible. The more points 
a hospital had on the questionnaire, the more comprehensive and integrated the program at 
that site. 
 
  203 
ALARM- The ALARM International Program was randomly allocated to hospitals in the 
QUARITE trial. As described above, the ALARM program directly targeted obstetrical 
quality of care though periodic maternal death reviews and training workshops in 
evidence-based obstetrical practices. We conducted a survey in participating hospitals in 
both control and intervention groups during the post-intervention period regarding 
maternal death reviews and continuous education practices. We collected detailed 
information on specific activities implemented during the intervention period in each 
participating hospital using in-depth interviews with health services managers. All the key 
components of the ALARM program were implemented in the intervention hospitals as 
required by the trial protocol: regular educational outreach visits by a certified instructor, 
regular audit meetings for MDR, regular on-site training.  
 
Outcome: The primary outcome of this study was patient intrapartum quality of care, as 
measured with a validated form of chart abstraction known as a criterion based clinical 
audit (CBCA). This tool has been described extensively elsewhere and is only briefly 
summarized here (196). A CBCA employs standardized criteria for evaluating good 
quality of care that are predetermined and then compared against data extracted from 
medical records to ascertain whether a minimal standard of care has been met (58). The 
CBCA used in this study contained 26 unweighted criteria that measured patient history 
taking, clinical examination at admission, laboratory examinations, delivery care and 
postpartum monitoring. For example, to assess the clinical examination at admission, we 
searched the patient’s medical record to see if a list of measures, including uterine height, 
blood pressure, pulse, temperature, and cervical dilation had been recorded.  Using this 
CBCA measure, we were able to calculate the percentage of criteria attained for each 
patient in this study; the greater the percentage attained, the better the care. Additionally, 
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in previous work, we demonstrated that CBCA scores below 0.70 were significantly 
associated with perinatal mortality (OR 1.84, 95%CI 1.01-3.34) (196). Based on this 
information, we categorized the care of a patient as good (≥ 0.70) or inadequate (<0.70). 
Data on the outcome measure were collected over six months starting in fall of 2010.  
 
Other measures of interest: Hospital resources- For each site, information was collected 
annually to compute a score of the structural capacity of each hospital. This score, called 
the Complexity Index Score, was derived from the WHO Global Survey on Maternal and 
Perinatal Health (136). It was comprised of eight categories describing: 1) basic services 
(running water, electricity, etc.); 2) screening tests (blood group, urine cultures, etc.); 3) 
basic emergency obstetrical resources (intravenous antibiotics and oxytocin, etc.); 4) 
intrapartum care (forceps, vacuum, etc.); 5) general medical services (intensive care unit, 
blood bank, etc.); 6) anaesthesiology resources (anaesthesiologist on call, anaesthesiology 
equipment, etc.); 7) human resources (obstetrician, midwives, etc.) and, 8) academic 
resources and clinical protocols (access to medical library, computer with internet, etc.). 
We used an Africa-specific grading scheme for the Index (215).  
 
Points for the Complexity Index were summed up for each hospital and could vary from 0 
to 100. For analyses, we centred the Complexity Index values around the mean to make 
the results more interpretable. A score of zero would indicate a hospital with an average 
amount of material and human resources while a score greater than zero would indicate a 
site with above average resources. We were interested in measuring and adjusting for 
hospital resources because quality of care is expected to be greater at better equipped sites 
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than less equipped sites (75). Further, we would expect more comprehensive PMTCT 
programs at better-equipped hospitals.  
 
Patient-level measures considered were age, parity, and the number of prenatal visits. 
Women at the extremes of reproductive age may receive differential care because they are 
at higher risk of obstetrical complication. The same may be true of nulliparous and 
multiparous women. Finally women with fewer than the WHO recommended four or more 
prenatal visits might not receive the same quality of care as women with the recommended 
number of visits.  
 
Statistical Methods 
All statistical analyses were conducted in SPSS 17.0. Two series of analyses were 
conducted. First, we used mixed linear regression models with restricted likelihood 
estimation and a random intercept. These models take into account clustering by hospital 
to examine predictors of quality of care, as measured by the CBCA score. We analyzed 
associations between the total PMTCT score, and its components, and quality of care. We 
controlled for country, hospital Complexity Index Score, the ALARM program, and the 
number of patient prenatal visits. We began by looking at the association of each PMTCT 
component (and the full score) with quality of care, while controlling for the 
aforementioned confounders. In the next model, we retained only those variables with p-
values below 0.20 (training in PMTCT, counselling, and nutritional complementary 
services). In the final model, we only retained the PMTCT components that were 
statistically significant (p<0.05) and assessed for multiplicative interactions between 
PMTCT and ALARM. We also assessed for potential confounding by the following 
variables: patient’s parity, patient’s age, and hospital categorization (district, regional, 
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capital). Inclusion of these variables in the models did not alter the results and we did not 
adjust for them in the final models. 
 
 In the second series of analyses, the outcome was the dichotomized the CBCA score 
(below 0.70 and 0.70 and above) which indicates good quality care versus moderate to 
poor care. Using generalized estimating equations and a logistic model, we assessed the 
associations of PMTCT components and ALARM on the dichotomized CBCA variable, 
adjusting for country, the Complexity Index Score, and the number of prenatal visits.  
 
Ethics 
The QUARITE trial received ethics committee approval from Sainte Justine Hospital in 
Montreal (ref. 2425), the Ministry of Health and Preventive Medicine in Senegal (ref. 
0869), and the National Ethics Committee for Health and Life Sciences in Mali (ref. 
034/MS-SG-CNESS).  
 
Results: 
Description of PMTCT programs in the region 
The sample consisted of 13 hospitals from Mali (42%) and 18 from Senegal (58%). These 
consisted of 10 district (32%), 11 regional (36%), and 10 capital (32%) hospitals. The vast 
majority of sites had 20 or fewer patients in their PMTCT program (18 or 79%) per year. 
Six sites (21%) had over 50 patients while 3 sites (10%) could not estimate how many 
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patients they provided PMTCT to per year. At all sites except for one, PMTCT was 
provided free of charge to patients. One hospital in Senegal charged for rapid HIV testing. 
This hospital is located in an area with an active separatist conflict; the region is less 
directly controlled by the government and traditionally underserved. Out of a total of 45 
points on the PMTCT questionnaire, the mean score was 27.3 (SD: 6.8). The minimum 
score of any hospital was 13.0 while the maximum score was 39.0 (Table 31). 
Questionnaire scores tended to be better for the sections describing general physical 
evaluation services, knowledge of newborn prophylaxis, and services and the location of 
newborn follow-up. Knowledge of the mother’s prophylaxis and monitoring while on 
treatment, as well as complementary nutritional services tended to score lower compared 
to other PMTCT components. 
Table 31: PMTCT mean, minimum, and maximum scores by questionnaire section (N=31 
hospitals) 
Questionnaire section  Points 
possible 
Hospital score 
(mean, SD) 
Min. and max. 
scores 
Training in PMTCT 5  3.2 (1.1) 1 ; 5  
HIV Counselling  4 2.6 (1.2) 0 ; 4  
Testing for virus 3 2.1 (1.0) 0 ; 3  
General physical evaluation  3 2.6 (0.8) 0 ; 3  
Laboratory clinical evaluation  6 3.4 (1.9) 0 ; 6  
Knowledge of prophylaxis for Mother  6  2.4 (1.5) 0 ; 5  
Monitoring of Mother on treatment 5 2.1 (1.4) 0 ; 5  
Knowledge of prophylaxis for newborn 4 2.9 (1.1) 0 ; 4  
Follow-up of newborn’s health 5 3.6 (1.5) 0 ; 5  
Nutritional services 4 1.1 (1.3) 0 ; 4 
Total PMTCT Score 45 27.3 (6.8) 13 ; 39 
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Association between PMTCT scores and quality of care 
Table 32 shows the relationship between the total PMTCT and quality of care scores, 
while adjusting for country and Complexity Index score. The total PMTCT score was not 
significantly associated with the CBCA measure of quality of care.  
Table 32: Mixed linear regression model showing the association between PMTCT and 
quality of care, as measured with the CBCA instrument (N=612 patients) 
 Estimate (95% CI) P-value 
Intercept 0.511 (0.402; 0.621) 0.000 
Country 
     Mali 
     Senegal (ref) 
 
0.166 (0.105; 0.226) 
- 
 
0.000 
- 
Complexity Score 0.004 (0.001; 0.007) 0.010 
Total PTMCT Score 0.003 (-0.001; 0.007) 0.154 
 
In addition to the total PMTCT score, we also looked at the relationship between program 
components and CBCA score (table 33). After adjustment, the training and nutritional 
components of PMTCT programs were independently associated with quality of care, 
even in the presence of a program directly targeting obstetrical quality of care (ALARM). 
There was no effect interaction on a multiplicative scale between the PMTCT and 
ALARM programs. In other words, the presence of both programs together did not results 
in quality improvement gains (or losses) in and above that which would be expected based 
on the independent contribution of each program.  
 
Figures 9 and 10 visually present the results from table 33 according to different scenarios 
for training and nutritional components’ scores. To calculate the CBCA scores in these 
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figures, we used the average Complexity Index Score of each country (4.1 in Senegal and 
-5.2 in Mali) and used the reference value (four or more visits) for the number of prenatal 
visits. A low, average, and high score corresponded to the minimum, average, and 
maximum score for that section of the questionnaire. Thus, a low training score was 1.0, 
an average score was 3.1, and a high score was 5.0. For the nutritional section, these 
scores were 0.0, 1.1, and 4.0 respectively. Results are shown according to the presence or 
absence of the ALARM intervention. 
 
Table 33: Mixed linear regression model showing the associations between PMTCT 
components and quality of care, as measured with the CBCA instrument (N=612 patients).  
 Estimate (95% CI) P-Value 
Training for PMTCT 0.027 (0.004; 0.049) 0.021 
Nutritional PMTCT complements 0.025 (0.008; 0.043) 0.006 
Intervention 
     ALARM 
     Control (ref) 
 
0.061 (0.018; 0.105) 
- 
 
0.008 
- 
Country 
     Mali 
     Senegal (ref) 
 
0.160 (0.106; 0.213) 
- 
 
0.000 
- 
Complexity Index Score 0.004 (0.002; 0.007) 0.002 
Prenatal Visits 
     < 4 visits 
     ≥ 4 visits (ref) 
 
-0.019 (-0.034; -0.004) 
- 
 
0.014 
- 
Intercept 0.460 (0.386; 0.534) 0.000 
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Figure 9: Estimated average patient CBCA scores for different hospital PMTCT 
training and nutritional services scores according to the presence or absence of the 
ALARM intervention in Mali. 
 
Figure 10: Estimated average patient CBCA scores for different hospital PMTCT 
training and nutritional services scores according to the presence or absence of the 
ALARM intervention in Senegal. 
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Table 34 shows the association between PMTCT components, ALARM, and the 
dichotomised CBCA score. A point increase in the training or nutritional sections of the 
questionnaire was associated with 40% greater odds of having an average CBCA score 
above 0.70, the threshold under which perinatal mortality appears to increase (196). The 
presence of the ALARM program was associated with 4.2 times the odds of having a 
CBCA score above 0.70. Returning to figures 9 and 10, in Mali, it can estimated that 
hospitals with average or greater training and nutritional scores on the PMTCT 
questionnaire would have CBCA scores above 0.70, irrespective of the presence or 
absence of ALARM. In contrast, in Senegal, this would only occur in hospitals with high 
PMTCT training and nutrition scores.  
 
Table 34: Association between PMTCT components and the ALARM International Program 
with the dichotomized CBCA score  
 Odds Ratio (95% CI) P-value 
Training for PMTCT 1.38 (1.07; 1.78) 0.01 
Nutritional PMTCT complements 1.38 (0.99-1.92) 0.06 
ALARM 4.20 (1.86; 9.52) 0.00 
*Estimates are adjusted for country, Complexity Index Score, and the number of prenatal visits. 
 
Finally, we also examined which aspects of the CBCA scores were being affected by the 
PMTCT components. Greater nutritional scores were significantly associated with criteria 
on the CBCA questionnaire related to better clinical examination of the patient at 
admission (p= 0.03). PMTCT training scores were not significantly associated with any 
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single section of the CBCA questionnaire. When we looked more in depth at the data, we 
found that hospitals which provide nutritional services to all women, irrespective of their 
HIV status, had significantly greater nutritional services scores on the PMTCT 
questionnaire (1.9 versus 0.87, p=0.06) than hospitals which provide no nutritional 
services or services to only HIV positive women.  
 
Discussion: 
We found substantial heterogeneity in the PMTCT programs in the two countries and 
although the simple presence of a PMTCT program is not associated with quality of care, 
two of its components are positively associated with improved maternal care. These 
components are maternity staff training and the provision of complementary nutritional 
services.  
 
Based on previous statements in the literature (94, 205), we anticipated that as laboratory 
infrastructures improved under well-financed HIV treatment programs, these 
improvements would benefit all patients irrespective of HIV status. Unexpectedly, clinical 
and laboratory services offered as part of a PMTCT program were not associated with 
CBCA scores.  We may not have found an association because the questionnaire did not 
adequately measure these services or these services were not integrated in the maternity 
(they are offered to HIV positive patients but not to other patients) and therefore did not 
strengthen overall maternal healthcare. In Mali, there is some evidence for the later 
hypothesis. Frequently, PMTCT and other treatment services are provided at separate 
units in the hospitals. These units are known as USACs (Unité des soins, accueil et 
  213 
conseil) and often provide all basic services to HIV patients without requiring these 
patients to visit other areas in the hospital. Women would receive counselling and testing 
in maternity during a routine prenatal visit and if found to be positive, follow-up at the 
USAC until delivery. 
 
The total PMTCT score was less informative than specific components of that score, e.g. 
the training of maternity staff and the provision of nutritional services. It is intriguing to 
consider why these particular components of a PMTCT program would independently 
predict obstetrical quality of care. Health professional training has been hypothesized 
elsewhere to contribute to overall health system strengthening (205). For example, 
continuing education programs that emphasized good clinical practices such as infection 
control would benefit all patients irrespective of HIV status (112). Indirectly, it is also 
possible that health professionals sent to PTMCT trainings return to work more motivated 
and more confident about their skills.  
 
In regards to complementary nutritional services, the link to obstetrical quality of care is 
less apparent. The provision of these services was significantly associated with better 
clinical examination scores on the CBCA questionnaire. Possibly, hospitals that provide 
comprehensive nutritional services to HIV positive women are more conscientious about 
the health of mothers in general. PMTCT programs with nutritional components may raise 
health professional awareness to issues such as micronutrient deficiencies and anaemia. 
Other studies have shown that the presence of PMTCT programs is significantly 
associated with greater numbers of women receiving nutritional counselling and iron and 
folic acid supplementation during prenatal care visits (104, 211). It is possible that this 
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concern about the nutritional status of the mother would continue through pregnancy and 
health professionals at centres concerned about nutritional problems conduct more 
thorough clinical examinations to assess whether issues, such as anaemia, are present 
during labour and delivery.   
 
On the other hand, greater nutritional scores on the PMTCT questionnaire may reflect 
better-administered health structures. This hypothesis is supported by the fact that 
hospitals that provided complementary nutritional components to all women had greater 
overall PMTCT scores. Despite having controlled for hospital human and material 
resource capacity and for the ALARM program, our measures may not have captured 
inter-personal and organisation factors that influence the application of capacity. For 
example, the provision of milk was one of the items for which a hospital could receive a 
point under the nutritional section of the PMTCT questionnaire. Many hospitals reported 
long-term stock-outs of milk, especially in Mali where the misappropriation of funds had 
led to the suspension of multiple contributions by the Global Fund  
(216, 217). Yet, some hospitals were able to manage the stock outs and still provided milk 
to their patients. Thus, the nutritional section of the questionnaire may have indirectly 
captured elements of hospital organisation and administration not measured by other 
variables in the study.  
 
Overall, these results suggest that continuing medical education programs, whether in the 
form of ALARM or through PMTCT training components, are associated with better 
obstetrical quality of care. Training programs are necessary, but could be better integrated. 
Integrated training curricula would reduce the amount of time that staff spends away from 
the hospital. Time away from health duties due to divergent international training 
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programs has been one of the major criticism of global health initiatives (92). As the 
ALARM program already has a training component dedicated to HIV/AIDS, it would 
seem reasonable to modify and improve this part of the program by integrating the 
training curricula of other PMTCT programs in the region. Further, given the evidence 
that ALARM improves obstetrical quality of care (212) and significantly reduces maternal 
mortality (218), and the low prevalence of HIV in the region (especially when compared 
to the risk of severe obstetrical complication and death), it would appear more efficient 
and less redundant to scale-up ALARM activities with a more thoroughly developed 
PMTCT component than to continue to proliferate PMTCT-only training programs.  
 
This study has several strengths. First, it is large study of 31 hospitals and over 600 
patients in two West African countries, examining both individual and hospital level 
predictors of quality. In particular, we were able to disassociate the effects of PMTCT 
from a program directly targeting quality of care in the region, reducing concerns about 
uncontrolled confounding. According to a recent systematic review on the indirect effects 
of PMTCT programs, control of potential or known confounders has been insufficient in 
previous studies (211). Further, all other studies on the subject have focused on the highest 
HIV prevalence countries in sub-Saharan Africa and, with scant exception (104), on the 
effects of these programs on HIV positive women only (211). In this study, we looked at 
the effects PMTCT on general obstetrical care in a population of women who were 
primarily HIV-negative. Further, this study took place in two countries with substantial 
health system constraints, but relatively low overall HIV prevalence, which is in direct 
contrast to all previous work on the subject. This study adds contextual diversity to the 
nascent literature on the indirect effects of PMTCT on maternal health. Finally, our study 
assesses concrete mechanisms by which PMTCT may lead to broader health system 
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impacts. As discussed above, it appears that training is one of the driving forces behind the 
greater quality of care scores associated with both PMTCT and ALARM and should be 
viewed as a strategic linkage between the different initiatives. The provision of 
complementary nutritional services may reinforce good general care by reminding 
providers to consider the overall health of pregnant women.  
 
There were limitations to this study. The PMTCT program questionnaire was completed 
by the maternity ward heads who, in theory, should know and understand the various 
programs being conducted under their supervision. However, this may not always be the 
case. Additionally, it is possible that activities reported to be conducted as part of the 
PMTCT program may not actually be conducted. To reduce this possibility, we added a 
number of validity checks into the questionnaire. For example, for questions about the 
treatment protocols of the mother and the newborn, we asked respondents to list the 
antiretrovirals used under a variety of situations and then we verified if the responses 
corresponded to WHO or State protocols. For other questions, such as those services under 
the clinical and laboratory evaluation sections of the questionnaire, responses were 
formatted in a Likert scale (always, most of the time, sometimes, rarely, never) and only 
those who responded always or most of the time were considered to offer the service at 
their maternity. Finally, we did not evaluate changes in PMTCT programs and quality of 
care over time. A longitudinal assessment of the indirect effects of these programs over 
time would be useful for answering questions about sustainability.  
 
Conclusion: 
We show that certain aspects of a PMTCT program, namely training and nutritional 
components, are independently associated with obstetrical quality of care. The association 
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of the nutritional component with of PMTCT with improvements of care may be 
bidirectional and reflect external factors related with the implementation of PMTCT at 
each hospital. However, the association between training in PMTCT and improvements in 
intra-partum care suggests that medical education programs, as part of PMTCT and 
ALARM, may lead to better obstetrical quality of care. 
 
 
 
 Chapter 13: Overall Discussion of Thesis Results 
 
In this chapter, we complement the discussions’ sections previously presented in the five 
research articles that compose much of this thesis. We begin with a general summary of 
the thesis, followed by a review of the key results and a discussion of the more general 
methodological limitations of the CRT design. We complete this chapter with a discussion 
of the implications of this research for global health policy and action. Finally, in the 
chapter to follow, we conclude with a list of concrete suggestions to improve obstetrical 
quality of care in West Africa.  
 
13.1 General summary of the thesis  
In this study, we aimed to assess the effects of two concomitant programs, one directly 
targeting maternal health (ALARM) and another targeting HIV-positive mothers 
(PMTCT), on the quality of obstetrical care in Mali and Senegal. As already discussed, 
this thesis was a sub-project in a CRT known as QUARITE. Upon thesis commencement, 
QUARITE researchers were collecting data on some measures related to quality of care, 
such as facility human and material resource availability. The contribution of this doctoral 
work was to add to these efforts by collecting process-measures of quality of care. To do 
so, we carried out a systematic review of the literature and contributed to the development, 
validation and application of a new tool to assess the effects of ALARM and PMTCT on 
quality of care. 
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Work from this thesis has enhanced our abilities to measure obstetrical quality of care in 
West Africa and to evaluate the mechanisms by which quality improvements in the region 
may impact care. One of the most important contributions of this thesis was the 
development of a user-friendly and validated tool- the CBCA questionnaire- to measure 
obstetrical practice. This tool was developed after extensive piloting using 185 medical 
records from eight hospitals and multiple feedback and revision from half-a-dozen 
international experts. While the questionnaire was primarily developed so that we could 
obtain process-measures of care at hospitals in the QUARITE trial, it was also intended to 
be user-friendly so that health professionals in the region could apply it to their own 
quality improvement efforts. With the CBCA instrument, and an audit of over 800 medical 
records, we were able to get a “snap-shot” image of the quality of care provided at referral 
hospitals in Mali and Senegal. This has allowed us to evaluate if and how ALARM and 
PMTCT programs may influence obstetrical procedures and practices in the region. With 
such information, we are able to make quality improvement suggestions and identify 
specific aspects of care in need of programmatic targeting.  
 
13.2 Review of Key Results 
While there are several ways to measure obstetrical quality of care, the method that best fit 
our purposes was a CBCA. This tool was particularly attractive because it provided a 
quantitative and standardized measure of care, was inexpensive, and did not require a 
medically-qualified auditor. However, the specific criteria to include in the audit 
instrument had not yet been decided when this research began. To determine which 
criteria to include, we conducted a systematic review of the literature with the intentions 
of finding an instrument that would be suitable to applying to the QUARITE trial (article 
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1). The review, however, revealed that no instrument yet existed that we could confidently 
use in the trial. More attention had been paid to applying CBCA than to assessing whether 
it was adequately measuring obstetrical quality of care. Almost no research had considered 
the reliability of the tool, and far too little had been given to issues such as selection bias 
and construct validity. Additionally, concerns about the quality of medical recordkeeping 
in the region (article 2) led us to conclude that there was a critical need to formally assess 
the measurement properties of CBCA.  
 
As a result of the aforementioned review, we developed and validated a CBCA 
measurement instrument (article 3). The purpose of this article was twofold. First, we 
described the development of an instrument adapted to the West African context. Second, 
addressing the gaps highlighted in the systematic review, we evaluated inter-rater 
reliability and construct validity. The CBCA questionnaire that we developed contained 
criteria measuring five domains of intrapartum quality of care: medical history-taking, 
clinical examination, laboratory analyses, delivery care, and post-partum follow-up. These 
sections were applied to all women sampled. The questionnaire also had three separate 
sections that applied specifically to women with post-partum haemorrhage, severe pre-
eclampsia and eclampsia, and HIV/AIDS. We validated the questionnaire in two phases. 
During the first phase, we applied the questionnaire to a development sample of patient 
records to evaluate inter-rater reliability and to improve content validity. We found that 
our CBCA had acceptable reliability. In the second phase, we used the finalized version of 
the CBCA questionnaire to assess construct validity. Analyses from this phase provided 
compelling evidence of validity, as the CBCA instrument performed according to theory. 
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For example, poor CBCA scores were significantly associated with perinatal mortality. 
With a validated CBCA instrument, we were able to move forward with the study. 
 
In article 4, we used the CBCA instrument to evaluate whether the ALARM program was 
associated with greater obstetrical quality of care scores. Our results showed that hospitals 
with the ALARM program had significantly greater patient CBCA scores than control 
hospitals. The ALARM program seemed particularly effective at improving the clinical 
examination of the mother at admission and postpartum monitoring. Overall, the mean 
difference in quality of care scores between ALARM and controls sites was five points, or 
about two criteria. At first glance, this seems like a small difference. However, each 
criterion in the CBCA was selected because it was considered essential to providing 
adequate intrapartum care. Apparently modest errors or omissions can lead to death, 
especially in the context of urgency that characterizes emergency obstetrical 
complications (67). For example, forgetting to take a woman’s pulse at admission could 
mean that shock is not detected. Similarly, overlooking the timely examination of a 
woman after birth could mean that post-partum haemorrhage goes unrecognised.   
 
From our results in article 4, it appears that the ALARM intervention was less effective at 
improving the care of complications such as severe pre-eclampsia/eclampsia and 
postpartum haemorrhage. We hypothesized that the limited availability of life-saving 
technologies and medications, such as magnesium sulphate, prevented the application of 
some of the evidence-based practices advocated by the ALARM program. However, we 
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also noted that many complications went unrecognised and this raises concerns for the 
suitable application of life-saving technologies and pharmaceuticals.  
 
In article 5 we employed the CBCA to assess whether PMTCT programs were associated 
with obstetrical quality of care. We showed that two components of a PMTCT program- 
training and nutritional complements- were significantly associated with greater patient 
CBCA scores. When evaluated together, both ALARM and PMTCT programs continued 
to be significantly associated with greater quality of care scores. This finding was 
important for the QUARITE researchers because, it meant that the observed relationship 
between ALARM and quality of care was unlikely due to confounding attributable to 
PMTCT scale-up. PMTCT programs were added to nearly half of the hospitals in the 
QUARITE study after ALARM had been randomized and thus presented a risk for 
confounding. An additional question was whether the two programs were mutually 
reinforcing. That is, we were interested in assessing for effect interaction between 
ALARM and PMTCT programs. We found no evidence of multiplicative interaction 
between the programs. The combined effect of both programs was not greater than would 
be expected based on the independent contributions of each. 
 
13.3 Limitations of the study 
In articles one through five, we describe the particular limitations of the sub-studies 
comprising this thesis. As the specific limitations of this research have already been 
described in detail in the previous chapters, here, we will focus on the more general 
limitations of using CRTs in health systems research.   
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It is generally accepted that CRTs are the gold standard for assessing interventions 
delivered to groups (197). It is not our intention to question this statement, but rather to 
focus on limitations in the application of this study design to complicated interventions 
such as QUARITE. Specifically, we contemplate whether the rigorous standardization 
required of trials may reduce the observed effectiveness of promising interventions and 
lead to miscalculations of study power. We also discuss how a promising intervention may 
succumb to contamination bias, precisely because it is successful. 
 
The QUARITE trial was based on a pilot study from a district hospital in Senegal. Results 
from this study indicated that MDR could reduce facility maternal mortality by up to 50 
percent. Our results showed that the ALARM program was associated with significantly 
better quality of care, but the difference between intervention and control sites was only 
five percent. This was much lower than the expected 15 to 35 percent improvement 
documented in other studies also using audit and feedback methods (139). We are not 
alone, it is common for CRTs to document small or non-significant results (219). We 
postulate that our results do not reflect a lackluster intervention but rather, difficulties 
standardizing contextual factors that contributed to the success of the pilot project and 
difficulties assessing the contribution of the trial itself to the observed results.  
 
In the paragraphs to follow, we discuss reasons why the trial design and intervention may 
have attenuated the observed association between the ALARM program and quality of 
care. Here, we define the measure of effect as the ratio between the treatment response 
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change (numerator) and the standard deviation of the response change (denominator). The 
numerator in this ratio thus refers the difference in CBCA scores between ALARM and 
control sites, while the denominator refers to the variation of this difference.  
 
Standardization & Scale-up:  
The success of any programmatic intervention is dependent on a variety of contextual 
factors such as the level of resources a program receives, staff morale and competence, 
support from other organizations and the surrounding community, among other things 
(219). In previous research, factors shown to contribute to audit effectiveness include: the 
provision of feedback from a senior person; continued feedback sessions over a long 
period; face to face feedback to individuals; and feedback combined with educational 
meetings (220). The Senegalese pilot study to QUARITE was likely successful, in part, 
because of a strong commitment to the project from the head of the maternity unit, a 
strong executive-coordination team and provision of annual written feedback to staff, 
support from health authorities and community representatives, and an equitable and 
successful cost-recovery system (221). As the authors themselves stated, it was difficult to 
ascertain the “active ingredient” of the intervention (221). 
 
Factors like leadership and community support are difficult to replicate for the purposes of 
a CRT. For QUARITE, 23 intervention sites were necessary to have sufficient power to 
detect an effect on maternal mortality. It is hard to imagine that all 23 ALARM sites 
would have the same levels of staff motivation, senior leadership, community support, etc. 
as the pilot study. All of these factors are highly context-specific; however, the 
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standardization necessary for a trial to test a “treatment,” such as ALARM, is entirely 
opposite to context specificity. Thus, researchers may see effect dilution in large CRTs 
when compared to pilot studies because factors that contribute to intervention success, 
such as motivated implementation by maternity staff, may not be reproducible at scale or 
amenable to standardization. In other words, the numerator for the measure of effect in 
large trials such as QUARITE may be smaller than anticipated based on pilot work. 
However, this may more realistically reflect what would happen should the intervention be 
converted to policy. 
 
Influence of the research project and team:  
When conducting a CRT, basic research infrastructure must first be established. In Mali 
and Senegal, infrastructure to conduct research at hospitals is highly limited. At the 
beginning of the QUARITE trial, there was an overall lack of recordkeeping culture at 
most hospitals. This was problematic because accurate medical records were necessary for 
verification of patient outcomes. Trial researchers therefore had to establish and maintain 
sufficient recordkeeping resources and practices. The efforts exerted to establish 
acceptable records, and particularly those necessary for maintaining these practices 
throughout the four years of the trial, were not standardized and were never measured, but 
probably influenced care in both arms of the trial.  
 
It is not unreasonable to believe that recordkeeping efforts improved quality of care, as 
recordkeeping is vital to the continuity of care (160, 168, 222). Given the lack of 
uniformity in efforts to maintain trial infrastructure, particularly around recordkeeping, 
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QUARITE may have inadvertently increased variation in quality of care scores at trial 
hospitals. For example, one of the recommendations commonly made during MDR 
(ALARM group) was to improve the quality of medical records. The audit process may 
have reinforced recordkeeping practices depending on audit recommendations and 
intensity. Thus, external efforts to maintain research infrastructure could have interacted 
with the ALARM intervention. This, in turn, would have led to greater variation in quality 
scores in the ALARM group (the denominator of our measure of effect) and reduced 
statistical power.  
 
The research process is an intervention that may produce a Hawthorne effect (219). When 
research staff and students regularly visit hospital sites with questionnaires and interviews 
and sort through medical archives, hospital staff may become more conscientious of the 
services they are providing. This effect may not be the same in each arm of the trial. For 
example, efforts to maintain research infrastructure and obtain data could have been 
disproportionately focused on the control group. One would assume the control group to 
contain hospitals providing the poorest quality of care, as they did not receive the 
ALARM International Program. Hospitals providing poor quality of care may require 
more intense research efforts. For example, at a handful of sites, the candidate and 
research coordinators were obligated to make repeat visits to collect data that elsewhere 
required only a day. Such efforts may have drawn staff attention to organization deficits in 
maternity services. Because we did not measure the intensity of trial-related support 
provided by the research team and because such efforts may have improved quality of 
care, the amplitude of observed difference between trial arms may have been reduced 
(smaller numerator).  
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Power:  
Power in a CRT depends on the number of clusters to be evaluated, the number of 
individuals per cluster, the strength of the intervention effect, the standard deviation 
around the effect, and the intraclass correlation coefficient (or between-cluster coefficient 
of variation). Standardization of an intervention such as ALARM may diminish the 
intervention’s effectiveness, reducing study power. Other factors may affect cluster 
variation, such as differences in the implementation and intensity the ALARM 
intervention. For example, according to the QUARITE protocol, ALARM sites were 
supposed to conduct MDR every month, but not all sites followed protocol. Further, at 
some sites, the intervention was met with motivated staff that went above and beyond 
expectation to implement ALARM. At other sites, the intervention was barely carried out. 
Such variations in protocol implementation will lead to a larger denominator in the 
measurement of effect.  
 
It is common for researchers to consider and evaluate the degree to which an intervention 
was implemented. Interventions are much less frequently conceptualized as something 
greater than the sum of their parts (219). Thus, questions such as, does the program have 
symbolic value and how is intervention integrity defined, are rarely discussed (219). 
Questions such as these are important to understanding what is driving an intervention. 
The pilot study may have been characterized by strong symbolic value linked to it being 
unique in the region and the continued presence of foreign researchers. These factors may 
not be replicable and their absence may lead to a smaller numerator in the measure of 
effect.  
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Contamination Bias:  
The ALARM International Program may have been a victim of its own success. In both 
countries, there is a moderate circulation of maternity staff from one hospital to another 
(90). The candidate vividly recalls a discussion in Senegal with a motivated midwife who 
left an intervention hospital to work at a control hospital. She was so impressed with the 
ALARM program that she was trying to implement it at the control site. At the end of the 
intervention, it was found that 8 hospitals in the control group had begun using maternal 
death reviews as part of their standard practice. This contamination of the control group 
likely entailed a smaller difference in numerators between the two arms of the trial.  
 
Implications of limitations:  
Overall, when conducting CRTs of health systems’ interventions, it is important to 
consider the compromises that must be made between intervention intensity and 
specificity and scalability and reproducibility. Pilot studies and smaller trials will be able 
to maximize on the former attributes while large trials and national programs will aim for 
the later. In the case of QUARITE, the ALARM intervention was shown to have a small 
to moderate effect on quality of care measures, but this may partially reflect difficulties 
standardizing factors such as leadership, community support, and symbolic value. In such 
a case, the results of QUARITE may more accurately reflect what would happen should 
the ALARM intervention be generalized into national policy. However, conclusions about 
the generalizability of ALARM must be nuanced against the fact that the role of the trial 
itself (Hawthorn effect) was never measured. If the efforts made to maintain research 
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infrastructure led to quality improvements and disproportionately affected the control 
group, then the effect of the intervention could have been greater than measured by the 
trial. Further, the trial documented substantial contamination of the control group 
suggesting that health professionals in the region recognised the value of maternal death 
reviews.  
 
Having discussed some of the limitations of using CRT to evaluate health systems 
research, we continue by discussing the implications of this research for health policy and 
future research. 
 
13.4 Implications of this research to global health policy and action 
The quality of obstetrical care in Mali and Senegal is markedly deficient. This study 
documents important gaps in basic obstetrical care. For example, routine clinical measures 
(pulse and temperature) necessary to detect shock and infection were rarely and less than 
adequately taken in Senegal and Mali, respectively. Sadly, our work confirms that the 
system intended to save women’s lives is, in fact, contributing to their risk of maternal and 
perinatal mortality. Work from partners in the region supports these results. In the Kayes 
region in Mali, researchers found that over half of maternal deaths could be primarily 
attributed to poor obstetrical care (72).  
 
The implications of our results call for critical reflection of some of the strategies 
advocated to reduce maternal and infant mortality.  For example, the UNFPA claims, 
“Skilled attendance at all births is considered to be the single most critical intervention for 
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ensuring safe motherhood” (http://www.unfpa.org/public/mothers/pid/4383, accessed 25 
July, 2012). The international community has set a goal to ensure that 90 percent of 
women give birth with a skilled attendant by 2015 (223). However, how can one expect a 
woman to seek care in a health facility in which one in three children are stillborn, as was 
the case at some of the sites included in this study? If the goal of skilled attendance is to 
reduce maternal mortality, then the quality of obstetrical care provided by these attendants 
must first be assured (56). The capacity of a healthcare professional to provide quality care 
is a function both of the application of their individual knowledge and skills and the 
environment within which they work (75). This study demonstrates that both aspects need 
substantial reinforcement in Mali and Senegal.  
 
While our results demonstrate that quality of care is deficient (often grossly so) at referral 
hospitals in Mali and Senegal, they also demonstrate that there are interventions that can 
improve care. The ALARM International Program appears highly promising. Sites with 
this program have four times the odds of having criterion attainment above 70 percent, 
which is the threshold associated with a significantly lower odds of perinatal mortality. 
This is an important finding because the backbone of the ALARM program, maternal 
death review, does not require external support from international partners (221). 
However, future work should assess the amount of time and energy necessary for reviews 
to be conducted and determine whether this is reasonable in the West African context 
where human resources are often already overstretched. Supplementary research by other 
researchers on the QUARITE trial is attempting to fill this knowledge gap. 
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From our results, it is clear that resource inputs into hospitals, particularly in Mali, are 
necessary to achieve quality improvement gains in and above those of the ALARM 
program. We can expect healthcare professionals to provide better quality care in more 
enabling settings, where basic equipment, pharmaceutical, laboratory, and human resource 
needs are met (75). While maternal death reviews do not necessarily require support from 
external donors, in countries where less than five percent of the gross domestic product is 
spent on health, it is highly unlikely that dramatic infrastructural and human resource 
improvements will occur in the absence of external financing. This in turn may cap the 
extent to which improvements can be made. 
 
Quality improvements resulting from the ALARM program were expected mostly for the 
treatment of obstetrical complications such as eclampsia and haemorrhage (221). The 
program advocated for the application of evidence-based practices such as the 
administration of magnesium sulphate for severe pre-eclampsia and eclampsia and the use 
of oxytocin to prevent and manage post-partum haemorrhage. However, field notes taken 
during the audits frequently documented that these basic resources were missing either 
because the hospital could not afford them or because of supply chain disruptions. In 
absence of basic resources, there are limits to the quality improvements one can expect 
because the essential elements for providing adequate care are missing. Further, there are 
financial costs, often quite elevated ones, associated with pharmaceutical and laboratory 
interventions. Health professionals may therefore be aware of the best obstetrical practice 
(such as treating eclampsia with magnesium sulphate), but choose to resort to the less 
expensive option (for example, using Valium instead of magnesium sulphate) because the 
patient cannot afford the previous option. Difficult decisions that health professionals 
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make in highly resource-constrained settings do not necessarily indicate poor quality of 
care. Without resource improvements to hospitals in these settings, judgements about 
quality of care become contentious. Is a health professional that provides a less expensive 
treatment, albeit less effective, providing poor care or simply responding to the realities of 
the context? 
 
Finally, our study showed that there are potential synergies between HIV/AIDS and 
maternal health programs. Certain components of PMTCT programs can improve 
obstetrical quality of care. As discussed in detail earlier, the training components of 
PMTCT curricula can and should be integrated with general maternal health training 
programs. This would reduce the number of days that health professionals spend away 
from work. Further, there is no reason that trainings on maternal health should not include 
a component on PMTCT or that PMTCT programs should not discuss general maternal 
health. There is a clear overlap between both types of training programs and health 
professionals in contexts characterized by limited human resources do not need to be 
attending multiple continuing educations courses on subjects so clearly interrelated.  
 
Finally, further investigation is needed to better understand why complementary 
nutritional components in PMTCT programs are associated with better quality of care. We 
hypothesize that hospitals that provide nutritional services may pay better attention to the 
general well-being of pregnant women. Also, there is anecdotal evidence from Mali to 
suggest that hospitals able to provide complementary nutritional services to pregnant 
women were better administered than hospitals not providing these services. The 
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provision of nutritional services may thus indirectly measure hospital organization and 
staff conscientiousness. If this is the case, it would be interesting to understand what 
elements of hospital organization and staff behaviour are associated with better quality of 
care and apply this information to future quality improvement programs in the region. 
 Chapter 14: Final Recommendations 
 
In conclusion, based on this research, we provide a list of concrete recommendations to improve 
obstetrical quality of care in Mali and Senegal. While these recommendations pertain to data 
collected from West Africa, it is our opinion that many of these suggestions are pertinent to other 
low-income countries.  
14.1 General Recommendations 
 Implement MDR at all hospitals in the region 
 Provide regular and integrated continuing education programs in maternal health and PMTCT to 
maternity staff 
 Increase the resources available to maternities in the region 
14.2 Specific suggestions 
 Improve the clinical monitoring of patients when they arrive and during labour, so as to detect and 
treat complications of the mother or the baby before they become serious 
 Improve the monitoring of pregnant women during labour and delivery by consistently using the 
partograph 
 Improve the prompt recognition of serious obstetrical complications 
 Improve the basic laboratory monitoring of patients: blood type, haemoglobin, HIV, syphilis 
 Improve the accessibility of pharmaceuticals proven to reduce maternal mortality and morbidity. 
These include: magnesium sulphate (eclampsia), Valium (eclampsia), oxytocin (haemorrhage), 
misoprostol (haemorrhage), zidovudine (HIV), and nevirapine (HIV)
 Epilogue 
Since beginning this doctoral research project in August 2008, a number of events occurred that 
have implications for the results of this thesis. First, data for the primary outcome of the QUARITE 
trial have been analyzed, and the results demonstrate the efficacy of the ALARM intervention. 
There were 15 percent fewer maternal deaths in the ALARM arm of the trial than in the control 
arm and the difference was significant (article forthcoming). This is exciting news, as there are 
almost no trials on record showing a significant reduction in maternal mortality in a low-income 
setting
23
. The reduction in maternal mortality at ALARM sites supports the thesis conclusions; the 
ALARM program improves obstetrical quality of care in terms of the medical procedures and 
practices applied during labour, delivery, and childbirth.  
 
Subsequent to the QUARITE trial, a number of activities in the region have commenced that 
perpetuate the intervention. In Senegal, with support from international organizations and NGOs, 
maternal death reviews have been implemented at control hospitals. In fact, some implementation 
of reviews occurred before the end of the QUARITE trial. In Mali, the leading professor of 
obstetrics, Mamadou Traoré, has created a young research team and a sentinel maternal health 
network for evaluating obstetrical practice. Training in evidence-based practices and support for 
audit teams continues at many hospitals in the country, supported, in part, by financing from 
Canada. 
 
                                                          
23
 Dharma Manandhar et al. (2004), in a cluster randomized trial, showed that women’s group activities that 
encouraged antenatal care, institutional delivery, and trained birth assistance, could reduce neonatal and maternal 
mortality significantly. Almost no other trials have documented a significant reduction of maternal mortality, although 
more success has been seen for neonatal mortality. Manadhar DS, Osrin D, Shrestha BP, Mesko N, Morrison J, 
Tumbahangphe KM et al. Effect of a participatory intervention with women’s groups on birth outcomes in Nepal: 
cluster randomized controlled trial. The Lancet. 2004; 364: 970-9. 
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Another piece of good news is that the international community has mobilized around PMTCT. In 
2011, the United Nations launched “Countdown to zero: Global plan towards the elimination of 
new HIV infections among children by 2015 and keeping their mothers alive” (224). Specifically, 
the global plan aims to reduce the number of new HIV infections in children by 90% and the 
number of AIDS-related maternal deaths by 50%. One of the strategies of the Global Plan is to 
bring HIV, maternal health, newborn and child health, and family planning programmes together. 
The authors of the Plan highlight the need for greater programmatic synergies and integration to 
reduce maternal to child transmission of HIV. With some success, the worldwide mobilization 
around PMTCT will lead to even greater scale-up of these programs and possibly, the 
reinforcement of pre-existing ones. Given the focus of the Plan to better integrate HIV programs 
with maternal and child health, there is a real possibility for health system’s strengthening and 
improved quality of care.  
 
Unfortunately, a series of other events may negatively outweigh the accomplishments of the 
QUARITE trial and the international mobilization around PMTCT. The most shocking of these 
was the coup d’état in Mali on March 22, 2012. Until March, Mali was heralded as a model of 
democracy on the African continent; in fact, national elections were already planned for the 
following month (225). The coup d’état destabilized the already fragile northern part of the country 
and the country was divided in two. For months, northern Mali was under rebel control with the 
enforcement of strict Shariah law. Extremism and in-fighting between rebel groups in the North 
resulted in multiple violent skirmishes and human rights abuses. Women were reportedly particular 
targets of extremist punishment (226).  
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In January of 2013, the Islamic rebel forces in the North began to move progressively towards 
southern Mali. This resulted in military action by France under the name of operation Serval (227). 
While the intervention by France has been largely welcomed by the Malian people (228) and has 
led to the re-taking of key cities including Tombouctou, Gao, and Kidal, the death toll of the 
military action and retaliatory strikes is unknown. More than 350 000 refugees have fled the 
country to neighbouring Mauritania, Niger, Algeria or Burkina Faso. Approximately 200 000 
people are internally displaced (229). The mass flows of displaced persons are placing significant 
pressures on this already very poor country, and the region as a whole. These difficulties are 
complicated by severe drought and an ongoing food crisis across the Sahel (229). 
 
As a result of the coup d’état, many governments around the world immediately suspended aid and 
development funds to Mali. Canada was among these countries (230). At the time of submitting 
this thesis, Canadian direct aid to Mali was still suspended. In a country highly dependent on 
foreign aid, these cuts will likely have dramatic consequences on health. Those aid agencies still 
present in the country are struggling in an environment characterized insecurity, violence and 
logistical challenges. Cholera outbreaks have already occurred in the northern Mali and are placing 
a huge strain on local resources (231). 
 
The funding consequences of the coup d’état occurred at an already difficult time. Prior to the 
coup, in September 2010, the Global Fund suspended grants to Mali that supported tuberculosis, 
malaria, and HIV/AIDS programs due to fraud (232). Personal contacts in the country have 
explained that the suspension of Global Fund money has led to long-term and persistent stock-outs 
of artificial milk and rapid tests for HIV and may ultimately lead to shortages of antiretroviral 
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drugs and HIV doctors (personal communication with Mamadou Traore, professor of gynaecology, 
and Souleymane Ag-Aboubacrine, HIV doctor, Bamako). Fortunately, as of September 24, 2012, 
new agreements between Mali and the Global Fund were possibly reached and there is a strong 
chance that HIV funding will be resumed in the New Year. This, in turn, may ease the concerns of 
other major bilateral and multilateral donors and open the door to resumed development aid to the 
country (personal communication with Soumaïla Diakité operations consultant, Regional Direction 
of Health, Kayes). 
 
Finally, for both Mali and Senegal, and low-income countries in general, the general climate of 
financial austerity is highly concerning. This year, for the first time in a decade, witnessed a 
decline in international aid to developing countries. International development assistance in 2011 
was less than half of what is needed to meet the goals set by world leaders in 2000 (233). In 2010, 
Médecins sans frontiers published a report signalling concerns about a global funding retreat for 
HIV/AIDS. The authors of this report were distressed about the increasing frequency of stock-outs 
of antiretroviral drugs (234). Subsequent groups have stated that there is now less money available 
to train health professionals on the treatment of HIV/AIDS and the use of diagnostic tests, and that 
many countries are scaling back the numbers of facilities offering antiretroviral treatment, 
especially in rural regions (235). Recently, UNAIDS published a discussion document about the 
potential impacts of austerity measures on women and girls. They state that during times of 
economic crisis, women and girls in low-income settings are more likely to be taken out of school, 
to reduce the quantity and quality of food they eat, to forgo essential medicines, and to sell sex in 
order to survive (236). All in all, what information is available about the effects of the global 
economic downturn and austerity measures on health is highly discouraging, especially for 
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countries such as Mali and Senegal, that are highly dependent on international aid to support their 
health systems. 
 
In conclusion, this author is incredibly proud to have worked on a project that saved a significant 
number of women’s and newborn’s lives. Even so, she is fearful that the extremely positive results 
of the QUARITE trial, and her own research, will amount to little in the future given the political 
instability in Mali and more generally, the global climate of fiscal austerity. It is hard for her to 
imagine how both Mali and Senegal will be able to continue to strengthen their health systems with 
severe cuts to international donor assistance. And, in the absence of reinforced health systems, it is 
difficult to foresee further improvements to maternal and child health. In the present climate, it is 
her personal opinion that one biggest contributions that global health researchers can make for 
maternal and child health in West Africa (and elsewhere), is to advocate for the continued support 
of international development assistance in low-income countries and to document in scientifically 
rigorous manner both the direct and indirect effects of programs supported through this assistance.
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 Appendix 1: Table listing various PMTCT components, activities, and 
rationale 
Components Activities Rationale 
Antenatal 
HIV-Testing 
Same-day testing: 
DETERMINE 
Test for HIV and reduce loss to follow-up  
Traditional testing (up to a 
week or more for results) 
Test for HIV 
Pre- and 
Post-test 
Counselling 
Group awareness session on 
HIV and its determinants 
Improve understanding of HIV and its 
causes; increase uptake of HIV screening; 
better understand results of test Group pre-test counselling 
Individual pre-test counselling 
Individual post-test 
counselling 
Post-test counselling of 
couples 
Antiretroviral 
prophylaxis 
of mother 
Single-dose nevirapine  Reduce risk of HIV transmission 
Short course zidovudine 
Tri-therapy 
Laboratory 
and Clinical 
Monitoring 
of mother 
CD4 count Determine whether to start or continue 
treatment for the mother’s health 
Viral load monitoring Determine whether to start or continue 
treatment for mother’s health and consider 
need for caesarean section 
Haemoglobin levels Detect anaemia which can be induced or 
aggravated by certain antiretrovirals (e.g. 
Zidovudine) 
Hepatic enzyme levels Detect hepatic toxicity which can be 
induced or aggravated by certain 
antiretrovirals (e.g. nevirapine) 
Breastfeeding 
Counselling 
Long term exclusive 
breastfeeding 
Reduce risk of co-morbidities and 
stigmatization 
Exclusive breastfeeding with 
early weaning (<6 months) 
Reduce risk of co-morbidities and 
stigmatization. Reduce risk of HIV 
transmission to infant. Most current 
guidelines no longer recommend early 
weaning.  
Exclusive formula feeding Reduce risk of HIV transmission to infant 
Antiretroviral 
prophylaxis 
of infant 
Single-dose nevirapine Reduce risk of HIV transmission to infant 
Nevirapine with zidovudine 
tail (14 days) 
Nevirapine with zidovudine 
and lamivudine tail (4 weeks) 
Follow-up of 
baby 
Contrimoxazole Prevent pneumonia and other opportunistic 
infections in the infant 
 
 xviii 
 
HIV-testing (clinical 
symptoms, immunology, or 
viral load) 
Determine child’s HIV status so that 
paediatric treatment can be provided if 
necessary 
 
 
Growth and development 
monitoring 
Child’s health; clinical indications of HIV 
infection 
Vaccination Child’s health 
Other Nutritional counselling Improve diet and overall health 
Nutritional supplementation Reduce nutrient deficiencies and improve 
adherence to antiretrovirals 
Treatment of other diseases 
(e.g. Tuberculosis) 
Treat co-morbidities in the mother 
 Appendix 2: Data collection form for the Hospital Complexity Index  
Partie réservée à la 
saisie 
Numéro d’enregistrement : Code Etablissement : Code Pays : 
INVENTAIRE DES RESSOURCES MATÉRIELLES 
NOM DE L’ 
ETABLISSEMENT : 
 PAYS :  
NIVEAU DE SOINS :     1. Centre Hospitalier  Universitaire ;        2. Centre Hospitalier Régional  
                                        3.  Centre hospitalier départemental ;     4. Centre de Santé de référence 
ETABLISSEMENT SOUS L’AUTORITÉ DIRECTE DE :                                  
 1. Municipalité ;                         2. District sanitaire ;                       3.  Région ou Province;   
4.  Ministère de la santé ;          5. Université ;                                                6. Privé ;  
7. Mutuelle ou Assurance ;         8. Ordre Religieux/Croix rouge ;  9. Armée ou autre  
Contexte – Zone de couverture 
1 QUEL EST LE CONTEXTE GEOGRAPHIQUE DE CET ETABLISSEMENT ? 
Indiquer si l’établissement draine une population en majorité  urbaine ; 
semi-urbaine, ou rurale 
1. Urbain 
2. semi-urbain 
3. rural 
2 QUEL EST LE NOMBRE APPROXIMATIF D’HABITANTS CONCERNES PAR 
CET ETABLISSEMENT (ZONE DE COUVERTURE) ? 
 Mettre le nombre d’habitants  
 
3 QUEL EST LE NOMBRE TOTAL DE LITS DONT DISPOSE 
L’INFRASTRUCTURE (Y COMPRIS LA MATERNITE)? 
 Mettre le nombre total de lits 
 
4 QUEL EST LE NOMBRE DE LITS DONT DISPOSE LA MATERNITE   
(LITS UTILISABLES AVANT, PENDANT ET APRES L’ACCOUCHEMENT) ? 
                                                                                                Mettre le nombre de lits  
Pre- Per-
partu
m 
pos
t 
QUEL EST LE NOMBRE D’ETABLISSMENTS PRESENTS DANS LA ZONE DE 
COUVERTURE  ET REALISANT DES ACCOUCHEMENTS ? 
Mettre le nombre 
d’établissements 
5 AUTRES ETABLISSEMENTS AVEC BLOC OPERATOIRE FONCTIONNEL  
6 AUTRES ETABLISSEMENTS SANS BLOC OPERATOIRE  MAIS AVEC 
ACCOUCHEMENTS 
 
 
 xx 
 
 
LES ÉQUIPEMENTS SUIVANTS SONT-ILS DISPONIBLES ET FONCTIONNELS ?   
7 EAU COURANTE   
8 TOILETTES OU LATRINES   
9 ELECTRICITE  
10 GROUPE ÉLECTROGÈNE  
11 REFRIGERATEUR   
12 TELEHONE   
 
Services disponibles 
 
LES SERVICES SUIVANTS SONT-ILS DISPONIBLES  ? 
   
Cocher pour chaque item    
13 DEPÔT DE SANG    
14 BANQUE DE SANG AVEC SÉCURITÉ TRANSFUSIONNELLE    
15 UNITÉ DE SOINS INTENSIFS ADULTE   
16 UNITÉ DE SOINS INTENSIFS NÉONATALS   
17 AUTRE UNITÉ DE SOINS NÉONATALS AVEC INCUBATEURS    
18 CONSULTATION SPÉCIALISÉE  POUR LES GROSSESSES À 
HAUT RISQUE  
  
19 LITS D’HOSPITALISATION POUR LES GROSSESSES À HAUT 
RISQUE 
  
20 CONSULTATION MÉDICALE SPÉCIALISÉE DE RÉFÉRENCE 
DANS LE MÊME BÂTIMENT  
  
21 SERVICE DE RADIOLOGIE   
22 ECHOGRAPHIE PELVIENNE ET OBSTÉTRICALE   
23 LABORATOIRE D’ANALYSES MÉDICALES   
24 EQUIPEMENTS POUR LA STÉRILISATION   
  
Examens biologiques   
LES EXAMENS SUIVANTS SONT-ILS RÉALISÉS? 
   
Cocher pour chaque item    
25 GROUPE  SANGUIN ET   RHÉSUS    
26 PROTÉINURIE    
27 HEPATITE B   
28 TEST DE TOLÉRANCE AU GLUCOSE (dépistage du diabète 
gestationnel) 
  
29 FROTTIS CERVICO-VAGINAL    
 xxi 
 
30  HIV    
31 SYPHILIS   
32 CULTURE D’URINE   
  
Soins anesthésiques   
33 ANESTHÉSISTE DE GARDE SUR PLACE 24H/24   
34 ANESTHÉSISTE DE GARDE MAIS EN DEHORS DE L’HÔPITAL   
35 INFIRMIÈR(E) OU AUTRE PERSONNEL PARAMÉDICAL DE 
L’HÔPITAL PRATIQUANT L’ANESTHÉSIE  
  
36 EQUIPEMENTS POUR ANESTHÉSIE GÉNÉRALE DISPONIBLES   
37 TOUTES LES INTERVENTIONS CHIRURGICALES SONT RÉFÉRÉES 
DANS UN AUTRE HÔPITAL 
  
Soins obstétricaux essentiels  
LES SOINS OBSTÉTRICAUX SUIVANTS SONT-ILS RÉALISÉS  ? Cocher pour chaque item    
38 ADMINISTRATION PARENTERALE D’ANTIBIOTIQUES     
39 ADMINISTRATION PARENTERALE D’OCYTOCIQUES    
40 ADMINISTRATION PARENTERALE DE 
SEDATIFS/ANTICONVULSIVANTS  
  
41 TRANFSUSION SANGUINE    
42 RÉANIMATION NÉONATALE    
43 RÉANIMATION MATERNELLE CARDIO-RESPIRATOIRE    
44 HYSTERECTOMIE   
  
EXITE-T-IL DU PERSONNEL QUALIFIÉ POUR LES SOINS SUIVANTS? 
   
Cocher pour chaque item    
45 AUSCULTATION CARDIAQUE FŒTALE  INTERMITTENTE    
46 SUIVI  ELECTRONIQUE DU RYRHME CARDIAQUE FŒTAL     
47 pH AU SCALP DU FOETUS   
48 SUIVI DU TRAVAIL AVEC PARTOGRAPHE    
49 ACCOUCHEMENT ASSISTÉ PAR FORCEPS   
50 ACCOUCHEMENT ASSISTÉ PAR VENTOUSE   
51 CÉSARIENNE PENDANT LE TRAVAIL    
52  ACCOUCHEMENT PAR LE SIÈGE    
53 SOINS DU NOUVEAU-NÉ   
  
 xxii 
 
Accouchement et césarienne  
LA QUESTION EST POSÉE SÉPARÉMENT POUR CHAQUE ITEM 
Cocher pour chaque item   
54 LES PATIENTES DOIVENT-ELLES AMENER AVEC ELLES 
DU MATÉRIEL (MÉDICAL/CHIRURGICAL) POUR 
L’ACCOUCHEMENT ? 
  
55 LES PATIENTES DOIVENT-ELLES AMENER AVEC ELLES 
DU MATÉRIEL (MÉDICAL/CHIRURGICAL) POUR UNE 
CÉSARIENNE ? 
  
56 LA MAJORITÉ DES PATIENTES PAYENT A L’HÔPITAL UN 
TARIF FIXE POUR L’ACCOUCHEMENT ? 
  
57 SI « OUI » A LA QUESTION PRÉCÉDENTE, LE TARIF EST-IL 
PLUS ÉLEVÉ POUR UNE CÉSARIENNE ? 
  
58 SI « OUI » À LA QUESTION PRÉCÉDENTE, LA CÉSARIENNE 
EST-ELLE EFFECTUÉE AVANT LE PAIEMENT DU TARIF 
HOSPITALIER ? 
  
59 EXISTE-T-IL UN SERVICE SOCIAL DANS L’HÔPITAL QUI 
PREND EN COMPTE LES INDIGENTS OU LES PLUS 
PAUVRES ? 
  
Formation continue et protocoles de soins 
 
 
LES RESSOURCES SUIVANTES SONT-ELLES DISPONIBLES AU SEIN 
DE L’ÉTABLISSEMENT ? 
 
Cocher pour chaque item 
 
60 BIBLIOTHÈQUE MÉDICALE   
61 ORDINATEUR AVEC ACCÈS INTERNET   
62 PROGRAMME DE FORMATION CONTINUE DU 
PERSONNEL 
  
63 SI « OUI », S’AGIT-IL D’UN PROGRAMME ÉLABORÉ PAR 
LE MINISTÈRE DE LA SANTÉ DE VOTRE PAYS ? 
Oui  
Si « NON », préciser quelle organisation a élaboré ce programme : 
64 BASE DE DONNÉES SUR LA LITTÉRATURE MÉDICALE 
CONCERNANT LA SANTÉ REPRODUCTIVE (OMS, Cochrane)  
 
Non 
65 PROTOCOLES DE SOINS PRÉNATALS  
Non 
66 PROTOCOLES DE SOINS INTRA-PARTUM  
Non 
67 PROTOCOLES DE SOINS POST-PARTUM  
Non 
68 PROTOCOLES DE SOINS NÉONATALS  
Non 
69 AUTRES PROTOCOLES DE SOINS MÉDICAUX OU INFIRMIERS  
Non 
 xxiii 
 
Système d’information 
 
Au niveau de cet établissement les informations concernant les patients sont-elles systématiquement 
enregistrées sur les supports suivants ?         
70 REGISTRE DES ACCOUCHEMENTS   
71 REGISTRE DES DECES MATERNELS    
72 REGISTRE DES DECES PERINATALS   
73 REGISTRE DES PATIENTES RÉFÉRÉES EN URGENCE  PAR 
D’AUTRES STRUCTURES DE SANTÉ 
  
74 REGISTRE DES PATIENTES EVACUEES VERS D’AUTRES 
STRUCTURE DE SANTÉ 
  
75 REGISTRE DES URGENCES 1 Oui  
76 REGISTRE DES ADMISSIONS (PATIENTS HOSPITALISÉS)   
77 REGISTRE DE LA MORGUE   
78 REGISTRE D’ÉTAT CIVIL   
79 DOSSIERS CLINIQUES    
Autre information complémentaire 
 
Au niveau de cet établissement, les examens complémentaires suivants sont-ils disponibles ?  
80 TEST ALPHA-FOETO-PROTEINE (dépistage des malformations fœtales)   
81 COLPOSCOPIE (dépistage des cancers du col de l’utérus)    
72 DOSAGE CD4 (prise en charge des patientes HIV+)   
73 DOSAGE DE CHARGE VIRALE  (prise en charge des patientes HIV+)   
 
 Appendix 3- QUARITE Patient Data Sheet 
 
 Appendix 4 : Copies of the Ethics’ Certificates 
Ethics’ certificates were obtained in Canada, Mali, and Senegal for the entire QUARITE 
programme, including the principal elements of this study.  
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Appendix 5: Pilot CBCA questionnaire  
Identification :Remplir toutes les sections ci-dessous  
Pays________________________________________________ 
 
Structure de santé_______________________________________ 
 
Numéro d’enregistrement_________________________________ 
 
Date d’admission_______________________________________ 
 
Initiales de la patiente______________________________________ 
 
Age de la patiente_______________________________________ 
 
POUR TOUTES FEMMES- LE REMPLISSAGE DU DOSSIER 
1) Remplissage du dossier médical : 
Cochez si cette section du dossier patient est remplie : 
État de la mère à l’arrivée    □OUI   □NON 
Date d’accouchement     □OUI   □NON 
Nom de la personne qui a accouchée la parturiente  □OUI   □NON 
Date de sortie                  □OUI   □NON 
État de la mère à la sortie     □OUI   □NON 
État de l’enfant à la sortie    □OUI   □NON 
 
A) Le partogramme de la patiente, est-il disponible (cochez la réponse)? 
□OUI   □NON 
2) État physique et histoire de la patiente : 
Cochez si cette section du dossier patient est remplie. Si oui, écrivez l’information donnée 
dans le dossier patient sur la ligne fournie.  
d) Nombre de CPN □OUI ________________  □NON 
e) Gestité   □OUI ________________  □NON 
f) Parité   □OUI ________________  □NON 
g) Pouls    □OUI ________________  □NON 
h) Pression artérielle  □OUI ________________  □NON 
i) Température  □OUI ________________  □NON 
j) État de conscience □OUI ________________  □NON 
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Cochez si cette section du dossier patient est remplie. 
k) Groupe sanguin?     □OUI  □NON  
l) Facteur rhésus?     □OUI  □NON 
m) Antécédents obstétricaux?   □OUI  □NON 
 
 
POUR TOUTES FEMMES- PARTOGRAMME  
3) Est-ce que les informations suivantes sont indiquées sur le partogramme? 
Cochez la réponse appropriée. Si oui, écrivez l’information donnée dans le dossier patient 
sur la ligne fournie. 
a) L’heure du premier examen?    □OUI  □NON 
Heure?___________________ 
b) L’heure d’expulsion?      □OUI  □NON 
Heure?___________________ 
c) La présentation foétale?     □OUI  □NON 
___________________________________ 
d) L’état des membranes?      □OUI  □NON 
___________________________________ 
e) Coloration du liquide amniotique?   □OUI  □NON 
___________________________________ 
f) Fréquence des contractions utérines?     □OUI  □NON 
___________________________________ 
g) Médicaments prescrits?     □OUI  □NON 
___________________________________ 
h) Ligne alerte franchie?                                        □OUI  □NON 
___________________________________ 
i) Ligne action franchie?                                       □OUI  □NON 
___________________________________ 
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POUR TOUTES FEMMES- TRAITEMENT PENDANT L’ACCOUCHEMENT 
 
4) Accouchement assisté par une personne qualifiée (médecin, infirmier, sage-femme)? 
       □OUI  □NON 
 
5) Ocytociques prophylactiques fournis à la femme en postpartum? 
□OUI  □NON 
POUR TOUTES FEMMES- SUIVI  
 
6) Est-ce qu’il y avait un suivi à 2 heures après l’accouchement? 
□OUI  □NON 
7) Est-ce qu’il y avait un examen de sortie? 
□OUI  □NON 
 
POUR LES FEMMES AYANT RECU UNE CÉSARIENNE 
1) Est-ce qu’une césarien a été effectuée ?  □OUI  □NON 
 
2) Indication pour la césarien a été effectuée est-elle fournie dans le dossier patient?  
      □OUI  □NON 
 
a. Indiquez si la césarien a été effectuée pour une des raisons suivants (cochez la 
réponse appropriée) 
Placenta prævia     □OUI   
Hématome retro-placentaire   □OUI   
Hémorragie post-partum   □OUI   
(Pré) Rupture-utérine     □OUI   
Présentation transversale   □OUI   
Présentation du front    □OUI   
Disproportion fœto-pelvienne   □OUI   
Autre                                                                □OUI préciser :………..                          
 
 xxxi 
 
3) Quel était le délai entre la décision de faire la césarien et la réalisation de la césarien 
(indiquez la réponse en heures et minutes)? 
_________________________________________ 
 
4) Est-ce qu’une prophylaxie antibiotique pour la césarien a été donnée (soit ampicilline ou 
céphalosporine de première génération)? 
□OUI  □NON 
 
POUR LES FEMMES AVEC UNE ÉCLAMPSIE 
  
1) Est-ce que la femme a eu une éclampsie ?    □OUI              □NON 
 
2) Est-ce que le sulfate de magnésium a été administré? 
□OUI  □NON 
3) Cochez si les analyses suivantes ont été effectuées ou non.  
Temps de saignement     □OUI  □NON 
Temps de coagulation     □OUI  □NON 
Numération plaquettaire    □OUI  □NON  
Test d’albumine     □OUI  □NON 
 
POUR LES FEMMES AVEC UNE HÉMORRAGIE 
 
1) Est-ce que la femme a eu une hémorragie ?  □OUI             □NON 
 
2) Est-ce que la surveillance clinique (pouls et pressure artérielle) a été effectuée chaque 
15 minutes pour 2 heures après le diagnostic? 
□OUI  □NON 
3) Est-ce que les ocytociques ont été utilisés ? 
       □OUI  □NON 
 3) Cochez si les analyses suivantes ont été effectuées ou non.  
Temps de saignement     □OUI  □NON 
 Temps de coagulation     □OUI  □NON 
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 Numération plaquettaire  □OUI  □NON  
 Test d’albumine   □OUI  □NON 
 
POUR LES FEMMES SEROPOSITIVES  
 
1) Est-ce que la femme est seropositive?   □OUI              □NON 
 
2) Est-ce qu’une prophylaxie antirétrovirale a été administrée à la mère avant et pendant 
l’accouchement (soit AZT ou NVP)?  
□OUI  □NON 
 
3) Est-ce qu’une prophylaxie antirétrovirale a été administrée à l’enfant après l’accouchement (soit 
AZT ou NVP)?      □OUI  □NON 
 Appendix 6: Cross-tables of inter-rater agreement for select criteria 
 
Cross tables for select Senegal data: 
1) Mother’s condition at exit 
 Auditor 2 
Absent Present 
Auditor 1  Absent 55 2 
Present 23 16 
 
2) Child’s condition at exit 
 Auditor 2 
Absent Present 
Auditor 1 Absent 82 4 
Present 4 6 
 
3) Parity 
 Auditor 2 
Absent Present 
Auditor 1 Absent 5 1 
Present 22 68 
 
4) Obstetrical antecedents 
 Auditor 2 
Absent Present 
Auditor 1 Absent 36 26 
Present 6 28 
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5) Assisted birth 
 Auditor 2 
Absent Qual ? Present 
Auditor 1 Absent 0 1 0 
Qual. ? 2 46 6 
Present 1 16 24 
Qual ? = qualification of the assistant unknown. 
 
6) Oxytocin 
 Auditor 2 
Absent Present 
Auditor 1 Absent 12 5 
Present 31 48 
 
7) Two-hour follow-up 
 Auditor 2 
Absent Time ? Present 
Auditor 1 Absent 34 16 1 
Time ? 20 15 2 
Present 1 0 7 
Time ?- There was a follow-up but the time was not given 
 
8) Colour Amniotic Fluid 
 Auditor 2 
Absent Present 
Auditor 1 Absent 5 4 
Present 4 9 
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9) Oxytocin for haemorrhage 
 Auditor 2 
Absent Present 
Auditor 1 Absent 1 2 
Present 3 6 
 
 
Cross tables for select Mali data: 
1) Condition of child at exit 
 Auditor 2 
Absent Present 
Auditor 1 Absent 70 4 
Present 10 5 
 
2) Number of prenatal visits 
 Auditor 2 
Absent Present 
Auditor 1 Absent 1 1 
Present 11 76 
 
3) Blood Pressure 
 Auditor 2 
Absent Present 
Auditor 1 Absent 3 1 
Present 3 82 
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4) Obstetrical antecedents 
 Auditor 2 
Absent Present 
Auditor 1 Absent 1 20 
Present 0 68 
 
5) Two-hour follow-up 
 Auditor 2 
Absent Time ? Present 
Auditor 1 Absent 2 3 0 
Time ? 4 0 1 
Present 6 20 53 
Time ?- There was a follow-up but the time was not given 
 
6)  Frequency of uterine contractions 
 Auditor 2 
Absent Present 
Auditor 1 Absent 1 0 
Present 4 56 
 
7) Magnesium sulphate for eclampsia 
 Auditor 2 
Absent Present 
Auditor 1 Absent 9 2 
Present 1 1 
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8) Albumin for eclampsia 
 Auditor 2 
Absent Present 
Auditor 1 Absent 4 8 
Present 0 1 
 
9) Complete blood count for haemorrhage 
 Auditor 2 
Absent Present 
Auditor 1 Absent 6 1 
Present 2 0 
 
 Appendix 7 – Lexicon of commonly used abbreviations 
 
Lexique- souvent nous trouvons des abréviations en lieu des termes entiers dans les dossiers 
patients. Afin de mieux comprendre le contenu des dossiers, ci-dessous une liste des abréviations et 
termes communs et utiles pour le remplissage de l’audit clinique. 
  
1) Termes liés à l’état de la mère à l’entrée et la sortie 
a. ABEG- assez bon état général 
b. Altération – état intermédiaire ou en détérioration 
c. BEG- bon état général 
d. EGP– mauvais état 
e. Inconsciente/obnubilée 
2) Termes liés à l’état de l’enfant à la sortie  
a. vivant,  
b. mortinaissance (mort-né) frais ou macéré 
3) G- Gestité  
4) P- Parité-  
a. Note- souvent on voit G et P ensemble. Par exemple 2G2P. 
5) π- Pouls  
6) TA- Pression (tension) artérielle 
7) To - Température 
8) ATCD- Antécédents obstétricaux  
9) Présentation fœtale 
a. Transversale 
b. Longitudinal : Siège, céphalique (face, sommet, front) 
c. Vicieux (une présentation qui n’est pas céphalique) 
10) État des membranes 
a. R= rompus  
b. I=intacte 
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11) Coloration de liquide amniotique  
a. C ou CL=claire  
b. T = teinté  
c. M =marron  
d. V = verdâtre 
e. S = sanguinolent 
12) Médicaments prescrits 
a. Aldomet- hypertension 
b. Ampi – ampicilline, antibiotique 
c. Augmentin – antibiotique injectable (en perfusion) 
d. AZT – zidovudine, antirétroviraux 
e. Catapressan- l’hypertension 
f. Curam – antibiotique 
g. Diazapam – anti-convulsivant 
h. Loxen- hypertension 
i. Hydralazine/ apresoline- hypertension 
j. Meth- methergine; pour la prévention de l’hémorragie post-partum 
k. Methyldopa- hypertension 
l. Nifedi Denk- hypertention 
m. NVP – nivirapine/ viramune; antirétroviraux 
n. Oxytocine/Uniject- prévention de l’hémorragie postpartum 
o. Oxacillin – antibiotique 
p. Perfalgan – antalgique et antipyrétique (baisse la fièvre, en perfusion) 
q. SGI – serum glucose isotonique 
r. SM-sulfate de magnésium 
s. Spasfon – anti-spasmatique 
t. SSI – serum salé isotonique 
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u. Synto- syntocinon pour la prévention de l’hémorragie post-partum 
v. Trabar- antalgique 
w. Valium- anti-convulsivant 
13) Exéat- examen de sortie  
14) Certaines complications 
a. DFP- Disproportion foeto-pelvienne 
b. Éclampsie / toxémie 
c. HRP- Hématome retro-placentaire  
d. HPP- Hémorragie post-partum  
e. HTA- hypertension 
f. PP- Placentia praevia  
g. Présentation transversale 
h. Présentation du front 
i. RU- Rupture utérine ET révision utérine dépendamment du contexte 
15) Analyses laboratoires 
a. NFS- Numération plaquettaire 
b. TCA/TCK- Temps de saignement, cette information est donnée en seconds 
c. TQ/TP- Temps de coagulation, cette information est donnée en pourcentage 
d. Alb- Test d’albumine  
16) Autres abréviations utiles  
1) CBT- césarienne 
2) CU- contraction utérine 
3) DAP- douleurs abdominaux pelviens 
4) HU- hauteur utérine 
5) MN- mort né 
6) OMI- œdème des membres inferieurs 
7) PDE- poche des eaux 
8) RAS- rien à signaler 
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9) RPM- rupture prématuré des membranes 
10) SA- semaines 
11) SFA- souffrance fœtale aigue 
12) SFC- souffrance fœtale chronique 
13) TV – touché vaginale 
14) TVV – toilette vaginale vulvaire 
15) VBP- (en référence aux enfants) vivant bien portant 
16) VPA- visite pré-anesthésique 
 Appendix 8: Modifications to the piloted CBCA questionnaire with 
revised and annotated questionnaire 
 
Here we discuss the changes made to the CBCA questionnaire based on its application to a 
development sample during the pilot study. At the end of this appendix, we show all of the 
modifications made to the questionnaire in red. We also have included comments in the 
margins describing alterations made to the computer program containing this questionnaire.  
 
Clarifications: Most of the clarifications to the questionnaire involved language 
modifications that aim to reduce ambiguity. For example, we have changed the criterion, 
“Is the patient’s partograph available” to, “Is the patient’s partograph available in the 
medical record?” We have also tried to clarify possible temporal ambiguities. For example, 
we twice ask if pulse, blood pressure, and temperature were taken. The first time, we ask if 
these measures were taken during the first clinical examination; the second time, we ask if 
these measures were taken during the monitoring of the labour and not during the first 
examination. Finally, for questions related to medications we have put in parentheses the 
names of acceptable medications, as there are often several names for the same medication. 
Similarly, for laboratory tests, we have put the common abbreviations used for the test next 
to the name of the test itself.  
 
In addition to language modifications, we made some changes to the format of the 
questionnaire to improve the quality of data recording. These modifications aim at 
increasing information while reducing inter-rater variability. For example, for the criteria, 
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“Condition of the mother at entry” the auditor can chose from five radio buttons in 
electronic questionnaire (good general condition, fair general condition, deteriorating 
condition, poor condition, and condition not given). Similarly, for the criterion, “Was the 
birth supervised by a qualified attendant?” the auditor can choose from the following 
options: no, doctor, midwife, interne, nurse, or accompanied but unknown qualification. 
This question format (with radio buttons) was repeated for several other criteria (see 
appendix 3). Finally, for the criterion, “was the name of the person who assisted the birth 
given,” the auditor is required to write down the name of this person. This information will 
be used to verify the qualification of the person who assisted the birth, but to assure staff 
confidentiality
24
, it will be erased from the database once this verification has occurred.  
 
Deletions:We deleted the following criteria from the CBCA questionnaire: 1) Was the level 
consciousness given (clinical history); 2) Were obstetrical antecedents given (clinical 
history); 3) Was the condition of the mother at exit given (completeness of record); 4) Was 
the condition of the newborn at exit given (completeness of record); 5) Was the alert line 
crossed (partograph section); 6) Was the action line crossed (partograph section); 7) Were 
prescribed medications noted (partograph section); 8) Was albumin tested (haemorrhage 
section).  
 
For the first criterion (level of consciousness), there was near perfect correlation with the 
criterion, condition of the mother at entry. Correlation in Mali was 1.00 and 0.99 in 
Senegal. Inclusion of level of consciousness gave us no additional information. The 
                                                          
24
 For all study sites, the QUARITE study keeps an updated list of all staff and their professional 
qualifications.  
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criterion on obstetrical antecedents had too much inter-rater variability and was not 
applicable to all women (see table 2). The Kappa statistic in Senegal was 0.357 and in Mali, 
it was 0.07. In regards to the criteria on the condition of the mother and child at exit, this 
information was rarely recorded in the medical record. With the exception of the condition 
of the mother at exit in Mali, these criteria were met 20% of the time or less. In Mali, the 
condition of the mother at exit was met 40% of the time. When these criteria were met, the 
agreement was fair to low (Kappa of 0.66 or below). We also deleted several questions 
under the partograph section (the monitoring of labour section in the revised questionnaire): 
Was the alert line crossed? Was the action line crossed? Were prescribed medications 
noted? We deleted these criteria because they were not applicable to all women receiving a 
partograph. That is, only women with obstructed labour will cross the alert and action lines 
of the partograph and not all women will be prescribed medications. Finally, under the 
haemorrhage section, we deleted the criterion was albumin tested because not testing for 
albumin does not indicate inadequate quality of care.  
 
Additions:We added twelve new criteria to the revised CBCA questionnaire. These 
included: 1) Was the uterine height recorded (first clinical examination section); 2) Was the 
foetal heart rate taken (first clinical examination section); 3) Were tests for HIV and 
syphilis performed (laboratory tests section);  4) Was the time of the deliverance of the 
placenta noted (delivery section); 5) Was the time of birth noted (delivery section); 6) Was 
the date of exit given (follow-up after birth section); 7) Was the condition of the newborn 
noted (follow-up after birth section); 8) Was the APGAR score for the newborn given 
(follow-up after birth section); 9) Was blood pressure taken every four hours after giving 
birth (eclampsia section); 10) Was the urinary flow measured one time in the 24 hours 
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following the birth (eclampsia section); 11) Was the placenta cleared (PPH section); and 
12) Is the woman already taking antiretrovirals (HIV section section). With these additions, 
there are more criteria related to the technical competence of staff, which was previously 
under-represented.  
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CBCA QUESTIONNAIRE USED IN FULL DATA COLLECTION 
IDENTIFICATION 
Remplir toutes les sections ci-dessous 
 
Pays____________________________________________________ 
 
Structure de santé__________________________________________ 
 
Numéro d’enregistrement____________________________________ 
 
Date d’admission__________________________________________ 
 
Heure d’admission_________________________________________ 
 
Initiales de la patiente______________________________________ 
 
Age de la patiente_______________________________________ 
 
 
POUR TOUTES FEMMES- INTERROGATOIRE INITIAL 
Sélectionnez une des options ci-dessous. Si l'information n'est pas disponible, sélectionnez 
non. Si oui, préciser l’information. 
 
1) État de la mère à l'admission (Non, Oui-BEG, Oui-ABEG, Oui-Altération de l'état, Oui-
Mauvais état général) 
 
2) Nombre de CPN  □OUI________________□NON 
3) Gestité   □OUI________________□NON 
4) Parité   □OUI________________□NON 
 
POUR TOUTES FEMMES- PREMIER EXAMEN CLINIQUE 
 
Ces questions s'appliquent aux informations disponibles lors du premier examen. Cochez 
oui si l’information est disponible dans le dossier médical, non si l’information n’est pas 
disponible. Si oui, préciser l’information. 
 
5) L'heure du premier examen □OUI  _______________ □NON 
6) La hauteur utérine   □OUI________________□NON 
7) Le pouls     □OUI________________□NON 
8) La pression artérielle   □OUI________________□NON 
9) La température   □OUI________________□NON 
10) La présentation fœtale  □OUI________________□NON       
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11) Les bruits du cœur fœtal      □OUI □NON 
12) L’état des membranes ou la couleur du liquide amniotique □OUI□NON 
13) Le dégrée de dilatation du col utérin     □OUI□NON 
  
 
POUR TOUTES FEMMES- EXAMENS DE LABORATOIRE 
 
Cochez oui si le résultat de laboratoire est disponible ou inscrit dans le dossier médical, 
non si l’information n’est pas disponible 
14) Groupe sanguin?        □OUI□NON 
15) Facteur rhésus?       □OUI□NON 
16) Dépistage VIH       □OUI□NON 
17) Dépistage syphilis      □OUI□NON 
 
POUR TOUTES FEMMES- SUIVI DU TRAVAIL 
 
Les questions 18 à 21 s'appliquent au suivi du travail et non pas au premier examen. On 
applique ces questions seulement aux femmes avec un suivi minimal de 4 heures. Cochez 
oui si l'information est disponible dans le dossier médical, non si l’information n’est pas 
disponible. 
 
18) Le partogramme de la patiente, est-il disponible dans le dossier médical ?  
          
 □OUI□NON 
 
19) La fréquence des contractions utérines ont-elles été évaluées au moins une fois par 
heure?           
 □OUI□NON 
 
20) L’heure du premier examen de la phase active a-t-elle été notée? □OUI□NON 
 
21) Pendant le suivi du travail (après l'examen initial), est-ce que les évaluations cliniques 
suivantes a été effectuées? 
A. Pouls       □OUI□NON 
B. Pression artérielle     □OUI□NON 
C. Température     □OUI□NON 
D. Bruits du cœur fœtal    □OUI□NON 
E. Le dégrée de dilatation du col utérin   □OUI□NON 
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POUR TOUTES FEMMES-ACCOUCHEMENT 
Toutes ces questions s'appliquent au moment de l'accouchement. Cochez oui si 
l'information est disponible dans le dossier médical, non si l’information n’est pas 
disponible. 
 
22) Nom de la personne qui a pratiqué l’accouchement  □OUI□NON 
Préciser nom et prénom:  _________________ 
23) L'heure de la délivrance (expulsion du placenta) ?   □OUI□NON 
 
Sélectionnez une des options ci-dessous. Si l'information n'est pas disponible, sélectionnez 
non. 
 
24) Accouchement assisté par une personne qualifiée (non, oui-médecin, oui-sage femme, 
oui-interne ou oui-DES, oui- infirmier, assisté mais qualification inconnue). 
 
25) Un bolus d'oxytocine (syntocinon) a-t-il été administré par voie parentérale (voie 
intramusculaire ou  intraveineuse) à la femme au cours de l’expulsion ou immédiatement 
après l’expulsion?  
□OUI GAPTA       □Oui-oxytocine seulement       □NON 
 
26) Date de l’accouchement   □OUI□NON 
27) L’heure de l’accouchement □OUI□NON _____________ 
 
POUR TOUTES FEMMES- SUIVI APRÈS L'ACCOUCHEMENT  
 
Cochez oui si l’information est disponible dans le dossier médical, non si l’information 
n’est pas disponible. 
 
28) Est-ce qu’il y avait un suivi (hauteur du fond utérin et au moins un signe vital évalué) 
de la femme? 
a. pendant les deux heures qui ont suivi l’accouchement 
b. après deux heures mais moins de quatre heures après l’accouchement 
c. après les quatre heures qui ont suivi l’accouchement 
d. pas de suivi noté dans le dossier médical 
 
 
29) Un examen de sortie de la femme (avant de quitter l’hôpital) à-t-il été effectué et noté 
dans le dossier médical?      □OUI□NON 
 
30) La date de sortie a-t-elle été notée?    □OUI□NON 
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31) L’état du nouveau né a-t-il été noté? 
e. Non 
f. Nouveau né vivant bien portant 
g. Nouveau né vivant avec souffrance 
h. Enfant mort-né 
 
32) Le score d’Apgar a-t-il été noté ? 
Score à 1 minute      □OUI□NON 
Score à 5 minutes      □OUI□NON 
 
 
POUR LES FEMMES AYANT EU UNE CÉSARIENNE 
Est-ce qu’une césarienne a été effectuée?         □OUI□NON 
 
33) L’indication de la césarienne a-t-été notée dans le dossier médical?□OUI□NON 
 
33a) Indiquez si la césarienne a été effectuée pour une des raisons suivants (cochez la 
réponse appropriée, selon l’information noté dans le dossier) 
Placenta prævia     □OUI 
Hématome retro-placentaire (HRP)   □OUI 
Utérus cicatriciel     □OUI 
Pré rupture utérine Rupture-utérine    □OUI 
Pré-éclampsie/ Eclampsie    □OUI 
Présentation transverse ou siège   □OUI 
Présentation du front ou face    □OUI 
Disproportion fœto-pelvienne(DFP)   □OUI 
Autre                                                                     □OUI , préciser:………..                             
 
34) Inscrivez l'heure de la décision de faire une césarienne. _____________________ 
 
35) Inscrivez l'heure de la réalisation (extraction du bébé) de la césarienne._____________ 
 
36) Des antibiotiques (e.g. Ampicilline, Curam, Oxacillin, Ceftriaxone) ont-ils été 
administrés par voie parentérale (intraveineuse ou intramusculaire) pendant la césarienne? 
   □OUI□NON   
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POUR LES FEMMES AVEC UNE ÉCLAMPSIE 
  
Est-ce que la femme a eu une éclampsie?    □OUI□NON 
 
37) Est-ce qu'un anticonvulsivant a été administré? 
□OUI, sulphate de magnesium      □OUI, Diazapam/Valium       □NON 
 
38) Est-ce que la tension artérielle a été mesurée et notée toutes les  heures pendant 4 
heures après l'accouchement?      
 □OUI□NON 
 
39) Est-ce que le débit urinaire a été mesuré au moins une fois pendant 24 heures après 
l'accouchement?        □OUI□NON 
 
40) Cochez si les analyses suivantes ont été effectuées ou non. 
Temps de saignement (TCA/TCK)    □OUI□NON 
Taux de coagulation (TQ/TP)    □OUI□NON 
Numération plaquettaire (NFS)    □OUI□NON 
Test d’albumine (Proteinurie à la Bandelette)  □OUI□NON 
 
POUR LES FEMMES AVEC UNE HÉMORRAGIE DU POST-PARTUM 
 
Est-ce que la femme a eu une hémorragie?    □OUI □NON 
 
41) Est-ce que la surveillance clinique (pouls et pression artérielle) a été effectuée chaque 
15 minutes pendant 2 heures après le diagnostic? 
□OUI□NON 
42) Est-ce qu’un bolus d'oxytocine (Syntocinon IV) ou d’ergometrine (Méthergin IM) a été 
administré?        □OUI□NON 
 
43) Est-ce qu’une perfusion d'ocytocine (Syntocinon) a été administré par voie 
intraveineuse         
 □OUI□NON 
44) Le placenta a-t-il été évacué?   □OUI, spontanément      □ OUI manuellement     
□NON 
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45) Cochez si les analyses suivantes ont été effectuées ou non. 
Temps de saignement (TCA/TCK)    □OUI□NON 
Taux de coagulation (TQ/TP)    □OUI□NON 
Numération plaquettaire (NFS)    □OUI□NON 
 
 
POUR LES FEMMES SÉROPOSITIVES 
 
Est-ce que la femme est seropositive?    □OUI□NON 
 
46) Est-ce que la femme prend déjà (avant d'être enceinte) un traitement antirétroviral ?  
         □OUI□NON 
 
47) Est-ce qu’une prophylaxie antirétrovirale a été administrée à la mère avant et pendant le 
travail (soit avec AZT ou NVP)? 
□OUI□NON 
 
48) Est-ce qu’une prophylaxie antirétrovirale a été administrée à l’enfant après 
l’accouchement (soit avec AZT ou NVP)? 
□OUI□NON 
 
 Appendix 9: Final suggestions to improve the CBCA questionnaire 
 
In the chapter on the pilot study, we discussed lessons learned from applying the CBCA 
questionnaire to a development sample. Based on these lessons, we modified the sampling 
method and revised the questionnaire. In 2010-11, we took these lessons to the field and 
applied the questionnaire to a larger sample of patients and hospitals. After the completion 
of data collection, we presented initial results to partners in Mali for feedback
25
.  
 
As with any new method, there is always room for improvement. Here, we discuss 
modifications that would improve the questionnaire should it be used in the future. We 
provide explanations to assist in CBCA questionnaire interpretation and propose final 
modifications to the questionnaire. 
 
Final revisions to CBCA questionnaire and comments for interpretation 
Table 1 presents a short list of comments about and modifications to select CBCA criteria. 
Minor revisions are suggested to improve the questionnaire.  
 
                                                          
25
 Due to financial limitations, we were only able to conduct one feedback session in one country. We chose 
Mali because data collection finished in this country and because health professionals had expressed an 
interest in applying the CBCA audit in their health centres. 
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Table 1: Comments about and suggested modifications to select criteria in CBCA questionnaire 
Criterion Comment Modifications 
Age 
(identification 
section) 
Age was not available for a small minority of women in the sample. It may be a sensitive 
indicator of quality of care as we know that women at the extremes of reproductive age are 
at higher risk of complication and death (39, 165). It is also rudimentary information 
expected to be present in all records (along with the patient’s name and address). 
Make age a criterion in the 
CBCA questionnaire. 
Therefore, move it from the 
identification section of the 
questionnaire to the initial 
discussion section of 
questionnaire. 
Condition of 
the mother at 
arrival (in the 
section on the 
initial 
discussion 
with patient) 
Many records, particularly those found at district hospitals in Mali, followed a checklist-
style format. Hospital personnel check-off if certain examinations and tests that have been 
conducted on the obstetrical patient and frequently do not write down additional 
information about the patient. Because the checklist does not contain a question on the 
condition of the mother at arrival, this information is rarely recorded. However, records 
which contain spaces for written notes almost always contain information about the 
condition of the mother; although, this information is not always recorded for the woman 
at admission (e.g. it is recorded during later examinations possibly because some admitting 
staff are not sufficiently medically qualified to make such a judgement). 
Not applicable 
Time of first 
clinical 
This information was inconsistently recorded in Senegal. The standardized obstetrical 
forms (used mostly outside of Dakar) contained a space for recording the time of 
Because recording of the 
time of the first clinical 
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examination 
(clinical 
examination 
section) 
admission of the patient but not for recording the time of the first clinical examination.  
There were, however, spaces to record the names of the person who admitted the woman 
and the person who conducted the first clinical examination. Often these names were 
different, which indicated that the time of admission did not correspond with the time of 
first clinical examination. In Mali, in contrast, there were spaces in the standardized 
obstetrical forms to record the time of the first clinical examination and this information 
was almost always recorded.  
examination is not an actual 
clinical measure and because 
obstetrical forms in Senegal 
did not obligate recording of 
this information, we felt that 
for the sake of consistency 
between the two countries, it 
was best to remove the 
criterion from the 
questionnaire. 
HIV and 
syphilis results 
(laboratory 
section) 
In both countries, HIV and syphilis results were rarely recorded in the obstetrical records. 
There may be a variety of explanations for this, but one that informants frequently cited 
was that this information is found in the prenatal booklet and thus, does not need to be 
recorded in the obstetrical records. However, on most standardized obstetrical records in 
both countries, there were recording spaces for HIV and syphilis results, as well as blood 
type and rhesus factor. This indicates that this information is supposed to be transferred to 
the obstetrical records. Further, discussions with several staff running HIV programs in 
Mali indicated that during the year of data collection, there were frequent stock-outs of 
HIV rapid-tests (Determine), which may also explain the low numbers recorded test 
results.  
Not applicable 
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Haemoglobin 
level 
(laboratory 
section) 
At the post-data collection meeting in Mali, participants pointed out that State guidelines 
require that haemoglobin levels for all women be assessed prior to delivery and recorded 
in the obstetrical dossier. They stressed the importance of this measure because anaemia is 
a significant public health concern for pregnant woman in Mali and increases the risk of 
complication and death associated with haemorrhage. Haemoglobin results are also 
supposed to be recorded on the standardized obstetrical forms in Senegal. 
Add this criteria to the 
laboratory section 
Frequency of 
contractions 
(monitoring 
during labour 
section) 
This question needs a slight clarification. It should read, “Was the 
frequency of uterine 
contractions measured every 
hour during the active phase 
of labour.” The addition is 
italicized.  
Time of the 
first 
examination of 
active phase of 
labour 
(monitoring 
during labour) 
This criterion is confusing and there is too much variability in terms of when women 
arrive at the hospital. The question is confusing because the active phase of labour starts 
earlier for primipares than multipares. Further, if a woman arrives during the active phase 
of labour, then her first examination automatically occurs during the active phase of 
labour. However, if the woman arrives during the latent phase of labour, the first 
examination during the active phase of labour may occur at a variety of moments from 4 
cm, to at birth, or not all. 
Remove question 
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Time of the 
expulsion of 
the placenta  
(delivery and 
birth section) 
This information was rarely recorded in Senegal but frequently recorded in Mali. In Mali, 
the checklist-style obstetrical records contained a question asking for the time of the 
placental expulsion. In Senegal, this information was almost only recorded if the woman 
had a caesarean section.  
Not applicable 
Name and 
qualification 
of the birth 
attendant 
(delivery and 
birth section) 
This information was rarely recorded in Senegal but frequently recorded in Mali. In Mali, 
the checklist-style obstetrical record contained a question asking for the qualification of 
the birth attendant. In Senegal, if the name and qualification of the attendant was recorded, 
it was generally because the woman gave birth by caesarean section and thus required a 
medical doctor. Nevertheless, according to State guidelines, the name of the person who 
assisted the birth is supposed to be recorded in Senegal. 
Not applicable 
Was there 
monitoring of 
the woman 
after birth 
(follow-up 
section) 
In Senegal, many women received follow-up examinations 24 or more hours after giving 
birth. Most severe post-partum complications, such as post-partum haemorrhage would 
have occurred within the first four hours after birth (145). Such late monitoring is nearly 
the same as no monitoring at all.  
Option C of the drop-down 
menu should be modified to 
read, “between four and 
twenty-four hours after 
birth.” Option D should be 
modified to read, “late 
follow-up (>24 hours) or no 
follow-up after birth.” 
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Caesarean 
section 
We continued to encounter problems with questions in this section. The indication for 
caesarean section was consistently recorded but all other criteria in this section were not. 
We believe that operating notes were often: not taken, not transferred/attached to the 
obstetrical records, or partially transferred/ attached to the obstetrical records. At all sites, 
we made concerted efforts to obtain operating notes but in sites without a gynaecologist, 
staff who conduct caesarean sections are not attached to the maternity and thus had little 
awareness of QUARITE. Because they were not a part of the trial, their records were often 
not archived and/or they were unwilling to share these records. 
Retain the question on 
whether a woman had a 
caesarean section and its 
indication for analyses 
purposes. Remove other 
criteria from the 
questionnaire.  
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Presented below in Table 5 is a list of discretionary modifications to the questionnaire. We 
consider these modifications discretionary because they are not necessary to assure the 
content validity of the questionnaire but may help the researcher obtain more detailed 
information about quality of care, depending on his/her particular goals.  
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Table 2: List of discretionary modifications to the CBCA questionnaire 
Criterion Suggested modification Explanation 
Was the foetal heart 
rate evaluated?  
(in the first clinical 
examination section) 
Create a multi-part question: 
Was the foetal heart rate evaluated? 
 □Yes     □No      
 
If yes, was the actual foetal heart rate 
recorded 
 □Yes     □No      
 
If yes, please record the foetal heart 
rate:_____/______ 
The presence or absence of the foetal heart rate was often the only 
information recorded. The actual foetal heart rate was not always 
provided and this information may be more informative for 
researchers interested in perinatal mortality. Sites that measured the 
actual heart rate versus simply its presence/absence may provide 
better quality of care because they can quantitatively assess foetal 
distress. Knowledge of the actual foetal heart rate can help 
researchers test specific hypotheses about the relationship between 
quality of care and stillbirths. For example, an important number or 
women with foetuses with healthy heart rates at first clinical 
examination and subsequent stillbirths would suggest insufficient 
patient monitoring and poor delivery practices (237). 
Dilation of the 
cervix  
(in the first clinical 
examination section) 
Create a multi-part question. 
Was the dilation of the cervix recorded? 
□Yes     □No      
Information on the dilation of the cervix may not be measured well. 
Often, it was measured in terms of the number of fingers which 
could fit into the dilated cervix (e.g. one finger or two fingers). This 
information is less precise than the number of centimetres of 
dilation. Further, there was an unrealistic number of women who 
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If yes, what was the measure? 
___cm or ___ fingers 
went from 2cm or 1 finger of dilation to birth in less than four 
hours. Because the CBCA questionnaire provides information on 
the time of admission and the time of birth, additional information 
about the dilation of the cervix at admission would help assess the 
number of women with unrealistic measures (a sign of poor quality 
of care). 
 
Medications Additional question (delivery and birth 
section) 
 
Were any medications, besides oxytocin, 
given during labour and delivery? 
 
If so, please record the names of the 
medications_______ 
In both Mali and Senegal, we witnessed the use of “cocktails,” 
which often involve a combination of Spasfon, oxytocin and other 
medications, to speed up labour. These cocktails may increase the 
chances of uterine rupture, especially in primiparous women and 
women with previous caesarean section.  One informant explained 
that midwives encourage women to accept the “quick labour” 
option (e.g. these cocktails) because midwives want to maximize 
the number of women who give birth during their rounds (and not 
during another midwife’s rounds). There is a complex gift economy 
in West Africa and midwives receive gifts, typically fabric, for 
assisting the birth of women. Researchers may be interested in 
recording the use of medications during labour and delivery to 
evaluate judiciousness of their administration. 
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APGAR (follow-up 
section) 
Record the actual APGAR scores at 1 and 5 
minutes in addition to asking if the APGAR 
had been recorded at these times. 
Researchers may not want to depend on qualitative evaluations of 
the newborn’s condition at birth, especially as these many not 
always be recorded. By recording the actual APGAR score at 1 and 
5 minutes, the researcher may be able to create additional outcome 
measures based on the APGAR scores and compare these with 
quality of care measures. For example, the researcher may 
hypothesize that centres with poor quality of care will have lower 
average APGAR scores at birth than those with better quality of 
care.  
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Conclusions 
Our results show that the pilot study allowed us to remove most ambiguity from the CBCA 
questionnaire. We have proposed some minor revisions (mostly deletions) to the 
questionnaire, as well as four discretionary revisions depending on the researcher’s specific 
goals. Many of the comments in table 2 point to the importance of context in interpreting 
the CBCA questionnaire. For example, Mali will likely have higher criterion attainment 
than Senegal because of the widespread use of a standardized, checklist-style obstetrical 
record. Because many criteria on our CBCA questionnaire, such as expulsion of the 
placenta or the qualification of the birth attendant, are expected entries in this standardized 
record, they are more likely to be recorded in Mali than Senegal. This information should 
be considered when comparing scores from the two countries, as lower quality of care 
scores in Senegal may better reflect the manner in which medical data are recorded than 
actual obstetrical practice. Nonetheless, good medical recordkeeping is, in of itself, an 
indication of good care (161). 
 
 
 
 
 Appendix 10: Summary of questions in the PMTCT questionnaire  
Question Scoring (points for each question) 
Training in PMTCT (5 questions) 
Received PMTCT training by government Yes = 1 ; No = 0  
Received PMTCT training by an organization 
other than the government 
Yes = 1; No = 0 
Who received this training Everyone in the maternity/ all midwives= 
1; Some midwives = 0 
Number of days of PMTCT training offered 
to hospital staff each year 
3+ days = 1; Less than 3 days = 0 
Times per year training was offered to 
hospital staff  
2+ times = 1; One time or less = 0 
Counseling (4 questions) 
Group educational session Yes = 1 ; No = 0 
Group counseling Yes = 1 ; No = 0 
Couples counseling Yes = 1 ; No = 0 
Who performs counseling Staff from Maternity/CPN = 1; Staff from 
elsewhere = 0 
HIV testing (3 questions) 
Location of testing Maternity/CPN = 1; Elsewhere = 0 
Type of test Rapid test = 1; Other/unknown test = 0 
Same day result Yes = 1 ; No = 0 
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Clinical Evaluation (3 questions) 
Height Mostly/always assessed = 1; All others: 0 
Weight Mostly/always assessed = 1; All others: 0 
Blood Pressure Mostly/always assessed = 1; All others: 0 
Laboratory Evaluation (6 questions) 
Blood count Mostly/always assessed = 1; All others: 0 
Syphilis Mostly/always assessed = 1; All others: 0 
Other STI Mostly/always assessed = 1; All others: 0 
Tuberculosis Mostly/always assessed = 1; All others: 0 
Malaria Mostly/always assessed = 1; All others: 0 
Parasites Mostly/always assessed = 1; All others: 0 
Treatment of the mother (6 questions) 
Correct antiretroviral prophylaxis for HIV 1 
detected during prenatal consultation or 
earlier 
State or WHO protocol= 1;  
Other protocol = 0 
Correct antiretroviral prophylaxis for HIV 2 
detected during prenatal consultation or 
earlier 
State or WHO protocol= 1;  
Other protocol = 0 
Correct antiretroviral prophylaxis for HIV 1 
detected during labour 
State or WHO protocol= 1;  
Other protocol = 0 
Correct antiretroviral prophylaxis for HIV 2 
detected during labour 
State or WHO protocol= 1;  
Other protocol = 0 
Who prescribes the antiretrovirals Maternity personnel = 1; Elsewhere = 0 
Where can patients obtain the antiretrovirals Maternity = 1; Elsewhere = 0 
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Laboratory monitoring of the mother (5 questions) 
CD4 count available Yes = 1; No = 0 
Knowledgeable of WHO/State CD4 threshold 
for putting a woman on treatment for her 
health 
Yes = 1; No = 0 
Viral load available Yes = 1; No = 0 
Monitors hemoglobin and removes AZT 
when woman is anemic 
Yes = 1; No = 0 
Monitors enzyme levels and removes NVP 
with liver toxicity 
Yes = 1; No = 0 
Treatment of newborn (4 questions) 
Correct antiretroviral treatment protocol for 
newborn 
State or WHO protocol= 1;  
Other protocol = 0 
Location of pediatric formulations Maternity/pediatric unit = 1; Other = 0 
Type of test for HIV antibodies PCR and/or antibodies = 1; Neither = 0 
Antiretroviral syrup Yes = 1; No = 0 
Follow-Up of Newborn (5 questions) 
Contrimoxazole Yes = 1; No = 0 
Growth monitoring Yes = 1; No = 0 
Vaccination Yes = 1; No = 0 
Who follows up on HIV positive newborns Midwife or pediatrician = 1; Other = 0 
Where are HIV positive newborns followed Maternity or pediatric unit =1; Other = 0 
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Complementary PMTCT nutritional services (4 questions) 
Nutritional group education session Yes = 1; No = 0 
Provision of food Yes = 1; No = 0 
Provision of milk Yes = 1; No = 0 
Other nutritional service Yes = 1; No = 0 
  
 
 
